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Abstract 
To compete in a market dominated by fossil fuels, biofuels must be economically competitive 
and also offer the variety of molecules and compounds which are currently derived from fossil 
fuels. This thesis offers potential strategies for biofuels to be both economically competitive and 
diverse. Effective and economical production of biofuels comes from the optimization of the 
biosynthetic pathway. We investigated and developed new combinatorial strategies for the 
optimization of the cellobiose utilization pathway, a pathway which is important in biofuel 
production. One strategy focused on optimizing enzyme combinations by creating a library of 
homologous proteins from the pathway. A second strategy investigated engineering all of the 
proteins in the pathway simultaneously. The improved pathway was assessed based on specific 
growth rate on cellobiose, with the final mutant exhibiting a 42% increase over the wild-type 
pathway. Metabolite analysis of the engineered pathway presented a 54% increase in cellobiose 
consumption (1.68 to 2.82 g cellobiose/(L·h)) and a 74% increase in ethanol productivity (0.59 
to 1.03 g ethanol/(L·h)). The second half of the thesis was focused on creating a biofuel molecule 
with more diverse applications than the commonly used bioethanol biofuel. A new pathway for 
biodiesel production was investigated, using a heterologous fatty acid synthesis pathway, which 
would provide a completely orthologous route for biodiesel production. In this strategy, the 
endogenous fatty acid flux would not be redirected from cellular metabolism. Through 
heterologous expression of a Type-I fatty acid synthase, the total production of fatty acid ethyl 
esters was increased 6.3-fold, from 1670 µg FAEE/ g CDW to 10,498 µg FAEE/ g CDW. The 
final work in the thesis surveyed three potential high-throughput screening methods to subject 
the biodiesel production pathway to the optimization strategies developed earlier in the thesis. 
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Chapter 1: Introduction
1
 
1.1 Sustainability 
 
The dwindling of natural resources is causing industries and governments to reconsider the 
design principles of many industrial processes. Sustainability has now become a major 
component in all sectors of industrial, governmental, and even societal agencies. Though the 
definition of sustainable development has been argued over the years, a standard definition has 
emerged as “. . . a process of change in which the exploitation of resources, the direction of 
investments, the orientation of technological development, and institutional change are all in 
harmony and enhance both current and future potential to meet human needs and aspirations. . . 
(It is) meeting the needs of the present without compromising the ability of future generations to 
meet their own needs” (1). 
 
1.1.1 Sustainable Development 
Sustainable development has been cited as the most difficult challenge that humanity has ever 
faced (1). To achieve sustainability, many fundamental and well-established processes at local, 
regional, and global levels must be reevaluated. Industrial sustainability will require a global 
vision that holistically considers economic, social, and environmental sustainability concerning 
more than just short-term profit margins, focusing instead on long-term investments. The most 
considerable challenge in this endeavor is that the sustainable product must be commercially 
                                                 
1
 Parts of this chapter have been published as: 
Eriksen, D.T. Chao, R. Zhao, H. (2013) “Applying Advanced DNA Assembly Methods For Library Generation” 
Wiley Biotech Series - Synthetic Biology. 3
rd
 Ed. (S.Y. Lee, J. Nielsen, G. Stephanopolous, Eds), In Press. 
Eriksen, D.T. Lian, J. Zhao, H. (2013) Protein Design for Pathway Engineering. Journal of Structural Biology. 
S1047-8477(13). 82-88.  
Eriksen, D.T. Li, S. Zhao, H. (2013)  “Pathway Engineering for Synthetic Biology Applications” Synthetic Biology: 
Tools and Applications. 2013. H. Zhao.  Academic Press, Elsevier, Waltham MA. ISBN: 978-0-12-394430-6 
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competitive with its non-sustainable counterpart, if the government does offer a subsidy or 
mandate. It must be cheaper, more durable, less toxic, and easily recyclable. These sustainable 
products need to be derived from renewable resources and contribute minimally to the net 
generation of greenhouse gases (1). These lofty aspirations may sound extreme, but the 
technologies to attain these goals are emerging. 
 
Many of these nascent technology fields are focusing on creating products derived from 
renewable resources such as trees and agricultural crops. An interesting discussion involves the 
life cycle of commodity chemicals such as dyes, solvents and synthetic fibers. At the beginning 
of the 20
th
 century, many of these chemicals were made from renewable sources like trees and 
agricultural crops. However, by the late 1960s, many of these bio-based chemical products had 
been replaced by petroleum derivatives, a non-renewable source (2). In recent decades, liquid 
petroleum consumption has increased dramatically for both commodity chemicals and energy. 
Currently, $24 billion worth of hydrocarbon feedstocks are used annually in the chemical 
industry (1). In recent years, there have been efforts considering ways to return to renewable 
sources for these chemicals; however the process for sustainable manufacturing of these 
commodity chemicals is very different from the early 20
th
 century.  
 
Though the chemical industry relies heavily on petroleum-based chemicals, the most significant 
use of petroleum is for energy. In 2011, the global consumption of petroleum reached 
87.42 million barrels each day (3). Furthermore, even though this number is startlingly high, 
experts predict the energy demand to grow by more than 50% by 2025 (2). The company British 
Petroleum (BP) has mapped energy consumption since 1986 and the trend illustrates an energy 
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demand increase at an alarming rate (Figure 1.1) (4). Due to this escalating global demand for 
more energy, it is imperative to identify sufficient resources to meet this demand. Recent efforts 
in tar sands, shale oil, shale gas, and natural gas have eased the current supply deficiencies. 
However, concern with large green-house has emission with the conversion of these resources 
and also the significant detrimental effects these sources have on the environment have spurred 
more sustainable strategies. This thesis focuses on potential alternatives for renewable energies, 
with a focus on microbial production of biofuels.  
  
1.1.2 Alternative and Renewable Energies 
There are many avenues for renewable energies originating from natural and renewable 
resources: sunlight, wind, rain, tides, biomass, and geothermal heat. Currently about 16% of 
global energy consumption comes from renewables: 10% is produced from traditional biomass 
(mainly for heating), 3.4% from hydroelectricity, and the final 3% is derived from new 
renewable technologies, such as biofuels, wind, and solar (5).  
 
To identify a strategy which will be the most influential on achieving sustainability, the largest 
consumption of energy must be considered. A breakdown of energy consumption with the 
United States yields the largest fraction of energy consumption to be hydroelectric power at 
40%, transportation fuels at 30%, industrial energy at 20%, and residential at 10% (Figure 1.2) 
(6). When considering the largest amount of energy consumption, hydroelectric power is already 
derived from renewable sources, thus the next most significant energy consumption is 
transportation fuels. These fuels are used for cars, planes, and trains. Therefore, to make the 
greatest impact in sustainable development, major focus must be on the attainment of renewable 
transportation fuels. 
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In the transportation industry, there has been some success with electric cars (7), and though 
there are other potential sustainable technologies relying on fuel cells and hydrogen, these 
strategies will probably not play a substantial role in heavy duty vehicles, shipping, and aviation 
because of their limited energy density (8). Moreover, the existing transportation fuel 
infrastructure relies on the burning of a carbon-based molecule. Thus, the easiest renewable 
resource for transportation fuels would be biomass which could produce a carbon-based 
molecule for combustion within the existing car engine. To this end, there has been some success 
with biofuels: in 2011 the equivalent of 10,000 barrels per day oil was produced as biofuel (4). 
 
1.1.3 Biomass and Strategies for Biomass Conversion 
Biomass is a carbon-based renewable energy source derived from garbage, plant, and/or waste. 
Significant research for biofuels focuses on plant biomass. Cellulose is the most abundant 
component of plant biomass, typically in the range of approximately 35 to 50% of plant dry 
weight (9). Cellulose is comprised of long polysaccharide chains of β-linked D-glucose 
molecules (10) (Figure 1.3). The cellulose fibers are often embedded in a matrix of other 
structural biopolymers, primarily hemicelluloses and lignin, comprising of 20 to 35% and 5 to 
30% of plant dry weight, respectively (9). The hemicellulose is a highly branched chain 
composed of cross-linked hexose sugars such as D-glucose and also the pentose sugars D-xylose 
and L-arabinose (10). The lignin consists of phenols and chloroform alcohols which are generally 
considered unusable. These biopolymers are the dominant structural feature of biomass (Figure 
1.4) and the degradation of which limits the rate and extent of biomass utilization (9).  
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The conversion of biomass into usable fuels can be completed either through thermochemical 
routes, including gasification and pyrolysis, or through biochemical routes, such as 
microorganism fermentation. Studies have shown that both processes are economically 
comparable for the production of biofuels (11). 
 
1.1.3.1 Thermochemical Routes 
One thermochemical process is gasification: a transformation of the biomass raw material into a 
gaseous mixture through a series of chemical reactions in a controlled amount of air and high 
temperature (12). The gaseous product is an energy rich mixture of H2, CO, CO2, CH4, C2H4, and 
other impurities such as nitrogen, sulfur, alkali compounds, and tars (13). Different gases or air 
used in the gasification chemical reaction can yield different products. Specific gasification of 
the biomass can be used to convert the biomass into a hot synthesis gas, „syn-gas‟ (14). Syn-gas 
can then be converted to a variety of fuels including hydrogen by a water gas-shift reaction, a 
standard reaction where CO reacts with water to form CO2 and H2. Methanol is also produced 
through methanol synthesis: after the water gas-shift reaction occurs, the CO reacts with water to 
form CO2 and H2, and then there is a hydrogenation of CO2 to methanol. Alkanes are produced 
from the biomass by Fischer-Tropsch synthesis using Co-, Fe-, or Ru-based catalysts, the overall 
chemical reaction shown below (12) . 
CO + 2H2 →(1/n)CnHn + H2O 
Another thermochemical process, pyrolysis can produce solid, liquid, and gaseous products from 
biomass (15). Pyrolysis is differentiated from gasification because the reactions are completed in 
the absence of oxygen. There has been significant success in chemical routes to produce 
transportation fuels from biomass (16). Some of these successes include a pilot plant built by 
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Honeywell for industrial scale biofuels, which is a 50 million gallon facility to produce green 
gasoline from biomass. 
 
1.1.3.2 Biochemical Routes 
Though thermochemical routes have been successful, the processes require expensive catalysts 
and high temperature and pressures. Thus, a more sustainable route is biochemical, i.e. microbial 
fermentation. This process uses lower temperatures, atmospheric pressure, and near-neutral pH. 
Biotechnology had been declared a key technology for a sustainable chemical industry (1), thus 
it has been a focus as a technology for sustainable production of commodity chemicals and 
biofuels. 
 
1.1.3.2.1 Pretreatment 
In order for the microorganisms to ferment the biomass, the complex biopolymer structure must 
first be broken down into simple sugars which the microorganisms can utilize. This degradation 
of the biomass, called pretreatment, has been cited as one of the most expensive processes for the 
biochemical conversion to biofuels (17). The lignin must first be removed from the biomass 
mixture and the remaining components are treated through a variety of different methods. The 
cellulose and hemicellulose can be broken down into individual sugars through either steam 
explosion, mechanical milling, high temperature treatment, and acid/base treatment to release 
individual sugar molecules (18). These methods are energy intensive and employ harsh solvents. 
Therefore, in efforts to make biochemical routes sustainable and economically competitive with 
petroleum products, steam explosion and mechanical milling are not good methods. Thus, the 
preferred treatment is enzymatic hydrolysis.  
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An in vitro enzyme cocktail is used to digest the hemicellulose and cellulose molecules. The 
cellulose molecule is broken down by cellulases, such as endoglucanases and cellobiohydrolases. 
These enzymes cleave the long polysaccharide chain into disaccharide cellobiose molecules. 
Subsequently, β-glucosidases hydrolyzes the β 1→4 bond of the cellobiose, releasing two 
D-glucose molecules (9). The hemicellulose fraction consisting of the linked pentose sugars are 
cleaved by hemicelluloses into single molecules of D-xylose and L-arabinose (19). The final 
hydrolyzate contains a mixture of pentose and hexose sugars such as D-glucose, D-xylose, and 
L-arabinose. In this enzymatic pre-treatment process, not only are significant amounts of 
enzymes required to completely break the biomass down into the simple sugars as D-glucose, 
D-xylose, but the enzymes  can be inhibited by the intermediate cellobiose (9,20). 
 
1.1.3.2.2 Biochemical Conversion 
The use of biological systems, such as microbes, is attractive for sustainable production of 
transportation fuels and other chemicals due to the low-energy, low temperature, and low 
pressure systems associated with the process. Additionally, no heavy metals, organic solvents, 
and strong acids/bases are used, in comparison with traditional chemical synthesis, thus making 
the biochemical route sustainable and environmentally-friendly (21). Additionally, for many 
processes, such as butanol and ethanol production, the microorganism has evolved over 
thousands of years to optimally produce that chemical. Thus biochemical routes for biofuel 
production hold significant promise. 
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Different organisms have been used for biofuel production, including Saccharomyces cerevisiae, 
Escherichia coli, Zymomonas mobilis, and strains of Clostridium. Both S. cerevisiae and E. coli 
are genetically tractable and desired for most work in microbial catalysis. S. cerevisiae is a 
common chassis based on the fact that the microorganism is very industrially robust: tolerant to 
low pH, resistant to phages, and has a fast doubling time. Additionally, industrial-scale 
fermentation of this microorganism has been achieved through the beer/wine industry. 
S. cerevisiae is most often used in current industrial-scale bioethanol production and is a goal for 
many future industrial processes. However, most of the advanced biofuel studies are conducted 
in E. coli because this organism is easier to work with.  
  
1.2 Engineering Microorganisms for Sustainable Chemical Production 
A major thrust in sustainability is to use microorganisms to produce commodity and specialty 
chemicals. These microorganisms can use renewable resources as a substrate to grow and 
components produced by the microorganisms will be non-toxic to the environment and to 
humans. Additionally, these microbes operate at low temperatures and pressures compared to 
traditional chemical catalysis, thus reducing the amount of energy needed to produce the 
chemicals. These advantages make microbial production of chemicals a significant area of 
research in the endeavor to achieve sustainability. 
 
The broad field of metabolic engineering has been established to engineer metabolic pathways 
within a microorganism to produce commodity and specialty chemicals. Enzymatic pathways 
within the microorganisms maintain the vitality of all living organisms. These biochemical 
routes have been exploited to produce numerous commodities since early civilization, examples 
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including beer, wine, and cheese. With the advance of biotechnology, various genetic tools 
became available for construction and manipulation of pathways to efficiently convert renewable 
feedstock to value-added compounds such as specialty chemicals, pharmaceuticals, and biofuels 
(21). Microbial production of these compounds is usually enabled by over-expressing 
endogenous or heterologous enzymes of the corresponding pathways. However, over-expression 
of pathway enzymes alone can be insufficient for optimal metabolite production because of an 
imbalanced flux through the pathway (21,22). A typical symptom of flux imbalance is the 
accumulation of unwanted and even toxic intermediates (23,24), which can be detrimental to the 
productivity of desired compounds. There is seldom a straightforward strategy to resolve the 
accumulation because enzymes within the pathway are not independent; instead the enzymes are 
intertwined and cross-regulated with each other and many intricate metabolic networks. 
 
1.2.1 Design and Construction of Pathways 
1.2.1.1 Computational Programs for Pathway Design 
The first major challenge in engineering microbes for chemical production is designing the 
enzymatic pathway to produce the target chemical. Identifying a pathway may require sorting 
through thousands of possible enzymes and reactions wherein all the parameters have different 
substrate preferences and kinetic features. Computational algorithms have proven vital in 
pathway design and have the ability to discover de novo pathways by combining enzymes from 
various sources to produce non-natural products.  
 
Several databases containing enzymes and enzymatic reactions have been developed: Kyoto 
Encyclopedia of Genes and Genomes (KEGG) (25), BRaunschwig ENzyme DAtabase 
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(BRENDA) (26), MetaCyc (27), the University of Minnesota Biocatalysis/Biodegradation 
Database (UM-BBD) (28,29), Retro-Biosynthesis Tool (ReBiT) (30), and the Universal Protein 
Resource (Uniprot) (31). With these databases, it is possible to identify a staggering number of 
different pathways for synthesis of the same target compound. Thus a major challenge in 
computational design is to rank candidate pathways to predict which pathway will have the 
highest yield of the desired compound.  
 
1.2.1.2 Pathway Construction 
1.2.1.2.1 Homologous DNA Recombination Techniques 
After identifying the enzymes needed to catalyze the reactions, the next challenge is assembling 
the genes encoding the enzymes together. The three main DNA assembly strategies are based on 
homologous recombination and DNA repair mechanisms: DNA assembler, SLIC, and Gibson 
assembly. In the DNA assembler strategy, the endogenous in vivo homologous recombination 
mechanism in yeast is used to create large pathways in a simple, one-step manner (32-34). The 
DNA fragments to be assembled are PCR-amplified by oligos designed with homologous regions 
to the 5‟ and 3‟ neighboring DNA sequences within the pathway. The linear DNA fragments are 
co-transformed with the linear plasmid backbone into Saccharomyces cerevisiae and the 
homologous regions are recognized by the endogenous homologous recombination machinery 
for repair. These fragments are then combined into a complete pathway.  
 
Mimicking the in vivo homologous recombination mechanisms, in vitro assembly has been 
accomplished by Sequence and Ligation Independent Cloning (SLIC), a two-step DNA assembly 
method (35). The DNA sequence of interest is PCR amplified with oligos containing a 30 base 
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pair (bp) sequence homologous to the 5‟ and 3‟ flanking DNA sequences. The linearized host 
vector and the insert DNA fragment are separately treated with T4 DNA polymerase in the 
absence of deoxynucleotide triphosphates (dNTPs). This enables the exonuclease activity of the 
T4 polymerase to chew back 3‟ terminal end, generating a 5‟ overhang which is homologous to 
the vector/insert. The second step involves addition of RecA and ATP, which can recombine the 
DNA fragments together into a plasmid, with four nicks in the DNA. Then upon transformation 
into E. coli for DNA amplification, the nicks are repaired by the in vivo DNA repair system. 
 
The Gibson assembly method (36) is similar to SLIC,  but exploits a specific exonuclease to 
chew back the 5‟ end to generate single stranded complementary overhangs and ligases are 
incorporated in the reaction mix to seal the DNA nicks. The DNA fragments are PCR amplified 
with about 15-30 bp of homologous DNA regions to the 5‟ and 3‟ adjacent DNA sequences. In a 
single reaction, both the vector and the insert are subjected to T5 exonuclease that chews back 
the 5‟ ends of the DNA fragments, and then the polymerase and ligase combine the homologous 
ends of fragments to a single circular DNA molecule. 
 
1.2.1.2.2 Restriction Digestion and Ligation Techniques 
Another family of advanced DNA assembly techniques have been developed based on Type IIS 
endonucleases, such as BsaI. These endonucleases cleave the DNA outside of their recognition 
sites, resulting in 5‟ or 3‟ DNA overhangs of nearly any user-defined nucleotide sequence 
(37,38). This strategy is more advanced than traditional restriction digestion-ligation method 
because it allows more flexibility in insertion location than cloning into the multiple-cloning site 
(MCS) on a plasmid. Use of Type IIS endonucleases through the Golden Gate assembly method 
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is a one-step reaction, which combines restriction digestion and ligation. This method has a high 
fragment assembly efficiency and proven to be effective in creating gene libraries (37). A 
continuing area of research with this technique is investigating a more modular approach for 
pathway and pathway library construction (39,40). 
 
The need for modularity in gene and pathway cloning is becoming more significant with recent 
focuses on high-throughput DNA assembly and automation. One of the most established 
strategies for standardized assembly is the BioBrick system (41-46). The BioBrick and BglBrick 
standards (such as vectors, promoters, RBS) rely on isocaudamer pairs of restriction enzymes to 
generate compatible cohesive ends, and upon ligation, result in a scar sequence that cannot be 
cleaved by either of the original restriction digests. DNA fragments flanked with these 
recognition sequences can be used for modular assembly of a pathway by iterative digestions and 
ligations. The ePathBricks have been recently developed for BioBricks and are biological 
components for the fast assembly of full pathways (47). The vectors developed in this system can 
be used to modify the multi-gene pathway regulatory elements such as promoters, operators, 
RBSs, and terminators. Modification of these components is significant for pathway 
optimization. 
 
1.2.2 Traditional Pathway Optimization Strategies 
These advanced DNA assembly technologies have made it relatively easy to quickly construct 
large pathways of enzymes which could produce complex chemicals. However, pathway 
engineering is more than just recruiting various enzymes and stringing them together (48). In 
early heterologous gene expression studies, it was discovered that there was significant growth 
inhibition in cells over-expressing superfluous genes. This inhibition was attributed to the 
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competition of protein synthesis machinery for essential proteins required for cell growth versus 
the production of the over-expressed proteins, and the demand for nucleotides in the replication 
of the DNA itself. The phenomenon became known as the metabolic burden and reduction of the 
metabolic burden has become essential in the pursuit to identify an optimal metabolic pathway 
(49-52). In addition to minimizing the metabolic burden, to find an optimal metabolic pathway, 
the enzymes within the pathway must be balanced. Often one or two enzymes in the pathway 
will not express well or have low activity. This causes a bottleneck or a build-up of intermediates 
in the pathway, thereby reducing the overall titer. There have been many examples of strategies 
to minimize the metabolic burden and to find a balanced pathway, ranging from transcriptional 
and translational engineering, to protein engineering for higher and more specific activity, to 
combinatorial pathway libraries.  
 
1.2.2.1 Transcriptional and Translational Engineering for Pathway Optimization 
Transcriptional and translational engineering is based on changing the quantity of proteins in the 
system. Often, a plasmid-based system is used to express the proteins in either an operon or 
individual promoter basis. There are disadvantages to the traditional plasmid-based expression 
system. Plasmid instability has shown to be a major problem. Due to the metabolic burden on the 
plasmid-bearing organism, it has a selective disadvantage compared to a plasmid-free cell. 
Without selection pressure, an entire culture could be dominated by the plasmid-free cell. 
Integration into the chromosome leads to long-term stability and circumvents the loss of 
productivity by allele segregation due to plasmid use. Tyo et al. (53) developed a technique 
called chemical inducible chromosomal evolution (CiChE) to integrate the heterologous genes 
into the chromosome at multiple sites, with up to 40 consecutive copies. 
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In transcription, studies have shown that different organisms have a bias toward preferred codons 
and if a gene from an organism with a certain codon bias is heterologously expressed in a host 
with a different codon bias, the translation of the recombinant protein will be suboptimal. This 
can be overcome by codon optimization, wherein the codon sequence of the target gene is altered 
to match that of the codon bias of the host. Codon optimization is commercially available from 
DNA synthesis companies and has proven to increase protein expression in multiple studies (54-
57).  
 
Grouping the genes of interest for the pathway into a single polycistronic mRNA can be 
beneficial to optimize the enzyme expression. This one-step gene expression allows for 
simplified induction processes and improved regulatory mechanisms. However, the design of the 
basic operon can greatly affect expression. Smolke et al. (58) showed that altering the mRNA 
stability by engineering the intergenic regions would increase protein production and thus overall 
titer. By introducing RNA hairpin turns into the 3‟ and 5‟ intergenic region of the gene of 
interest, the mRNA was less susceptible to mRNA degradation.  
 
Promoters can be mutagenized to achieve precise strength and regulation of protein expression. 
These promoters of varying strengths have been applied to exhibit a broad range of genetic 
control, which can be selected to construct an optimal metabolic pathway. Alper et al. (59) used 
a library of mutant promoters with varying strengths to regulate the expression of the dxs gene, 
which led to the improvement of the volumetric productivity of lycopene. It was found that 
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optimal lycopene titer did not involve the strongest promoter, an example of the balancing act 
needed to optimize the metabolic burden and protein activity.   
 
1.2.2.2 Directed Evolution and Rational Design of Proteins for Pathway Optimization 
Protein engineering can be used to modify and optimize pathways. The previously discussed 
strategies for optimization rely on balancing protein expression, but these strategies cannot 
overcome innate inefficiencies in enzymes themselves. Thus, engineering the proteins in the 
pathway can sometimes be the only way to improve the flux through the pathway. 
As one of the most powerful tools in protein engineering, directed evolution mimics the 
Darwinian evolutionary process in a test tube and involves iterative rounds of creating genetic 
diversity followed by selection or screening (60-62) (Figure 1.5). The most common genetic 
diversity creation methods include error-prone PCR, DNA shuffling, chemical mutagenesis, use 
of a mutator strain, and saturation mutagenesis. To identify improved mutants from this genetic 
diversity, a myriad of screening/selection methods have been developed such as colorimetric 
assays, colony size-based growth assays, and fluorescence activated cell sorting (FACS). A 
major advantage of directed evolution is that no prior knowledge of the enzyme structure or 
mechanism is required to improve enzymatic properties. Another advantage is the ability to 
mutate the entire enzyme, thus identifying residues distant to the active site that can affect 
activity through allosteric interactions. However, a major disadvantage of directed evolution is 
the impossibility of exploring all sequence diversity, even with the most powerful screening or 
selection method. Additionally, it can be difficult and time consuming to develop a high 
throughput screening/selection method for a target enzyme property (Figure 1.5a). 
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Rational design is a knowledge-driven process which uses a priori information about enzymes 
such as sequence or structure. This knowledge is used to make specific, targeted amino acid 
mutations which are predicted to affect enzymatic properties vital for the efficiency of the 
desired reaction (Figure 1.5b). This strategy can be valued more than directed evolution because 
it limits the onerous task of screening the large libraries from directed evolution. In a sequence-
based knowledge approach, researchers pursue systematic comparisons of homologous protein 
sequences to identify possible residues that could alter protein activity. When the 
three-dimensional crystal structure of the target enzyme or a homologous enzyme is available, a 
more direct structure-function relationship study between residues can be investigated. Critical 
residues that are hypothesized to affect the desired function are targeted for mutagenesis. By 
visualizing the active site, rational design can be used to mutate the large residues to smaller, 
hydrophobic residues, thus enlarging the active site and allowing a larger substrate to bind. 
Various computational tools have been developed to compare the homologous sequences and 
structural databases to create a mutability map for a target protein (63-65) (Figure 1.5b). 
 
Distinctions between rational design and directed evolution are becoming less clear, as 
researchers commonly combine these techniques (Figure 1.5c). Though strategies to conjoin the 
methods vary, one strategy involves a two-step process of directed evolution and then identifying 
hotspots for rational design, or vice versa if used in de novo protein design. Another strategy to 
combine these techniques is semi-rational design. The power of semi-rational design lies in the 
reduction of the library size to be screened and an augmentation of the success rate for 
identifying  positive hits (66). Semi-rational design can target specific residues for saturation 
mutagenesis or target and mutagenize a specific domain that is suspected to have critical 
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function. These intelligent libraries rely on the ability to identify key beneficial mutations 
through critical structure-function relationships and knowledge of mutational effects on protein 
folding and activity. This design process harnesses the power of the directed evolution but 
reduces the onerous screening. Techniques to develop these smart libraries have been diverse and 
efficient (61,62).  
 
1.2.2.2.1 Engineering Enzyme Specificity or Selectivity 
Both rational design and directed evolution have successfully been used to engineer enzyme 
specificity or selectivity to improve a pathway performance. Often, the promiscuity of enzymes 
tends to correlate with low catalytic activity and undesired side-reactions. This yields an 
inefficient pathway with build-up of intermediates and by-products, which can be toxic to the 
cell. By redesigning proteins for increased specificity or selectivity toward the desired substrate, 
less substrate is required for a high titer and fewer by-products are formed. This strategy has 
proven to be one of the most successful strategies to optimize a pathway through protein design.  
One particular example of reducing side-reactions of enzymes is the production of specialty 
chemical triacetic acid lactone (TAL) (67). The fatty acid synthase (FAS) is a bifunctional 
enzyme, but was rationally designed through sequence homology and structure-function 
relationships to inactivate the keto reductase domain. This eliminated the enzyme‟s ability to 
utilize NADPH, making one function inactive. As a result, the carbon flux was shifted 
exclusively to the desired product TAL. Another example did not completely eliminate 
secondary activity, but increased selectivity towards the desired reaction. Nair and Zhao (68) 
engineered a xylose reductase with preferred selectivity for xylose over arabinose. Screening the 
error-prone PCR library revealed mutations clustering around the (β/α)8-barrel, which led to 
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speculation that this region was involved in substrate recognition. Targeting this secondary 
structure, the site-saturation mutagenesis led to a final mutant with an increased selectivity from 
2.4- to 16.5- fold preference for D-xylose.  
 
Zhang and coworkers (69) engineered a promiscuous KivD for preferred substrate selectivity, 
which expanded E. coli metabolism to produce unnatural C5 to C8 alcohols, used for biofuels. 
The KivD specificity constant kcat/Km was engineered through rational design to 40-fold higher 
preference for 2-keto-4-methylhexanoate than its cognate substrate, 2-ketoisovalerate. This was a 
10-fold increase over the wild-type selectivity. The α-keto acid binding pocket was enlarged by 
mutating proximal residues to smaller, hydrophobic amino acids, allowing binding of the larger 
substrate. In this same report, LeuA was rationally designed for increased activity for the 
substrate of interest, 2-keto-3-methylhexanoate. The crystal structure suggested that steric 
hindrance of the methyl group in the 2-keto-3-methylhexanoate could be relieved by mutating 
proximal residues. The mutation, S139G, was identified to increase the kcat by 7-fold towards the 
substrate of interest. The combination of the mutated KivD and LeuA produced several 
non-natural alcohols, which were not produced in the wild-type pathway.  
 
Just as significant as the substrate, the cofactor NAD(P)
+
 and NAD(P)H usage can be engineered 
to increase the overall efficiency of the pathway. Properly designed proteins can reduce the 
competition for the cofactors between cell metabolism and enzymes in the pathway. An internal 
cofactor regeneration strategy was incorporated into the xylose utilization pathway to reduce the 
imbalance between the xylose reductase (XR) and xylitol dehydrogenase (XDH) for biofuel 
production. In one study, the XDH enzyme was engineered for switched cofactor specificity to 
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NADP
+
, which would complement the XR cofactor preference of NADPH (70,71), creating an 
internal cofactor regeneration mechanism. In another study, the XR was altered to have a 
preference for NADH, to complement the XDH of NAD
+
, which led to a 40-fold increase in 
ethanol productivity over the wild-type enzyme (72).  
 
1.2.2.2.2 Improving Protein Activity 
Though improving the substrate/cofactor specificity or selectivity of enzymes can increase flux, 
there are many other ways to engineer enzymes to increase the overall performance of a 
pathway. More active enzymes can increase the performance of pathways, and the higher 
enzymatic activity can be achieved by improving the catalytic efficiency, protein solubility, and 
stability. Additionally, the pathway can be optimized by increasing the activity of the transport 
system that transfers the extra-cellular substrates into the cell.  
 
Leonard and coworkers (73) engineered two enzymes from the diterpenoid biosynthetic pathway, 
geranylgeranyl disphosphate synthase (GGPPS) and levopimaradiene synthase (LPS) for 
levopimaradiene production. Saturation mutagenesis was applied to possible critical residues of 
the LPS while error-prone PCR was utilized to engineer the GGPPS. The most improved GGPPS 
(S239C/G295D) and LPS (M593I/Y700F) were cloned into the full pathway and when combined 
with metabolic engineering strategies, resulted in a 2,600-fold increase in levopimaradiene 
production. The mutations in the GGPPS were hypothesized to affect the GGPPS catalysis by 
improving the binding efficiency of the magnesium ions needed for substrate anchoring. 
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Increasing the overall enzyme activity through traditional directed evolution was eloquently 
illustrated by Atsumi and Liao in a study focusing on 1-propanol and 1-butanol synthesis in E. 
coli (74). A combination of error-prone PCR and DNA shuffling through six rounds of directed 
evolution identified a top candidate, called CimaA3.7. The kcat/Km of CimaA3.7 for acetyl-CoA 
was 6.7 times greater than the wild-type enzyme at 30 ºC. The enzyme activity was screened at 
varying temperatures and CimA3.7 showed higher activity than wild-type at all temperatures 
tested. Once re-inserted into the pathway, this enzyme yielded a 9.2-fold improvement in 
1-propanol production and a 21.9-fold improvement in 1-butanol production. 
 
Transporters can be the greatest limiting factor in a pathway. However, engineering these 
proteins has been an underutilized strategy for improving the performance of pathways. Lack of 
three-dimensional crystal structure has limited the engineering of these proteins to error-prone 
and directed evolution. Young and coworkers (75) engineered xylose transporters with an 
improved growth rate of up to 70% on xylose as the sole carbon source. In this engineering 
effort, the transporters with increased affinity towards xylose were also discovered to have a 
lower Vmax.  
 
1.2.3 Pathway Libraries for Pathway Optimization 
Pathway library screening strategies, as compared to traditional pathway engineering strategies, 
can be more efficient in the search for an optimized pathway. Traditional strategies optimize 
individual components of the pathway one at a time to increase flux to the desired product 
(71,73,76), as previously discussed. However, pathway libraries screening and combinatorial 
strategies can tune multiple components of the pathway simultaneously, which increases the 
likelihood of obtaining an optimized flux via balanced gene expression and protein activity 
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within the pathway. These combinatorial mutagenesis strategies allow for a comprehensive 
exploration of the potential diversity of a target pathway, which could discover unexpected 
synergistic effects and identify the global optimum across the pathway amongst several 
mediocre, local optimums (77,78). Additionally, a pathway library strategy is advantageous 
because one does not need a priori information about pathway bottlenecks, as all components of 
the pathway are simultaneously tuned. 
 
1.2.3.1 Pathway libraries constructed through traditional DNA Assembly Methods 
One of the first examples of pathway libraries was demonstrated in controlling gene expression 
within an operon. Smolke et al. (58) showed that altering the mRNA stability by engineering the 
intergenic regions would increase protein production and thus overall titer. This idea of 
independently controlling gene expression within an operon was further explored by 
Pfleger et al. (24). By creating a library of tunable intergenic regions (TIGRs), the expression of 
several genes within an operon was simultaneously tuned for optimal expression. The TIGRs 
contained control elements that include mRNA secondary structures, RNase cleavage sites, and 
ribosomal binding site (RBS) sequestering sequences. The library of mutated intergenic regions 
was constructed and applied to the mevalonate pathway. The final mutant product concentration 
was increased sevenfold compared to the original wild-type pathway.  
 
 
1.2.3.2 Pathway Libraries Constructed Through Advanced DNA Assembly Methods 
The Gibson assembly method was applied to generate a large combinatorial library of promoters 
and enzymes of a heterologous acetate utilization pathway in E. coli, comprised of an acetate 
22 
 
kinase (ackA) and a phosphotransacetylase (pta) (79). This combinatorial library was based on 
three promoter sequences with assorted strengths and four orthologous variants of both genes, 
generating 144 possible unique combinations of the promoters and genes. The ackA and pta gene 
variants were chosen from ClustalW protein alignment scores from the organisms 
Methanosarcina acetivorans (mac), Clostridium phytofermentans (cph), Ruminococcus gnavus 
(rgn), and Pelobacter carbinolicus (pca). Each gene cassette was synthesized with a RBS, a 
terminator, and a unique 40-bp DNA linker sequence consisting of homologous DNA directly 
upstream and downstream of the gene at the terminal ends of the cassette (Figure 1.6). The same 
40-bp linker sequence was also cloned into the DNA cassette of the promoters: recA (high 
strength), ssb (medium strength), and lacI (low strength). To force the gene assembly into a 
defined promoter-gene order, a unique linker sequence was used for gene 1 and another unique 
sequence used for gene 2.  
 
The library was assembled via a Gibson assembly reaction, with equimolar amounts of each 
DNA fragment, then transformed into an acetate utilization knockout E. coli strain, and plated on 
potassium acetate as a carbon source for selection. The total library size was approximately 10
4
, 
affording 70-fold coverage of the 144 possible combinations. Investigation of the assembly 
efficiency showed that over 80% of the selected clones harbored a correctly assembled pathway. 
Sequencing data accounted for 8/16 possible gene pair combinations and 7/9 possible promoter 
pair combinations, and 14 unique promoter-gene combinations were present out of a theoretical 
144. A bias was noted towards a specific combination of genes from the organisms cph and pca, 
even though each gene fragment was assembled in equal combinations. This bias could have 
been the result of an assembly bias or it could be the result of a screening bias, as the library was 
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screened on acetate and these genes could be the most efficient for acetate utilization in E. coli. 
Though pathway optimization was not explicitly demonstrated, the efficient and diverse 
assembly of genes and their regulatory elements into a large pathway library was established.  
 
Simultaneously modifying all the regulatory elements of the pathway has also been 
accomplished through ePathBrick from the BioBrick standards assembly platform (47). In this 
strategy, a more concise library was generated, with each combination constructed individually 
by the ePathBrick vectors. With this system, Xu and coworkers demonstrated a modular 
engineering approach for significant titer improvement of a multi-gene fatty acid metabolic 
pathway by fine tuning gene expression through plasmid copy number and RBS engineering 
(80). The E. coli fatty acid biosynthetic pathway was apportioned and overexpressed into three 
modules. The first module, the GLY module, contained genes from the glycolysis pathway, the 
second module, ACA, was the acetyl-CoA activation module, and the final module, FAS, was 
composed of the fatty acid biosynthetic pathway genes. These modules were successfully 
expressed on compatible ePathBrick vectors with varying plasmid copy numbers. The total fatty 
acid production was optimized by overexpressing each module on high, medium, or low copy 
number plasmids. The highest fatty acid production occurred only when the FAS module was 
highly expressed and the GLY module was under moderate gene expression, while no correlation 
was found for ACA expression. The balanced gene expression pathway produced a 4-fold 
increase in fatty acid titer compared to the lowest-producing pathway.  
 
This pathway library illustrated that the supply of malonyl-CoA (GLY module) and consumption 
of malonyl-ACP (FAS module) were very important for pathway optimization. Further 
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improvement strategies focused on translation initiation rates of these modules because RBS 
engineering has proven to be successful in pathway optimization (81). A library of three different 
strength RBSs were chosen from the MIT Registry of Biological Standard Parts and applied to 
the GLY and FAS modules. Maximum fatty acid production was observed under strong RBS of 
the FAS module and moderate strength RBS of the GLY. The RBS engineering improved fatty 
acid production by an additional 1.3-fold compared to the pathway with the optimal plasmid 
copy number.  
 
A randomized BioBrick strategy has also been developed, which combines the power of Gibson 
assembly and the modularity of the BioBrick standards (82). In this method, all promoters, 
ribosome binding sites, and transcriptional terminators were randomized within the pathway. 
Each component was cloned with 18-28 bp linkers of homologous DNA regions to the 5‟ and 3‟ 
DNA. Three promoters, three RBSs, and three terminators were simultaneously randomized for 
the three gene pathway for the lycopene biosynthetic pathway (crtE, crtB, and crtI), generating a 
library of nearly 20,000 unique clones. After assembly, the library was screened on plates for the 
orange-colored lycopene product. Of the red-orange colored colonies, 12 were selected and DNA 
sequencing analysis demonstrated that 7/8 randomized pathways were distinct and four pathways 
had gene deletions. The study cautions the metabolic burden placed on the cells during the 
library screening which could have caused the mutations. 
 
A modified version of the DNA assembler method was used by Wingler and Cornish to establish 
a reiterative recombination method for the in vivo assembly of multi-gene pathway libraries into 
the chromosome (83). This method involved a 5-day multi-step process for chromosomal 
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integration of several genes one-by-one. The strategy utilized a pair of alternating orthogonal 
endonucleases and selectable markers. Homologous recombination and gap repair were used to 
construct a plasmid containing the gene of interest, marker, and endonuclease, which were 
recombined into an acceptor strain. This acceptor strain carried a predefined target locus for 
integration into the chromosome. Galactose-induced expression of the endonuclease initiated the 
integration. The endonuclease cleaved the double stranded DNA, triggering the homologous 
recombination and leading to integration of the gene of interest and the auxotrophic marker into 
the chromosome. The strains were then selected for the new auxotrophic marker and cured 
against excess donor plasmid. Proof of concept for pathway integration and mock library 
assembly was demonstrated using the lycopene biosynthetic pathway. Three rounds of induction, 
curing, and selection were needed to assemble the three pathway genes: crtE, crtB, and crtI. The 
resulting recombinants from the pathway integration were screened on plates through the orange-
colored phenotype of the lycopene metabolite and 99% exhibited the correct assembly. Wingler 
and Cornish also investigated if this method could be used to create large (>10
4
) pathway 
libraries. The library contained different combinations of the genes in the chromosome, 
constructed by integration of the plasmid with a library of variant genes at each integration step. 
To investigate the diversity of the library, the mock library contained various ratios of crtB and 
crtI alleles that contained either nonsense or silent mutations, which could produce interrupted or 
working pathways. The diversity could be judged based on the actual and theoretical percentages 
of working pathways versus interrupted pathways, visualized based on the color of the colonies 
on the plate. Each library had the expected percentage of working pathways, indicating a non-
biased library assembly into the chromosome.  
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An example of plasmid-based pathway libraries was constructed by the DNA assembler method 
and focused on a combinatorial library of different promoter strength for all the genes within the 
library (84). As a proof of concept in pathway library generation, the xylose and cellobiose 
utilization pathways for ethanol production were optimized. The fungal xylose utilization 
pathway consists of three heterologous genes, xylose reductase (XR), xylitol dehydrogenase 
(XDH), and xylulose kinase (XKS), each expressed under control of PDC1 promoter, ENO2 
promoter, and TEF1 promoter, respectively. The cellobiose utilization pathway consists of the 
β-glucosidase (BGL) and cellodextrin transporter (CDT) under the ENO2 and PDC1 promoters, 
respectively. The promoters PDC1, ENO2, and TEF1 were mutagenized through nucleotide 
analog-based error-prone PCR to induce a very high mutation rate and produce promoters of 
various strengths. After mutagenesis, mutants for each promoter were characterized through 
green fluorescence protein expression and ten promoters of defined strengths were selected for 
library construction. These ten promoters in each position of the library resulted in a theoretical 
library size of 10
2
 and 10
3 
for the cellobiose and xylose utilization libraries, respectively. Each 
mutant promoter was cloned into a helper plasmid which contained 400 bp sequences 
homologous to the 5‟ DNA region (Figure 1.6). The mutant promoter/gene expression cassettes 
were co-transformed into a yeast strain with a total library size of 10
5
. To confirm the diversity 
of the library, over 40 individual colonies from each library were screened from an antibiotic 
selection marker for plasmid-pathway assembly and not based on sugar utilization. Each colony 
from this plasmid-marker selection exhibited a unique growth curve on its respective carbon 
source, which was indicative of a diverse library. 
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To screen for an optimal pathway with increased sugar utilization, improved pathway phenotype 
was assessed on the basis of its ability to consume the sugar for growth when that sugar is the 
sole carbon source available. This could be visualized in a high-throughput manner through 
colony size on agar plates, wherein larger colony sizes were suggestive of faster sugar utilization 
and improved growth. In the xylose utilization pathway, a very efficient mutant pathway was 
identified in a single step. This pathway conferred a xylose consumption rate of 0.73 g/L·h, 
comparable to some of the fastest xylose consumption rates from strains which had been 
subjected to multiple generations of optimization strategies. The strain harboring the wild-type 
pathway did not produce any ethanol, while the mutant pathway conferred an ethanol 
productivity of 0.17 g/L·h. In the cellobiose utilization strategy, the strain harboring the 
optimized pathway yielded a 5.4-fold improved cellobiose utilization rate and a 5.3-fold increase 
in ethanol productivity in a single optimization step.  
 
1.2.4 Engineering Biochemical Pathways for Sustainable Biofuels 
As previously mentioned, hexose (D-glucose) is a main constituent of biomass; however pentose 
sugars such as D-xylose and L-arabinose from the hemicellulose fraction can contribute to a large 
component of the biomass. An efficient lignocellulosic biofuel production process will need to 
utilize all sugars from the biomass. However, S. cerevisiae and E. coli cannot utilize the pentose 
sugars. Thus, a significant amount of engineering has occurred to design these microorganisms 
to efficiently utilize these sugars. Bio-ethanol has emerged as a first-generation biofuel and has 
been the focus of many biofuel processes. However, recent research thrusts have investigated 
more efficient fuels, as bioethanol has low heating properties and is incompatible with current 
engines. Advanced biofuels such as butanol, biodiesel, alkanes, and hydrocarbons have become a 
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major research area. Though many studies recently focused on producing advanced biofuels, 
either through E. coli or S. cerevisiae, no study has linked pentose utilization to advanced biofuel 
production. 
 
1.2.4.1 Pentose Sugar Utilization and Bioethanol Production 
Optimizing the pentose sugar utilization pathway has two main research areas: engineering 
transporters to transport the sugars into the cell without incurring a diauxic shift and optimizing 
the enzymes which convert the sugars to ethanol.  
 
The diauxic shift describes a phenomenon wherein a microorganism will preferentially utilize 
hexose sugars in a mixture of pentose and hexose sugars. This sequential sugar utilization greatly 
decreases overall efficiency of the process (10,85-87). Many metabolic engineering techniques 
have been used to try to overcome this phenomenon. It has been shown that using 
pentose-specific transporters can reduce the diauxic shift, because the sugars do not enter the cell 
by the same transporters as the glucose molecules, allowing for simultaneous transport. More 
than just discovering pentose-specific transporters, it is also possible to engineer the transporters 
for a higher activity (75,88). 
 
Another strategy for reducing the diauxic shift is to utilize cellobiose as a carbon source. This 
strategy also relies on using individual transporters for the pentose and hexose sugars. But a very 
efficient cellobiose transporter was found to be specific for cellodextrins (89). Previous work has 
reduced the diauxic shift by co-expression of the cellodextrin transporter and a β-glucosidase 
with the xylose utilization genes (90,91). 
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One of the most successful strategies for xylose utilization is the heterologous expression of the 
fungal xylose utilizing pathway. The xylose is reduced to xylitol by a xylose reductase (XR). 
Then the xylitol is oxidized to D-xylulose by a xylitol dehydrogenase (XDH). Finally, a xylulose 
kinase (XKS) converts the D-xylulose to D-xylulose-5-P, which is then shuttled to the pentose 
phosphate pathway for ethanol production (Figure 1.7). The arabinose pathway is similar: the 
arabinose is reduced to L-arabitol by the XR, a L-arabitol 4-dehydrogenase (LAD) reduces the 
arabitol to L-xylulose, which is then converted to D-xylulose by a L-xylulose reductase (LXR). 
Though the xylose pathway has shown to be efficient (84,92,93), the arabinose pathway is not. 
 
The imbalance of the cofactor usage between the enzymes is suspected to be the greatest limiting 
factor (94). Strategies to overcome this limitation were previously discussed in the chapter, 
involving engineering enzymes for altered cofactor specificity. Thus internal cofactor 
regeneration mechanisms were established. Significant work has looked at balancing the 
promoters of the xylose utilization enzymes. These studies have shown that a high XR 
expression is important for an efficient pathway (84). 
 
1.2.4.2 Advanced Biofuels  
Advanced biofuels, such as butanol, biodiesel, alkanes/alkenes, and hydrocarbons have more 
similar properties to petroleum-based fuels than ethanol, and are termed „drop in‟ fuels because 
they can readily be used by current engines in cars and planes. Recent work has focused on the 
Ehrlich pathway or the 2-keto-acid pathway for production of butanol and isobutanol. 
Intermediates of the amino acid pathway, keto acids, are decarboxylated into aldehydes and then 
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reduced to the products. Isobutanol is perhaps one of the products produced by microbes which 
are closest to industrial use, with a high energy content and extensive branching (higher octane 
number). The octane number is a measure of a fuel‟s resistance to knocking in spark ignition 
engines (95). The 2-keto-acid pathway was introduced into E. coli, the promiscuous 
decarboxylase and aldehyde dehydrogenase were engineered for increased substrate specificity 
in order for the final production of the non-natural carbon chains (69). 
 
Coupling microbial catalysis and chemical catalysis has been shown to be successful with 
isoprenoid based biofuels, such as farnesane (96) and bisabolane (97). The intermediates 
farnesene and bisabolene are produced microbially and then chemically converted to farnesane 
and bisabolane, which are currently being investigated for as alternative biosynthetic diesel. 
Plants are known to produce terpenes, thus, plant isoprenoid synthases were screened for 
efficient conversion of farnesyl diphosphate from the mevalonate pathway into bisabolene (97).  
The cell membrane mainly consists of fatty acids. Certain organisms often overproduce fatty 
acids which are used for energy storage. The long hydrocarbon fatty acyl chain is energy rich, 
and can be used as a biofuel. Fatty acids are biosynthesized naturally by either a large 
multienzyme system the fatty acid synthase or small sub-unit proteins. The multienzyme system 
uses malonyl-CoA as a building block. Fatty acyl chains are elongated on acyl carrier proteins 
(ACPs) through repeated cycles of decarboxylative condensation, β-keto reduction, dehydration 
and enol reduction (95). Thioesterases have been used to release the long-chain fatty acids to 
produce free fatty acid ethyl ester (FAEEs) (98). Combined with the deletion of genes in the 
fatty-acid degradation pathway (β-oxidation), free fatty acids have been produced at high titers 
(1.2 g/L)  in E. coli (99). 
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 Alkane biosynthesis has recently been a major research focus. Derived from fatty acids, alkanes 
are a predominant component of diesel. Alkane biosynthetic genes were recently discovered in 
cyanobacteria (99). The acyl-ACP reductase (AAR) was used to reduce the acyl-ACP to 
aldehydes which were then converted into alkanes by an aldehyde decarboxylase (ADC). A 
combination of expression of these enzymes in E.coli produced alkanes from C13-C17 with final 
yield of 300 mg/L. A figure summarizing some of the advanced biofuel pathways is available as 
Figure 1.8. A more detailed discussion of advanced biofuels is available in Chapter 4. 
 
1.3 Scope of Thesis 
There are two major components of this thesis: pathway optimization and pathway construction. 
This thesis is explores new pathway optimization methods through combinatorial protein 
engineering strategies on the pathway scale. Different schemes for protein pathway libraries are 
described in Chapters 2 and 3. Chapter 4 describes the design and construction of a heterologous 
pathway for FAEE production, establishing the pathway using a various combination of 
traditional pathway optimization strategies to establish the pathway. Chapter 5 once again 
considers protein pathway libraries in the investigation of a high throughput screening strategy. It 
is expected that once a high-throughput screen is established, the combinatorial pathway libraries 
strategies established in Chapters 2 and 3 can be applied to the FAEE pathway. 
 
1.3.1 Chapter 2 Project Overview 
This chapter introduces and discusses the importance of cellobiose utilization in S. cerevisiae for 
biofuel production. Cellobiose is a sugar released from biomass pretreatment and efficient 
cellobiose utilization by S. cerevisiae could help to make the biofuel production process more 
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economical. The original wild-type utilization pathway was discovered by our collaborators at 
UC Berkeley, consisting of a cellodextrin transporter (CDT-1) and a β-glucosidase (GH1-1), 
both heterologously expressed in S. cerevisiae from the filamentous fungi Neurospora crassa 
(89-91). Though the pathway was functional and S. cerevisiae was able to utilize cellobiose, it 
was not very efficient. The strain harboring the wild-type pathway took nearly 50 hours to 
consume all the cellobiose and unwanted reactions were creating detrimental by-products. We 
investigated a combinatorial pathway library strategy to consider many different homologous 
cellodextrin transporters and β-glucosidases. Due to difficulty in cloning and low protein 
activity, the library consisted of seventeen β-glucosidase enzymes and four cellodextrin 
transporters. After screening the library based on specific growth rate on cellobiose and ethanol 
productivity, no statistically significant combination of proteins were found to be better than the 
original wild-type pathway. 
 
1.3.2 Chapter 3 Project Overview 
Chapter 3 resumed the work of Chapter 2, in the endeavor to optimize cellobiose utilization in 
S. cerevisiae. We chose to continue working with the original wild-type pathway (CDT-1 and 
GH1-1) due to the abundance of data available on this pathway. Our next approach for 
optimizing the pathway was based on protein engineering. Often protein engineering strategies 
will engineer one enzyme at a time, but the strategy we developed allowed for all proteins in the 
pathway to be engineered simultaneously. In this work, we chose to conduct error-prone PCR to 
introduce random mutations into the proteins of the pathway, screening for the desired 
phenotype, and then repeating the mutagenesis in a directed evolution manner. After two rounds 
of directed evolution, we identified a 64% increase in ethanol productivity and a 49% increase in 
cellobiose consumption. The β-glucosidase protein which conferred the improved phenotype was 
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shown to have two mutations, one from each round of directed evolution: H23L and L173H, 
respectively. The cellodextrin transporter which conferred the improved phenotype was also 
shown to have two amino acid mutations, one from each round of directed evolution, D433G and 
C82S, respectively. We characterized the mutations to rationalize how these mutations could 
have conferred an increase in the pathway phenotype. In vitro protein assays of the β-glucosidase 
suggested an increased specificity towards cellobiose as a substrate. It was found in the 
homology structural model of the β-glucosidase, that the L173H mutation introduced a new 
hydrogen bond directly to the cellobiose molecule, which has been shown to increase substrate 
specificity (100-102). Analysis of the cellodextrin transporter suggested an improved overall 
activity, mainly due to mutation C82S. A sequence-mapping software predicted this mutation 
was located in the first transmembrane helix. 
 
1.3.3 Chapter 4 Project Overview 
Chapter 4 changed directions from Chapter 2 and 3 slightly, focusing on the construction of a 
heterologous pathway, which will later be optimized through the strategies of the previous 
chapters. The pathway of interest was for the heterologous production of FAEEs, biodiesel. 
Many reports in FAEE production in yeast have significantly low titers. It is expected that this 
low titer is due to the endogenous regulation of the cell, limiting the energy intensive fatty acid 
synthesis (103). We hypothesized that we could overcome the regulation by overexpressing a 
heterologous fatty acid synthase, which would not be subject to endogenous regulation and 
would provide a completely orthologous fatty acid synthesis route, to decrease the re-direction of 
endogenous fatty acids from cellular metabolism. The pathway consists of the wax ester 
synthatase/acyl-coenzyme A:diacylgylcerol acyltransferase (WSDGAT or WS) enzyme, which 
catalyzes the transesterification of a fatty acid with ethanol to produce the FAEE and a 
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heterologously expressed fatty acid synthase (FAS). Many traditional pathway engineering 
strategies were employed in establishing this pathway: varied copy number plasmids, 
combinations of different plasmids, use of different heterologous enzymes, and employment of 
various promoters for strongest expression. This project illustrates the arduous endeavors 
employed in traditional pathway engineering. After testing several promoters, a strain expressing 
the ws gene  and the fas gene under control of the HXT5 promoter (DE04) resulted in a 6.3-fold 
increase in total FAEE production compared to a strain expressing only the ws gene. Independent 
biological clones for this project were shown to have great variation in the FAEE titer, however 
the strain DE04 reproducibly produced significantly increased titer of FAEEs. 
 
1.3.4 Chapter 5 Project Overview 
After establishing the desired pathway and confirming heterologous expression of the genes in 
Chapter 4, Chapter 5 revisits the pathway-scale library strategies of Chapter 2 and 3. However, a 
high-throughput screening method must first be developed. This chapter investigated three 
different strategies for a high throughput screening strategy to optimize either fatty acid 
production or FAEE production. The first strategy was a growth-based strategy which was 
applied in a S. cerevisiae strain with the endogenous fatty acid synthesis knocked-out. This 
allowed for a growth-based screen relying on the complementation of the heterologous FAS to 
provide FA for growth. The second strategy investigated the use of Nile Red stain, which is a 
widely-known and commonly-used quantification method for fatty acids. A final screening 
strategy involved the promoter POX1, which is shown to be sensitive to fatty acid concentration. 
The promoter controlled GFP expression and through fluorescence studies, the fatty acid 
concentration could be monitored. Out of the three strategies, it is suggested to use the growth 
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curve strategy in the FAS knockout-strain. However, further work must be repeated in the Nile 
Red Assay.  
 
1.4 Conclusions 
The global energy demand is rising at an alarming rate. To meet these escalating demands, 
alternative energies that promote sustainable development must be identified. One of the most 
exciting alternative energies is biofuels. Engineering microorganisms to produce these biofuels is 
promising. Though there are many possible ways to engineer these microorganisms, pathway 
engineering and optimizing the flux through the pathway has been very successful. Protein 
engineering can be particularly helpful in optimizing the flux and this thesis focuses on the 
development of new protein based combinatorial strategies to optimize a pathway. A novel 
biofuel pathway was also constructed and preliminary work in designing a screening method was 
accomplished, for the application of the protein library strategies to optimize the newly 
constructed pathway.  
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Figure 1.1: Energy consumption by region as predicted by British Petroleum in 2012 (4). Global 
energy demand is increasing significantly. Alternative energy sources must be found to meet 
these increasing demands. 
 
 
Figure 1.2: Breakdown of energy resources and consumption in the United States in 2011. Each 
number on the line indicates the percentage of that component (6). Transportation fuels utilize 
the greatest percentage of petroleum and one of the largest sectors of energy consumption.  
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Figure 1.3: Cellulose is a long polysaccharide chain of glucose monomers. This is the largest 
constituent of biomass and must be broken down into simple sugars (such as a glucose 
monomer) for efficient biomass conversion to biofuels. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4: Illustration of the many components of biomass (104). Cellulose makes up the 
largest component, with pentose sugars in the hemicellulose fraction. 
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Figure 1.5: A schematic of main protein engineering strategies consisting of directed evolution, 
rational design, and a combined approach. The combined method uses both directed evolution 
and rational design, though the methodology can vary, one example is using directed evolution 
which can identify hotspots and then rational design proximal residues to those hot-spots. 
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Figure 1.6:  Preparation of DNA fragments for large library generation. Each unique design 
represents a unique promoter or gene. Varied strength promoters, orthologous genes, or mutated 
pathway components generate diversity. If the DNA is assembled with homology regions, 
upstream and downstream of the DNA fragment of interest, the pathway can assemble properly 
into many different combinations. Each strategy has incorporated different lengths of homology, 
which can contribute to the efficiency of correct assembly. These DNA fragments are then 
subjected to the desired DNA assembly reaction with the linearized vector and transformed into 
the host. 
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Figure 1.7: Suggested pathway for pentose sugar utilization in yeast, based on the fungal 
pathway. These pathways were studied extensively by the Zhao Research Group. 
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Figure 1.8: Biosynthetic pathways for different advanced biofuels (105). 
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Chapter 2: Combinatorial Library of Homologous Proteins for the Cellobiose Utilization 
Pathway
2
 
2.1 Background 
2.1.1 Cellobiose Utilization 
 
The saccharification of lignocellulosic biomass into fermentable sugars is recognized as one of 
the most expensive operations in biofuel process economics (1,2). Hydrolysis, an enzymatic 
process for biomass pretreatment, requires an exorbitant amount of enzymes, to release the 
simple fermentable sugars. The first step in the process requires endoglucanases (EC 3.2.1.4) and 
exoglucanases (EC3.2.1.74) to collectively break down the cellulose into cellobiose, a 
β-1,4-glucose disaccharide. Then, β-glucosidases (EC 3.2.1.21) hydrolyze the cellobiose to 
glucose, which is subsequently fermented by normal cellular metabolism (3). In this process, not 
only is a significant amount of enzyme required to completely break the biomass down into the 
simple sugar glucose, but there is also another problem: an inhibiting build-up of the 
intermediate cellobiose (1,2). Therefore, to make this process more efficient and to reduce the 
requirement of these in vitro hydrolytic enzymes, recent research has investigated the option of 
utilizing cellobiose itself as a fermentable sugar. Cellobiose utilization would be advantageous to 
the biofuel production process by reducing the in vitro enzyme load and inhibition, thus reducing 
the price of pretreatment, lowering the overall cost of biofuel production (1,2). 
 
                                                 
2
 Parts of this chapter were previously published in: 
Eriksen, D.T. Chao, R. Zhao, H. (2013) “Applying Advanced DNA Assembly Methods For Library Generation” 
Wiley Biotech Series - Synthetic Biology. 3
rd
 Ed. (S.Y. Lee, J. Nielsen, G. Stephanopolous, Eds), In Press. 
Eriksen, D.T. Hsieh, P.C.H. Lynn, P. Zhao, H. (2013) Directed evolution of a cellobiose utilization pathway in 
Saccharomyces cerevisiae by simultaneously engineering multiple proteins. Microbial Cell Factories. 12:61. 1-11.  
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More than just improving the pretreatment process, cellobiose utilization can also be used to 
overcome a major challenge in biofuel production: the diauxic shift. The diauxic shift is 
characterized by a lag in growth when the organism‟s metabolism shifts from its preferential 
carbon source hexose sugars to pentose sugars. The major sugars released from biomass include 
both pentose and hexose sugars and in an efficient process the microorganisms will utilize both 
sugars simultaneously (4,5). S. cerevisiae exhibits a very significant diauxic shift in a mixture of 
xylose and glucose, preferentially utilizing the glucose molecules first before slowly consuming 
the xylose. Engineering S. cerevisiae to co-utilize pentose sugars and hexose sugars has been a 
major research thrust and has been an extremely difficult challenge (5-9). It was hypothesized 
that by engineering S. cerevisiae to utilize cellobiose, efficient co-fermentation of cellobiose and 
xylose could be achieved (10-12).  
 
Three main strategies for heterologous cellobiose utilization have been developed. The first 
strategy involves cell-surface display of extracellular β-glucosidases (13-17) (Figure 2.1a). In 
this strategy, the cellobiose is hydrolyzed extracellularly by β-glucosidases docked to the surface 
of the yeast, then the cell transports and metabolizes the glucose molecules. The hydrolytic 
pathway is a second strategy, which involves heterologous expression of a cellodextrin 
transporter and an intracellular β-glucosidase (11,12). After being shuttled into the cell by the 
transporter, the cellobiose is hydrolyzed by the β-glucosidase into two glucose molecules, which 
are then metabolized by the cell (Figure 2.1b). A third strategy, the phosphorolytic pathway, 
relies on heterologous expression of a cellodextrin transporter and a cellobiose phosphorylase 
(18-20) (Figure 2.1c). The cellobiose is transported into the cell and the intracellular 
phosphorylase cleaves the disaccharide with an inorganic phosphate, producing a glucose 
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molecule and α-glucose-1-phosphate, which is quickly metabolized. Though each strategy has its 
own advantages, no method is as efficient as glucose consumption, which is considered one of 
the most rapid sugar utilizations. Further engineering is required to improve the cellobiose 
utilization rates to rival glucose consumption.  
 
Studies in our laboratory have focused on the hydrolytic cellobiose utilization pathway. Though 
the current pathway is functional, it is not efficient (12). We endeavored to optimize the pathway 
productivity and sugar utilization. Chapter 1 gave an in-depth description of both traditional and 
pathway library optimization strategies. Promoter-based optimization has been extremely 
successful in both of these strategies, even for the cellobiose utilization pathway (21,22). 
However, engineering the promoters will not optimize the intrinsic inefficiencies of the enzymes 
themselves. The detrimental effects of side reactions, cofactor specificities, or substrate 
specificities cannot be improved through promoter engineering. As such, the enzymes of the 
cellobiose utilization pathway were shown to be inefficient (12), the β-glucosidase exhibited 
transglycosylation activity and the cellodextrin transporter would transport the cellodextrins 
outside the cell. Therefore, it is important to consider optimizing the pathway based on the 
enzymes within the pathway. It is possible to consider a synthetic biology approach to use 
different orthologs of homologous enzymes that can confer varying activities and characteristics 
for pathway optimization. A combinatorial library search strategy with these enzymes could be 
advantageous (23).               
   
2.1.2 Previous Research in Enzyme Combinatorial Library Strategies  
The fungal xylose utilization pathway has been shown to be especially sensitive to cofactor 
imbalances and unbalanced enzyme expression (24-27) and was selected as a good target 
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pathway to optimize through this strategy.  Various combinations of enzymatic properties such 
as catalytic efficiency, cofactor specificity, stability, and substrate specificity could be explored, 
allowing for a comprehensive search of the entire potential pathway optimums to identify the 
most improved optimum.  
 
The homologous genes used in the library were identified through a nucleotide BLAST search of 
the xylose utilizing enzymes including xylose reductase (XR), xylitol dehydrogenase (XDH), 
and xylulose kinase (XKS) from the organism Scheffersomyces stipitis. Twenty XR genes, 
twenty-two XDH genes, and nineteen XKS genes were cloned, which resulted in a total 
theoretical library size of 8,360 possible unique combinations of the corresponding enzymes. 
Each enzyme was characterized to show varied activities and cofactor dependencies. The 
homologous gene sequences were cloned into helper plasmid expression cassettes, containing 
promoters, terminators, and at least a 400 bp region homologous to the 5‟ and 3‟ DNA regions of 
the pathway at the termini of the expression cassette (Figure 2.2). The linear expression cassettes 
were transformed into a yeast strain, which were then recombined by the homologous 
recombination mechanism to create a diverse library of pathways containing a unique 
combination of the enzymes. To confirm the diversity of the library, over 40 individual colonies 
from each library were screened from an antibiotic selection marker for plasmid-pathway 
assembly, not based on sugar utilization. Each colony from this plasmid-marker selection 
exhibited a unique growth curve on xylose as a sole carbon source, which was indicative of a 
diverse library. Sequencing results of random colonies showed all the genes were recognizable 
with no major mutations or hybrids and there was no significant bias in the library towards a 
certain gene. This study improved the xylose utilization in S. cerevisiae and allowed for a 
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comparison study of fast and slow xylose utilizing pathways to identify important enzyme 
activity ratios and cofactor specificities of xylose utilization (23). 
 
2.1.3 Strategy Applied to the Cellobiose Utilization Pathway 
Similar to the study completed on the xylose utilization pathway, we assembled a library of 
genes from filamentous fungi encoding for enzymes which are homologous to the enzymes of 
the cellobiose utilization pathway. The wild-type heterologous pathway consists of a 
β-glucosidase from Neurospora crassa [GenBank Accession number XM_951090] and 
cellodextrin transporter [GenBank Accession number XM_958708], also from N. crassa (11,12). 
Through this combinatorial strategy, we were able to explore various combinations of enzymes 
in the pathway with different enzymatic properties, such as catalytic activity and substrate 
specificity (Figure 2.3). 
 
2.1.4 Enzymes of the Pathway 
2.1.4.1 β-Glucosidase  
β-Glucosidase enzymes catalyze the transfer of glycosyl groups between oxygen nucleophiles on 
different types of substrates and are classified into two glycosidase hydrolase families: GH1 and 
GH3 (28). Both of these families were represented in the library. GH1 enzymes are members of 
the 4/7 super family, consisting of a common (β/α)8-barrel (29). The active site is located on 
β-strands 4 and 7, within a deep cleft formed by the connection loops at the C-terminal end of the 
β-sheets of the TIM barrel (30). The conserved catalytic residues of the GH1 family enzymes 
involve the catalytic acid/base Glu 166 and the nucleophile Glu 377, which cleave the glycosidic 
bond via the common double displacement mechanism (31). This mechanism acts on 
β-1,4-linked glucose derivatives and the enzyme is promiscuous, being active towards a range of 
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substrates with varying affinities (30). The GH3 family of the β-glucosidases has a two-domain 
structure, a (β/α)8-barrel followed by a β/α-sandwich, comprising a 6-stranded β-sheet 
sandwiched between three α-helices on either side. The active site is situated between the 
(β/α)8-and the (β/α)6-sandwhich domains, each of which contributes one catalytic carboxylate 
residue (32). GH3 enzymes are suspected to be the best at hydrolyzing cellobiose (33). Thus our 
library consisted of both GH1 and GH3 β-glucosidase enzymes. 
 
A strong reduction in hydrolytic activity has repeatedly been documented for substrate 
concentrations above the KM of the enzyme (28). The enzyme is very sensitive to product 
inhibition, which results in transglycosylation activity. Transglycosylation will yield 
cellodextrins rather than glucose molecules. During hydrolysis, the cellobiose is cleaved, 
yielding a glucose leaving group and a covalent glycosyl–enzyme complex. During the second 
step of the hydrolysis, the intermediate undergoes a nucleophilic attack by a water molecule. 
However, in transglycosylation, the nucleophile that attacks the covalent glycosyl-enzyme 
complex is the hydroxyl group of a cellobiose or glucose molecule, which forms a complex 
saccharide molecule instead of the glucose monomer. 
 
Transglycosylation is considered a major problem in the saccharification of lignocellulosic 
biomass and was also observed in the original studies of the S. cerevisiae cellobiose utilization 
with the accumulation of glucose and other cellodextrins (2,11,12,28,33). Different 
β-glucosidase enzymes have varied sensitivities to product inhibition, with some enzymes having 
extremely high tolerance (34). Therefore, it was hypothesized that conducting a combinatorial 
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search of homologous enzymes might result in a cellobiose utilization pathway with protein 
characteristics more conducive to optimal sugar utilization and ethanol productivity.  
 
2.1.4.2 Cellodextrin Transporters  
Biological membrane transporter proteins are divided into two groups: channels (facilitators) and 
carriers (symporters). Facilitators function as selective pores that open in response to a chemical 
stimulus, allowing the movement of a solute down the gradient. Symporters use an energy 
intensive process to translocate one or more substrates across the phospholipid membrane against 
a concentration gradient (35).  
 
Structural characterization of these proteins is problematic, because membrane proteins are 
notoriously challenging to crystallize. One reason for the difficulty is the amphipathic nature of 
the protein surface, with a hydrophobic area in contact with membrane phospholipids on both 
sides of the membrane (36). However some three-dimensional molecular crystal structures of 
transporters have been reported and among the crystalized structures, major similarities are 
observed (35,37). The transporters all have α-helical structures of the membrane-spanning 
domains, with about 10-12 transmembrane helixes, and some helices have irregular shapes with 
kinks and bends (35).  
 
In the original cellobiose utilization pathway (10-12), two cellodextrin transporters were 
characterized from N. crassa. The first transporter, cellodextrin transporter 1 (CDT1), is a 
symporter and the second, cellodextrin transporter 2 (CDT2), is a facilitator. Comparatively, 
CDT1 has a higher cellobiose uptake activity (Vmax) but requires ATP for transport, while CDT2 
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has little energy requirements but has a much lower activity than CDT1 (10). Though the 
facilitator would theoretically be more efficient in anaerobic conditions, we chose to use 
homologs of both transporters in the library to incorporate a diverse library which would allow 
for a more comprehensive search for an optimal pathway. 
 
2.2 Results 
2.2.1 Gene Cloning 
Homologous genes were identified using the bioinformatics tool NCBI BLAST. We investigated 
putative β-glucosidase genes encoded by the cDNA from a myriad of filamentous fungi. Over 
forty β-glucosidase genes were successfully amplified from the cDNA, cloned into the helper 
plasmid, and transformed into S. cerevisiae for activity analysis. Upon enzyme activity 
screening, it was found that only a few of the β-glucosidase enzymes had activity. Subsequent 
sequencing identified introns to be present in all the inactive genes. We removed the introns 
through rigorous gDNA decontamination and over-lap PCR construction as necessary. All genes 
were sequenced to confirm intron removal and proper construction, however only a few new 
enzymes exhibited activity. A final total of seventeen β-glucosidases were shown to have activity 
with p-nitrophenyl β-D-glucopyranoside (p-NPG), a common synthetic substrate for 
β-glucosidase (30,31). This substrate was used instead of the substrate of interest, cellobiose, due 
to its ease of use in high-throughput assays. It was noted that in the enzymes we had cloned, the 
family GH 1 has significantly higher activity than GH 3 for p-NPG (Figure 2.4).  
 
Cloning cellodextrin transporters also proved to be difficult. Initial cloning characterized the 
transporter clones in a high copy plasmid. However, it was found that upon sub-cloning into a 
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single-copy plasmid (required for controlled library creation and screening), that many strains 
harboring the transporters were unable to grow on cellobiose (Figure 2.5). It was hypothesized 
that the activity of the transporters was so low that the high expression of the multi-copy plasmid 
was necessary to transport a sufficient amount of cellobiose needed for growth. Only three 
transporters (CDT-1 and CDT-2 and CDT-3) had activity levels which allowed for strains 
expressing the heterologous transporter in a single copy plasmid to grow on cellobiose.  
 
At this junction, BP researchers discovered two new cellodextrin transporters, named AN1 and 
CG2, codon-optimized from Aspergillus nidulans and Chaetomium globosum, respectively. 
These proteins were discovered after a search for enzymes homologous to CDT-1 and CDT-1 in 
filamentous fungi. Reports from EBI (38) indicated a slower growth rate on cellobiose compared 
to CDT-1, but an increased ethanol production (Figure 2.6). These transporters were cloned into 
the single copy plasmid system and strains harboring these plasmids were able to grow on 
cellobiose as a sole carbon source. A list of all cloned β-glucosidases and cellodextrin 
transporters used in the library are available in Table 2.1. 
 
2.2.2 Library Assembly 
The combinatorial enzyme library was constructed using DNA Assembler, as previously 
described (21,23). The homologous gene sequences were cloned into helper plasmid expression 
cassettes, containing promoters, terminators, and at least a 400 bp region homologous to the 
5‟ and 3‟ DNA regions of the pathway at the termini of the expression cassette. These expression 
cassettes were amplified from the helper plasmids and then the linear DNA fragments were 
combined in equimolar concentrations to create the DNA library. This library was then 
transformed into an industrial strain of S. cerevisiae and through the in vivo homologous 
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recombination mechanism, the linear DNA fragments were automatically assembled into a 
diverse pathway library. The library comprised of the seventeen β-glucosidase clones from GH1 
and GH3 families, identified above, and the five active cellodextrin transporters. These 
parameters yielded a theoretical library size of eighty-five possible unique combinations of the 
enzyme pathway.  
 
The diversity of the library was confirmed by randomly selecting ten colonies from YPD plates 
containing a selection marker for correct plasmid assembly (not based on cellobiose growth) and 
then characterizing the diverse growth on cellobiose (Figure 2.7). The total library size screened 
on cellobiose plates was 10
4
. Over 1,000 colonies were screened for improved specific growth 
rate on cellobiose, visualized by large colonies on the agarose plate (21,23). Thirty of the largest 
colonies were selected for further characterization and fermentation screening.  
 
The strains harboring these pathways were compared to a strain containing the original, 
wild-type pathway previously established (11,12). The wild-type pathway consists of 
β-glucosidase gh1-1 [GenBank Accession number XM_951090] and cellodextrin transporter 
cdt-1 [GenBank Accession number XM_958708]. Two top candidates were identified to have a 
better or comparable phenotype to the strain containing the wild-type pathway. The plasmids 
from these selected strains were isolated and retransformed into fresh yeast to ensure that the 
improved phenotype was a result of the pathway and not genomic modification. After 
transformation, it was shown that these pathways did not have significantly improved activity 
compared to the wild-type GH1-1 and CDT-1 pathway (Figure 2.8). Additionally, no 
improvements in transglycosylation activity and transportation of cellodextrins to outside the cell 
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were observed. Thus, the search for more efficient enzymes for the cellobiose utilization pathway 
did not identify enzymes with improved characteristics. However, the pathways were a unique 
combination of the β-glucosidase and cellodextrin transporters for a novel cellobiose utilization 
with similar characteristics of the wild-type pathway. 
 
2.3 Discussion and Conclusion 
Though no significantly improved pathway was discovered, some observations about the 
enzymes of the best performing pathways can be made. The screen utilized for this library was 
based on fast growth rate on cellobiose. All of the pathways which conferred the highest growth 
rate on cellobiose contained the CDT-1 transporter, suggesting that this transporter conferred an 
activity which is needed for fast growth. Screening the library for a different property, such as 
ethanol production, might identify a strain consisting of another cellodextrin transporter which 
may confer a slower overall growth rate on cellobiose, but exhibit an increased ethanol 
productivity.  
 
All of the fastest growing pathways contained the CDT-1 transporter, suggesting that this is the 
transporter which confers the fastest growth rate. However there was more diversity in the 
β-glucosidase enzymes screened from the library. Pathway 1 consisted of the β-glucosidase from 
Aspergillus niger [GenBank Accession number XM_001390218] in the GH1 family. Pathway 23 
consisted of the β-glucosidase from Podospora anserina [GenBank Accession number 
XM_001908385], also in the GH1 family. These two enzymatic pathways performed as well as 
the wild-type pathway containing the β-glucosidase, GH1-1, from N. crassa [GenBank 
Accession number XM_951090]. β-glucosidases from A. niger are well-known for their high 
activity and use in hydrolytic processes. To the best of our knowledge, P. anserina 
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β-glucosidases are not largely known for high activity and are not frequently used in hydrolytic 
processes. This study suggests that a more rigorous investigation of P. anserina for 
β-glucosidases could lead to the discovery of important enzymes that could be useful in 
improving hydrolytic processes. All of the fast-growing strains on cellobiose contained pathways 
with β-glucosidases from the GH1 family. Though it was believed that enzymes from the GH3 
family are best at hydrolyzing cellobiose (33), this study suggests that to achieve fast growth 
rates on cellobiose, the GH1 β-glucosidase family may be more useful than β-glucosidases from 
the GH3 family. 
 
2.4 Materials and Methods 
2.4.1 Strains, Media, and Culture Conditions 
The industrial Saccharomyces cerevisiae strain Still Spirits (Classic) Turbo Distiller‟s Yeast was 
purchased from Homebrew Heaven (Everett, WA). Yeast strains were cultivated in YP media 
(1% yeast extract, 2% peptone) with 2% glucose (YPD) or 2-8% cellobiose (YPC). YPC with 
8% cellobiose used in fermentation analysis while 2% cellobiose was used for plate screening. 
S. cerevisiae strains were cultured at 30°C with orbital shaking at 250 rpm for aerobic growth or 
100 rpm for oxygen limited conditions. As needed, 200 µg/mL G418 (KSE Scientific, Durham, 
NC) supplemented YPD for plasmid selection. Escherichia coli DH5α (Cell Media Facility, 
University of Illinois at Urbana-Champaign, Urbana, IL) was used for recombinant DNA 
manipulations. E. coli strains were cultured in Luria broth (LB) (Fischer Scientific, Pittsburgh, 
PA) at 37 °C and 250 rpm, supplemented with 50 µg/mL ampicillin. Yeast and bacterial strains 
were stored in 15% glycerol at -80 °C. All chemicals were purchased from Sigma Aldrich or 
Fisher Scientific. 
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The filamentous fungi were obtained from ARS Culture Collection (NRRL) in Peoria, IL. Each 
strain was cultivated in YP media (1% yeast extract, 2% peptone) with 2% glucose (YPD) for 
growth with 250 rpm orbital shaking. To amplify the genes of interest, the strains were grown on 
YP with 2% cellobiose agarose plates or in liquid media and the tissue was extracted for mRNA 
preparation. 
 
2.4.2 Gene Cloning 
The total RNA from the sample, which was presumably expressing the gene of interest, was 
isolated from fresh samples using the RNeasy Plant Mini Kit (Qiagen, Valencia, CA) following 
manufacturer‟s instructions. Isolated RNA samples were cleaned using TURBO DNA-free Kit 
(AMBION INC, Austin, TX) based on the Rigorous gDNA Decontamination step. Finally, the 
mRNA was then reverse transcribed into cDNA using the Transcriptor First Strand cDNA 
Synthesis kit (Roche, Mannheim, Germany) with the oligo-dT primer following the 
manufacturer‟s instructions. 
 
2.4.3 Plasmid and Strain Construction 
Restriction enzymes were purchased from New England Biolabs (Ipswich, MA). All cloning 
work was performed through the DNA assembler method, mediated by yeast homologous 
recombination (39). Yeast plasmids were isolated using Zymoprep Yeast Plasmid miniprep II kit 
(Zymo Research, Irvine, CA), then transformed into E.coli for isolation of high purity DNA. 
E.coli plasmids were isolated using Qiagen Spin Plasmid Mini-Prep Kit (Qiagen, Valencia, CA). 
PCR fragments were purified by QIAQuick Gel Purification Kit (Qiagen, Valencia, CA). 
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The β-glucosidase genes were expressed using a PYK promoter and an ADH terminator. The 
cellobiose transporters were expressed using a TEF promoter and a PGK terminator as 
previously constructed (12). To facilitate the creation of a library of cellobiose utilizing 
pathways, helper plasmids were constructed. A helper plasmid containing the PYK promoter and 
the ADH terminator followed by the TEF promoter with a unique restriction digest site BamHI  
between the PYK promoter and ADH terminator was used for cloning the β-glucosidase genes. A 
helper plasmid containing an ADH terminator followed by a TEF promoter and the PCK 
terminator, with a unique restriction digest site NotI between the TEF promoter and the PCK 
terminator was used for cloning the cellodextrin transporters. The helper plasmids were 
linearized using the respective restriction digest enzymes and assembled with the PCR-amplified 
genes.  
 
2.4.4 Library Creation 
Linear DNA fragments were amplified from the helper plasmid which contained the gene, and 
the promoter/terminator of the gene of interest, including a 500 bp homologous region to the 
neighboring DNA as shown in Figure 2.2. The library was created according to the previously 
described method (21,23). The total library size obtained was 10
4
. Ten colonies were randomly 
selected from the YPD+G418 plate and their plasmids were isolated and sequenced to confirm 
the diversity of the library (Figure 2.7). 
 
2.4.5 Library Screening 
The library was screened on YPC plates for large colony selection (21,23). After confirmation of 
the top 5 clones with the fastest growth rate, the plasmids were isolated and retransformed. This 
retransformation ensured that no adaptation occurred in the screening process and the increased 
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activity is derived from mutations on the plasmid. After retransformation, the cells were seeded 
overnight in YPD+G418, washed twice with sterile water, and then inoculated into 50 mL YPC 
in 250 mL flask at 100 rpm and 30 °C. The cultures were sampled and analyzed for growth and 
also for metabolite production as described previously (21,23).  
 
2.4.6 Fermentation Analysis 
Seed cultures were inoculated from freshly streaked frozen stocks. YPD+G418 seed cultures 
were used for fermentation tests. YPC seed cultures were used for final mutant pathway analysis. 
The seed cultures were grown at 30 °C and 250 rpm overnight, then washed with sterile water 
twice before inoculating 50 mL YPC in 250 mL un-baffled flasks to an initial OD of 0.2. The 
cultures were incubated at 30 °C and 100 rpm for oxygen limited growth. The cultures were 
sampled and analyzed for growth and metabolite production. 
 
2.4.7 β-Glucosidase Enzyme Activity Assays 
Classic strains harboring the β-glucosidase genes were grown to mid-exponential phase and 
washed three times with potassium phosphate buffer (pH 7). A final cell mass equivalent to an 
OD of 20 was harvested. Cell free extracts were prepared through YPER Extraction Reagent 
(Thermo Scientific, Rockport, IL). 125 µL of YPER was used to lyse the cells for 20 minutes at 
25 °C, vigorously shaken at 700 rpm in a thermo-mixer (Eppendorf, Germany). After lysing, the 
cell membrane was pelleted for 10 minutes with 15,000 rpm at 4 °C. The protein concentration 
was determined via the BCA protein assay kit (Pierce, Rockford IL), following the standard 
manufacturer protocol. 
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The lysate was tested for p-NPG activity by quantifying the absorbance change of 1 mM p-NPG 
in 100 mM potassium phosphate buffer at pH 7. The colorimetric change was monitored at 405 
nm in a 96-well Biotech Synergy 2 plate-reader (Winooski, VT) for 30 minutes at 30°C. The 
change in absorbance was converted to units (1 U = 1 µmol of p-NP/min) using Beer-Lambert 
law. The extinction coefficient was determined by a standard curve using p-NP at pH 7.  
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2.6 Tables  
 
Table 2.1: List of fungal gene names and ID 
 
Abbreviated Gene 
Name 
Gene Name Gene ID 
Cellodextrin Transporters 
AN2 Aspergillus nidulans ANID_08347.1 
CG1 Chaetomium globosum P_001220469.1 
CDT1 Neurospora crassa XM_958708.1 
CDT2 Neurospora crassa XM_959259.1 
CDT3 Neurospora crassa XM_958780.1 
β-glucosidases 
Ncrassa1 Neurospora crassa XM_951011 
Nhaem2 Nectria haematococca XM_003051016 
Tstipitatus3 Talaromyces stipitatus XM_002478144 
Anidulands5 Aspergillus nidulans XM_659164 
Aoryzae6 Aspergillus oryzae XM_001816779 
Nhaem8 Nectria haematococca XM_003051795 
Tstipitis9 Talaromyces stipitatus XM_002479153 
Aflavus10 Aspergillus flavus XM_002374789 
Aniger11 Aspergillus niger XM_001390218 
Ncrassa18 Neurospora crassa XM_951090.1 
Acu19 Aspergillus aculeatus JN121997.1 
Aniger21 Aspergillus niger DQ220304 
Aniger22 Aspergillus niger XM_001212225 
Aterreus23 Aspergillus terreus XM_001209807 
Aterreus24 Aspergillus terreus XM_001212225 
Aoryzae32 Aspergillus oryzae XM_001816940 
Aoryzae33 Aspergillus oryzae XM_001819003 
Tstipitus37 Talaromyces stipitatus XM_002479606 
Tstipitus38 Talaromyces stipitatus XM_002480435 
Aniger50 Aspergillus niger EU233788 
Panserina51 Podospora anserina XM_001907664 
Zrouxii52 Zygosaccharomyces rouxii XP_002497082.1 
Mgrisea63 Magnaporthe grisea XM_364315.2 
Ncrassa67 Neurospora crassa XM_956275.2 
Aterreus68 Aspergillus terreus XM_001210773.1 
Panserina 70 Podospora anserina XM_001908385.1 
Aterreus72 Aspergillus terreus XM_001210773.1 
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2.7 Figures 
 
 
Figure 2.1:  Illustration of the potential cellobiose utilization pathways which have been 
developed. (a) cell-surface display of extracellular β-glucosidases, where the cellobiose is 
hydrolyzed extracellularly by β-glucosidases docked to the surface of the yeast and then the cell 
transports and metabolizes the glucose molecules. (b) The hydrolytic pathway involves 
heterologous expression of a cellodextrin transporter and an intracellular β-glucosidase, the 
cellobiose is transported into the cell, and the intracellular cellobiose is hydrolyzed by the 
β-glucosidase into two glucose molecules, which are then metabolized by the cell. (c) The 
phosphorolytic pathway relies on heterologous expression of a cellodextrin transporter to bring 
cellobiose into the cell where an intracellular phosphorylase cleaves the disaccharide with an 
inorganic phosphate, producing a glucose molecule and α-glucose-1-phosphate.  
a) 
b) 
c) 
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Figure 2.2 Preparation of DNA fragments for large library generation in a three gene pathway. 
Each unique design represents a unique gene. The DNA is assembled into helper plasmids, as 
shown on the left. Each helper plasmid has homology regions, upstream and downstream of the 
DNA fragment of interest. With this homology region, the pathway can assemble properly into 
many different combinations. This strategy requires 400 bp length of homology, which can 
contribute to the efficiency of correct assembly.  
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Figure 2.3: Workflow for the homologous enzyme library. (1) Amplify homologous genes from 
cDNA of filamentous fungi. (2) Clone the genes into helper plasmids, designed with promoter 
and terminator for expression, and homologous DNA regions consisting of upstream and 
down-stream DNA sequences used for recombination. (3+4) Using DNA Assembler, the library 
can be generated through in vivo homologous recombination. (5) Plate library on cellobiose 
plates and screen for largest colonies. (6+7) Quantitative analysis through flask fermentation. 
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Figure 2.4: Characterizing all the different β-glucosidases enzymes for library through in vitro  
whole cell lysate assays. (a) β-glucosidases activity of the GH1 family with p-NPG. 
(b) β-glucosidases activity of the GH3 family with p-NPG. The GH1 family had significantly 
higher overall activity towards p-NPG. 
     (a)       
       (b)  
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Figure 2.5: Growth of strains harboring high (pRS 424) or low (pRS414) copy plasmids of the 
cellodextrin transporter in YPC media. High and low copy number plasmids translate into either 
high or low expression levels of the gene. This growth curve indicates that strains harboring the 
same transporter can only grow on cellobiose when the transporter is highly expressed. Strains 
harboring the single copy plasmids did not grow on cellobiose as the sole carbon source. A 
single copy plasmid is required for controlled library screening, therefore these transporters 
cannot be used in the library. 
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                   (a)  
(b)  
(c)  
Figure 2.6: BP researchers discovered two cellodextrin transporters AN2 and CG1 from 
Aspergillus nidulans and Chaetomium globosum, respectively. CBT1 and CBT are CDT1 and 
CDT2 respectively. (a) Growth rate of strains harboring transporters on cellobiose as sole carbon 
source. (b) Cellobiose utilization of strains harboring transporters. (c) Ethanol production of 
strains harboring transporters. These transporters were used in the library. 
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Figure 2.7: Confirmation of the diversity of the library. Assembled pathways are selected based 
on antibiotic resistance (G418) and are tested for the diversity based on growth on cellobiose. 
Ten randomly selected clones have a wide range of growth on cellobiose, demonstrating the 
library has been assembled with a wide variety of potential enzymes with varying degrees of 
efficiency. 
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Figure 2.8: Characterization of the retransformed strains harboring top candidate pathways from 
the homologous enzyme library. (a) Cellobiose consumption. (b) Ethanol production. No 
significant increase in cellobiose consumption or ethanol production was identified. However, 
the CDT-1 was in all the top-performing pathways, but two β-glucosidases performed as well as 
GH1-1, Pathway 1 consisted of β- glucosidase from Aspergillus niger,  Pathway 23 consisted of 
the β-glucosidase from Podospora anserina, both from family GH-1. 
(a)  
(b)  
76 
 
Chapter 3: Developing a Directed Evolution Strategy for the Optimization of Heterologous 
Metabolic Pathways by Simultaneously Engineering Multiple Proteins
3
 
3.1 Background 
3.1.1 Directed Evolution 
Directed evolution is an iterative multi-step optimization strategy and is established as a very 
powerful technique in synthetic biology for optimizing protein activity (1,2). This thesis chapter 
expands the application of directed evolution to include pathway-scale protein engineering. 
Chapter 2 of this thesis focused on optimizing the cellobiose utilization pathway by searching for 
enzymes which did not confer inefficient activities, such as transglycosylation. No homologous 
enzymes resulted in a more improved pathway than the original wild-type pathway. Therefore 
we chose to engineer the original wild-type enzymes for an improved activity. The novelty in 
this protein engineering project was the expansion to pathway-scale, by engineering multiple 
proteins simultaneously. Application of directed evolution on the pathway scale is a powerful 
strategy because no a priori information about pathway bottlenecks or structural information 
about the pathway enzymes is needed. Another advantage of a pathway-scale protein engineering 
stems from the major driving force of pathway library strategies- the comprehensive search for a 
maximum, global pathway optimum rather than a mediocre, local optimum. 
 
                                                 
3
 Parts of this chapter were previously published in: 
Eriksen, D.T. Chao, R. Zhao, H. (2013) “Applying Advanced DNA Assembly Methods For Library Generation” 
Wiley Biotech Series - Synthetic Biology. 3
rd
 Ed. (S.Y. Lee, J. Nielsen, G. Stephanopolous, Eds), In Press. 
Eriksen, D.T. Hsieh, P.C.H. Lynn, P. Zhao, H. (2013) Directed evolution of a cellobiose utilization pathway in 
Saccharomyces cerevisiae by simultaneously engineering multiple proteins. Microbial Cell Factories. 12:61. 1-11.  
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3.1.2 Directed Pathway Evolution Strategies to Improve Cellobiose Utilization 
Yuan and Zhao applied directed evolution to mutant promoter pathway libraries of the hydrolytic 
cellobiose utilization pathway (3). The promoters PDC1, ENO2, and TEF1 were mutagenized 
through nucleotide analog-based error-prone PCR, which induced a very high mutation rate. An 
average mutation rate of 12-16 nucleotide substitutions per kilobase for the PDC1 and ENO2 
promoter was obtained. The pathway genes were not mutagenized and these non-mutated DNA 
fragments were co-transformed with the error-prone promoter library, assembled into a diverse 
pathway library by the homologous recombination mechanism of S. cerevisiae. The total size of 
the library was 10
4
. The pathway phenotype improvement was assessed by fast sugar utilization, 
visualized by large colonies on agar plates. 
 
The first round of directed evolution identified a strain with a 5.7-fold increase in cellobiose 
consumption rate and a 5.5-fold increase in ethanol productivity. Further rounds of evolution 
yielded incremental subsequent increases (Figure 3.1). After characterizing the mutant 
promoters, it was found that the expression level ratios had significantly changed. While the 
parent BGL:CDT relative expression ratio was 13.8:1, the first round of mutagenesis altered the 
ratio to 2.5:1. This significant increase in relative cellodextrin transporter expression suggested 
that balancing of the protein expression levels was a bottleneck. 
 
Directed evolution was very successful in the promoter engineering optimization; however, as 
previously mentioned in Chapter 2, engineering the promoters will not optimize the intrinsic 
inefficiencies of the enzymes themselves. Though balancing and optimizing the protein 
expression can greatly improve the pathway, the detrimental effects of side reactions, cofactor 
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specificities, or substrate specificities cannot be improved through this strategy. Therefore, it is 
important to consider optimizing the pathway based on the enzymes within the pathway. Chapter 
2 of this thesis investigated different protein combinations of the cellobiose utilization pathway 
in order to find enzymes with reduced unwanted activities. The original cellobiose utilization 
pathway (CDT1 and GH1-1) was found to confer one of the highest productivities from the 
library of homologous proteins. However, the proteins in the pathway were still inefficient. Since 
nature did not provide a more efficient set of enzymes, the next strategy was to engineer the 
enzymes in the laboratory for an improved activity. 
 
3.1.3 Directed Pathway Evolution Strategies to Improve Protein Activity  
Current methods for protein engineering often involve isolating the protein from the context of 
the pathway and engineering it independently. In this study, we have investigated a 
complementary strategy for protein engineering wherein we simultaneously modified multiple 
proteins in the context of the pathway (Figure 3.2). This strategy combines the strength of 
pathway-scale libraries, which can comprehensively search for a global maximum optimum, 
with protein engineering. This combination could allow the identification of concurrent 
mutations in multiple proteins, which could synergistically increase the desired activity. This 
approach can be widely applicable to any pathway where a high-throughput screening/selection 
method for the desired phenotype is available. The implementation of this directed evolution 
strategy will further enhance researcher‟s abilities to optimize pathways, introducing a new step 
in metabolic engineering involving pathway-driven approaches for protein engineering.  In this 
chapter, we describe the first example of simultaneously engineering multiple proteins, 
β-glucosidase (gh1-1) [GenBank Accession number XM_951090] and cellodextrin transporter 
(cdt-1) [GenBank Accession number XM_958708] in Saccharomyces cerevisiae for biofuel 
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production. Through this directed pathway evolution strategy, key mutations were found in both 
of the proteins, which synergistically improved the overall cellobiose utilization by 49% and 
ethanol productivity by 64%. These mutations were directly linked to improved activity or 
altered substrate specificity of the proteins. Though improving the cellobiose utilization for 
biofuel production is of interest, these results also augment recent research in β-glucosidase 
substrate specificity (4-7) and continued research in transporter engineering (8-12).  
 
3.2 Results 
3.2.1 Library Construction and Screening 
We created the library of gh1-1 and cdt-1 genes by independently mutagenizing each gene 
through error-prone PCR. The genes were then co-assembled through in vivo homologous 
recombination in S. cerevisiae (13), into the single copy plasmid pRS-KanMX, under control of 
the PYK1 and TEF1 constitutive promoters, respectively. The intended mutation rate was one 
amino acid substitution per protein on average. Considering the combination of both genes, the 
theoretical total number of mutant pathways was 9.9×106 (14). Due to limitations of the 
transformation efficiency into the industrial yeast host, the actual screened library size was ~104 
mutant pathways. The specific growth rate of the strain on cellobiose was used as an assessment 
of pathway improvement, which allowed for screening to be based on colony size from agar 
plates (15,16). Large colonies from the library were visibly distinct from the colonies harboring 
the wild-type pathway (Figure 3.3). The large colonies were picked for quantitative analysis and 
the strains exhibiting increased specific growth rates on cellobiose were chosen (Figure 3.4). 
These plasmids were extracted and retransformed into fresh yeast cells to confirm that the 
increased specific growth rate resulted from the mutated pathway, not from genome 
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modification. We successfully screened through two rounds of directed evolution, resulting in 
mutant pathways, R1 and R2, which conferred a higher specific growth rate on cellobiose when 
compared to the wild-type pathway (Figure 3.5). A third round of mutagenesis was performed 
but screening of the library did not result in the identification of a strain with an improved 
specific growth rate.  
 
3.2.2 Characterization of the Mutant Cellobiose Utilizing Pathways 
The first mutant pathway from round one of the directed evolution, identified as R1, involved a 
L173H mutation in the β-glucosidase and a D433G mutation in the cellodextrin transporter. The 
second round of mutagenesis resulted in pathway R2, with additional mutations: H23L in the β-
glucosidase and C82S in the cellodextrin transporter. R1 and R2 pathways conferred an 
increased specific growth rate on cellobiose, improved cellobiose utilization, and higher ethanol 
productivity compared to the strains harboring the wild-type cellobiose pathway in oxygen-
limited conditions (Figure 3.5; Table 3.1). Oxygen-limited conditions were conducted at 100 rpm 
orbital shaking in un-baffled flasks, which reduced aeration to the culture (17). There was a 47% 
increase in specific growth rate in the final mutant strain (0.102 ± 0.002 h-1) compared to the 
wild-type strain (0.0694 ± 0.003 h-1). For the metabolite analysis, end-point values at the time 
required to consume more than 95% of total sugar was used to determine rate, yield, and 
productivity. The strains harboring the engineered pathways presented a 49% increase in 
cellobiose consumption and a 64% increase in ethanol productivity (Table 3.1). Extracellular 
glucose production (Figure 3.6), an undesired byproduct, was produced only when the cellobiose 
had been almost completely consumed and then was quickly consumed itself. The final strain 
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containing mutant pathway R2 consumed 80 g/L cellobiose in a little less than 30 hours with an 
ethanol productivity of 1.00 ± 0.03 g/(L·h). 
 
To exclude the possibility that the improved phenotype was a result of improved gene 
expression, we performed quantitative PCR analysis of the mutant and wild-type strains. We also 
observed the specific protein abundance by monitoring the fluorescence per cell with green 
fluorescence protein (GFP)-tagging of the proteins and through Western Blot analysis. There was 
no statistically significant difference in mRNA levels or protein abundance between the wild-
type and mutant proteins, indicating comparable gene expression levels throughout the strains 
(Figure 3.7 and 3.8).  
 
To determine which mutations conferred the increased specific growth rate and ethanol 
productivity, the individual and combined mutants from each round were analyzed (Figure 3.9). 
The most significant mutants for the phenotype improvements of the strains were shown to be 
the L173H mutation in the β-glucosidase and the C82S mutation in the cellodextrin transporter. 
Specifically, the L173H mutation was attributed to increased specific growth rate, while the 
C82S mutation increased both the growth rate and ethanol productivity.  
 
3.2.3 Activity Assays 
3.2.3.1 β-Glucosidase Assay 
The enzymes were assayed in vitro to better identify how the mutations affected the activity of 
the individual enzymes. We assayed the activity towards cellobiose by enzymatically quantifying 
the glucose produced by a timed reaction of β-glucosidase with cellobiose. The L173H mutant 
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increased the specific activity towards cellobiose by nearly 90% compared to the wild-type. The 
single H23L mutant had only slightly higher specific activity than the wild-type enzyme. The β-
glucosidase combined mutant L173H and H23L increased cellobiose hydrolytic activity by over 
150% compared to the wild-type enzyme, illustrating additive effects from the combined 
mutations (Table 3.2). Further tests involved p-nitrophenyl β-D-glucopyranoside (p-NPG), a 
synthetic substrate commonly used for determining β-glucosidase activity (4,6). Compared to the 
wild-type, the L173H mutant decreased hydrolytic activity towards p-NPG by 34%. The single 
mutant H23L protein had activity slightly higher than wild-type. The combination of the L173H 
and H23L mutations increased the activity to be slightly higher than the single L173H mutation.  
 
3.2.3.2 Cellodextrin Assay 
The specific activity of the cellodextrin transporter was measured through a modified oil-stop 
assay based on the rate of radiolabeled sugar uptake (18,19). The single mutation D433G 
conferred an 18% increase in cellodextrin transporter activity. When compared to wild-type, the 
single mutant protein containing C82S increased the transporter activity by 48%. The 
combination of D433G and C82S mutations increased the protein activity over wild-type by 60% 
(Table 3.3), demonstrating a synergistic affect to improve the overall pathway productivity. 
 
3.2.4 Structure/Sequence-Function Relationships 
A homology model was constructed for the β-glucosidase and the mutations were investigated 
for possible structure-function relationships. The H23L mutation is on the periphery of the 
enzyme, far from the active site (Figure 3.10). The homology model predicted that the L173H 
mutation was located within the active site, in a domain which has previously been identified as 
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the substrate entrance region (5). The amino acid L173 did not have any predicted interactions 
with cellobiose (Figure 3.11a). When the residue was mutated to H173, the model predicted a 
direct hydrogen bond to the hydroxyl group of the C1 atom of the cellobiose (Figure 3.11b).  
 
Since no crystal structure is available for the cellodextrin transporter, to visualize and 
hypothesize how these mutations affected the protein, a sequence-based analysis was performed 
with the aid of HMMTOP software (20,21). This software is used to predict transmembrane helix 
domains, helix tail domains, and extra/intracellular loop structures (Figure 3.12). Based on the 
predicted structure, the cellodextrin transporter is comprised of 12 transmembrane helices with 
one large inside loop and one large outside loop. The D433G mutation is predicted to be located 
on the large outside loop and the C82S mutation is projected to be in the first transmembrane 
helix. 
 
3.3 Discussion 
Efficient production of biofuels and specialty chemicals hinges on optimization of the metabolic 
pathways associated with the desired product. In this endeavor, a variety of successful pathway 
optimization methods, mainly based on transcriptional engineering, have been developed (16,22-
28). Though successful, these methods are unable to overcome inefficiencies based on innate 
enzyme characteristics such as Vmax and Km, therefore protein engineering strategies must also be 
applied (29). To improve these properties, often the enzymes are removed from the pathway 
context and engineered in vitro or in vivo for the highest activity. Engineering each enzyme 
independently can be arduous and there is no guarantee the engineered enzyme will reduce the 
bottleneck when it is reinstated into the pathway. We are introducing a new approach to combine 
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pathway and protein engineering, involving the evolution of all proteins within the pathway 
simultaneously. Through this strategy, no a priori information about pathway bottlenecks or 
enzymes is required for the directed evolution. Mutant proteins of the pathway are not chosen for 
high activity, but instead interrogated as a whole for a balanced, increased activity and flux 
which is demonstrated by an improved pathway phenotype. Perhaps the most advantageous 
reason for a pathway-scale protein engineering strategy is the ability to comprehensively search 
all the possible global pathway optimums to identify the high optimum, which could be a 
combination of unexpected synergistic effects (26,30). 
 
 Recent advances in large-scale library creation with high efficiency have made the multiplex 
protein engineering library a possibility (15,16,31-33). Our study illustrates an in vivo library 
creation for the simultaneous engineering of multiple proteins in a pathway through directed 
evolution in S. cerevisiae. To the best of our knowledge, there has been only one example of 
mutagenesis of multiple proteins through directed evolution, which was illustrated in Escherichia 
coli for arsenate resistance (34). This strategy has not been widely implemented and has not been 
applied to other systems. Our work optimizes a sugar utilization pathway for increased 
metabolite production with a simple one-step assembly method, allowing for quick and efficient 
rounds of evolution. This represents the first example of pathway optimization through multiple 
protein engineering in S. cerevisiae. 
 
The final optimized pathway (R2) increased cellobiose consumption by 49% and ethanol 
productivity by 64%. Characterization of the strains expressing the mutations which conferred 
these improved phenotypes illustrated that, the highest specific growth rates on cellobiose were 
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achieved only when the β-glucosidase L173H mutation is present. In the cellodextrin transporter, 
the most significant mutation was the C82S mutation. It was shown that the optimized pathway 
involved an overall increase of protein activity: the β-glucosidase had an increased specificity 
towards cellobiose and the cellodextrin transporter exhibited a higher overall activity. 
 
3.3.1 β-Glucosidase Characterization 
The β-glucosidase from glycoside hydrolase family 1 (GH1) contains the standard (α/β)-barrel 
structure of the enzyme family. The active site is located in a deep cleft formed by the 
connection loops at the C-terminus of the β-sheets of the TIM barrel with negatively charged 
residues surrounding the bottom of the active site (6). The conserved catalytic residues of the 
GH1 family involve the catalytic acid/base Glu 166 and the nucleophile Glu 377, which cleave 
the glycosidic bond via the common double displacement mechanism (4). This mechanism acts 
on β-1,4-linked glucose derivatives; the enzyme is promiscuous, being active towards a range of 
substrates with varying affinities (6). In this study, the wild-type GH1-1 β-glucosidase enzyme 
exhibited an innate substrate preference for p-NPG over cellobiose. The mutation L173H shifted 
the substrate specificity towards cellobiose. Homology modeling suggested the H173 residue 
could have a direct hydrogen bond with the hydroxyl group of the C1 atom of the cellobiose 
(Figure 3.11), which was not predicted with the wild-type β-glucosidase. It is possible that this 
new hydrogen bond could increase the affinity of the enzyme for cellobiose by firmly keeping 
the substrate in place during hydrolysis, a hypothesis previously established by studies in 
substrate recognition for the β-glucosidase family (7). There has been significant interest in 
substrate specificity of the GH1 family, which is suggested to occur via an extensive network of 
polar interactions with well-ordered water molecules and enzyme-substrate bonding (4-7). A 
86 
 
specific study of interest involved, a β-glucosidase from Trichoderma reesei [GenBank 
Accession number AB003110.1] which was recently investigated to identify critical residues 
within the substrate entrance region (5). Through rational design, substitutions at residue 172 
were shown to improve substrate recognition, thermostability, and enzyme activity. This β-
glucosidase has a 73% sequence identify to the GH1-1 enzyme studied here. Sequence alignment 
and structural modeling predicted this residue to be in the same position as the L173 residue 
from this work, corroborating the importance of this residue position. The H23L mutation is 
hypothesized to be an overall activity enhancer, with only slightly improved enzyme activity 
towards both substrates p-NPG and cellobiose. H23 is located on the periphery of the enzyme, 
distant from the active site (Figure 3.10).  
 
3.3.2 Cellodextrin Characterization 
Engineering sugar transporters has recently been shown to greatly enhance pathway productivity 
(8,12), a result also illustrated here. In our directed evolution effort, the combined D433G and 
C82S mutations of the cellodextrin transporter increased the specific activity by 60% compared 
to the wild-type. The specific activity is directly proportional to the Vmax of the transporters, 
which is the protein property that has been most often enhanced by sugar transporter engineering 
(8,12). It is probable that this property is the most likely to be improved due to the screening 
conditions, which were performed at saturating conditions. The cellodextrin transporter model 
predicted that the D433G mutation is located on a large outside loop. It is possible that this loop 
could have been causing a steric hindrance for the mass transfer of cellodextrin to the transporter, 
which could have been alleviated by the altered loop structure associated with this mutation. The 
C82S mutation, which conferred the highest increase in activity, is predicted to be located in the 
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first transmembrane helix (Figure 3.12). The location in the helix and the increased activity 
suggest that this mutation could be directly associated with cellobiose interactions or the protein 
complex stability. Young et al. investigated directed evolution of xylose transporters and 
identified mutations which tended to cluster around the first transmembrane helix (8), a similar 
finding to this study.  
 
3.4 Conclusion 
Cellobiose utilization has recently become a significant consideration in economical biofuel 
production. Efficient utilization could decrease the expensive in vitro enzyme load in biomass 
pretreatment. We successfully optimized the hydrolytic cellobiose utilization pathway through a 
new directed evolution strategy: simultaneously engineering multiple proteins within the context 
of the pathway. The optimized pathway involved a β-glucosidase mutant with an increased 
specificity towards cellobiose and a cellodextrin transporter mutant with an increased overall 
activity. By applying directed evolution to the entire pathway, engineered proteins can be found 
which synergistically improve the phenotype either through a balanced flux of the pathway or 
through overall protein activity improvement. Simultaneous multi-protein engineering is 
expected to expand researchers‟ abilities to optimize biosynthetic metabolic pathways. 
 
3.5 Materials and Methods 
3.5.1 Strains, Media, and Culture Conditions 
The industrial Saccharomyces cerevisiae strain Still Spirits (Classic) Turbo Distiller‟s Yeast was 
purchased from Homebrew Heaven (Everett, WA). Yeast strains were cultivated in YP media 
(1% yeast extract, 2% peptone) with 2% glucose (YPD) or 2-8% cellobiose (YPC). YPC with 
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8% cellobiose was used in fermentation analysis while 2% cellobiose was used for plate 
screening. S. cerevisiae strains were cultured at 30 °C with orbital shaking at 250 rpm for aerobic 
growth or 100 rpm for oxygen limited conditions. As needed, 200 µg/mL G418 (KSE Scientific, 
Durham, NC) supplemented YPD for plasmid selection. Escherichia coli DH5α (Cell Media 
Facility, University of Illinois at Urbana-Champaign, Urbana, IL) was used for recombinant 
DNA manipulations. E. coli strains were cultured in Luria broth (LB) (Fischer Scientific, 
Pittsburgh, PA) at 37 °C and 250 rpm, supplemented with 50 µg/mL ampicillin. Yeast and 
bacterial strains were stored in 15% glycerol at -80 °C. All chemicals were purchased from 
Sigma Aldrich or Fisher Scientific. 
 
3.5.2 Plasmid and Strain Construction 
Restriction enzymes were purchased from New England Biolabs (Ipswich, MA).  All cloning 
work was performed through yeast homologous recombination mediated by the DNA Assembler 
method (13). Yeast plasmids were isolated using Zymoprep Yeast Plasmid miniprep II kit (Zymo 
Research, Irvine, CA), then transformed into E. coli for isolation of high purity DNA. E. coli 
plasmids were isolated using Qiagen Spin Plasmid Mini-Prep Kit (Qiagen, Valencia, CA). PCR 
fragments were purified by QIAQuick Gel Purification Kit (Qiagen, Valencia, CA). 
 
The β-glucosidase gene gh1-1 (GenBank Accession number XM_951090) from N. crassa was 
expressed using a PYK promoter and an ADH terminator. The cellobiose transporter gene cdt-1 
(GenBank Accession number XM_958708) from N. crassa was expressed using a TEF promoter 
and a PGK terminator as previously constructed (19). To transfer the pathway to the pRS-
KanMX plasmid, primers kanMX-PYKp-F and PGKt-kanMX-R (Table 3.4) were used to 
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amplify the full cellobiose utilizing pathway. To facilitate the creation of a library of cellobiose 
utilizing pathways, a helper plasmid was constructed. The helper plasmid contained the PYK 
promoter and the PGK terminator, separated by a unique restriction enzyme recognition site 
BamHI for plasmid linearization. The helper plasmid will later be linearized and used as a 
backbone for the library creation. The PYK promoter was amplified using primers kanMX-
PYKp-F and PYKp-BamHI-PGKt-R (Table 3.4). The PGK terminator was amplified using 
primers PYKp-BamHI-PGKt-F and PGKt-kanMX-R (Table 3.4). 
 
3.5.3 Library Creation 
The ADH terminator and TEF promoter were not subjected to random mutagenesis, thus this 
cassette was amplified using primers middle-BGL-ADHt-F and middle-TEFp-CDT-R (Table 
3.4). This fragment was transformed with the error-prone PCR fragments and linear helper 
plasmid. The gh1-1 and cdt-1 genes were subjected to error prone PCR and error rates of 2-3 bp 
mutations per 1kb were used for library creation. The library was created according to the 
previously described method (15,16). The total library size obtained was 10
4
. Ten colonies were 
randomly selected from the YPD+G418 plate and their plasmids were isolated and sequenced to 
confirm the diversity of the library. 
 
3.5.4 Library Screening 
The library was screened on YPC plates for large colony selection (15,16). After confirmation of 
the top 5 clones with the fastest growth rate, the plasmids were isolated and retransformed. This 
retransformation ensured that no adaptation occurred in the screening process and the increased 
activity is from mutations on the plasmid. After retransformation, the cells were seeded 
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overnight in YPD+G418, washed twice with sterile water, and then inoculated into 50 mL YPC 
in 250 mL flask at 100 rpm and 30 °C. The cultures were sampled and analyzed for growth and 
also for metabolite production as described previously (15,16). After confirmation of improved 
mutant pathways, the plasmids were isolated and sequenced to identify the mutations within the 
genes in the pathway. After confirmation of the mutations, that pathway was used as a template 
for a second round of error-prone PCR. The library creation and screening process was repeated. 
 
3.5.5 Fermentation Analysis 
Seed cultures were inoculated from freshly streaked frozen stocks. YPD+G418 seed cultures 
were used for the single/double mutant fermentation tests. YPC seed cultures were used for final 
mutant pathway analysis. The seed cultures were grown at 30 °C and 250 rpm overnight, then 
washed with sterile water twice before inoculating 50 mL YPC in 250 mL un-baffled flasks to an 
initial OD of 0.2. The cultures were incubated at 30 °C and 100 rpm for oxygen limited growth. 
The cultures were sampled and analyzed for growth and metabolite production. 
 
3.5.6 Construction of Single Mutants  
The single mutant genes were constructed through site-directed mutagenesis and the mega 
primer PCR method with primers listed in Table 3.4. After PCR amplification, the genes were 
transformed into the Classic strain along with the ADHt/TEFp cassette into a linearized pRS-
KanMX helper plasmid. The final plasmid was purified and sequenced for confirmation.  
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3.5.7 β-Glucosidase Enzyme Activity Assays 
Classic strains harboring an empty vector, the wild-type, and mutant pathways were grown to 
mid-exponential phase and washed three times with potassium phosphate buffer (pH 7). A final 
cell mass equivalent to an OD of 20 was harvested. Cell free extracts were prepared through 
YPER Extraction Reagent (Thermo Scientific, Rockport, IL). 125 µL of YPER was used to lyse 
the cells for 20 minutes at 25 °C, vigorously shaken at 700 rpm in a thermomixer (Eppendorf, 
Germany). After lysing, the cell membrane was pelleted for 10 minutes with 15,000 rpm at 4 °C. 
The protein concentration was determined via the BCA protein assay kit (Pierce, Rockford IL), 
following the standard manufacturer protocol. 
 
The lysate was tested for p-NPG activity by 1 mM p-NPG in 100 mM potassium phosphate 
buffer at pH 7. The colorimetric change was monitored at 405 nm in a 96-well Biotech Synergy 
2 plate-reader (Winooski, VT) for 30 minutes at 30°C. The change in absorbance was converted 
to units (1 U = 1 µmol of p-NP/min) using Beer-Lambert law. The extinction coefficient was 
determined by a standard curve using p-NP at pH 7. For cellobiose-based enzymatic assay, the 
linear range of the β-glucosidase was determined. The reactions were carried out at 60 mM 
cellobiose in 100 mM potassium phosphate buffer at pH 7. After addition of lysate, the reaction 
was allowed to react for 15, 30, 45, and 60 minutes at 30 °C. The reaction was stopped by 
boiling at 100 °C for 10 minutes. The samples were then centrifuged at 15,000 rpm for 5 minutes 
before being stored on ice. The amount of glucose which had been produced in the allotted time 
frame was then measured using the D-glucose kit (R-Biopharm, Germany). Standard 
manufacturer‟s instructions were followed. One unit (U) is defined as micromoles of glucose 
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produced per minute. The specific activity was determined by normalizing the rate to the amount 
of protein in the assay.  
 
To determine the β-glucosidase protein abundance in each strain, the wild-type and mutant 
proteins were fused to GFP. There was no statistically significant difference in β-glucosidase 
abundance of each strain (Figure 3.7 and 3.8). The total protein concentration, as determined 
through BCA assay, was comparable in each lysate. Therefore, the ratio of β-glucosidase to total 
protein was assumed constant, and hence the activity was normalized to total protein 
concentration. One unit (U) is defined as one micromole of glucose produced per minute. 
 
3.5.8 CDT Activity Assay 
The cellodextrin transporter was assayed using the oil-stop protocol previously reported (18,35) 
with few modifications. Cultures of the wild-type and mutant pathways were grown to an OD of 
15-20, washed three times with ice-cold assay buffer (30 mM MES-NaOH + 50 mM ethanol), 
and then normalized to an OD of 20. 50 μL of cells were added to 50 μL of [3H]-cellobiose at 30 
°C and layered over 100 μL of silicone oil (Sigma 85419), incubated for 10, 20, 40, and 80 
seconds. The cells were then centrifuged through the oil at 15,000 rpm for 30 seconds. After 
ethanol/dry-ice bath, the cell pellets were solubilized in NaOH overnight. The amount of [3H]-
cellobiose present in the cells was then quantified via a liquid scintillation counter. The amount 
of labeled cellobiose that was taken up by the cell was plotted against the time of reaction. One 
unit (U) is defined as the micromoles of cellobiose taken up by the cell per min. The dry cell 
weight of the cells was determined and the rate of the cellobiose uptake was normalized by the 
gram cell cry weight (gdcw). The rate of the cellobiose uptake was normalized by the transporter 
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abundance determined through GFP fluorescence measurements and Western Blot analysis 
(Figure 3.7 and 3.8) and the gram cell dry weight (gcdw). 
 
3.5.9 qPCR Analysis 
Samples of cultures grown in the same conditions as protein activity assays, beginning-mid 
exponential phase, and were used to compare relative mRNA expression levels of the mutant 
pathways via quantitative PCR (qPCR). The total RNA was isolated from fresh samples using 
the yeast FastRNA SPIN kit (MP Biomedical Solon, OH) following manufacturer‟s instructions. 
Isolated RNA samples were cleaned using TURBO DNA-free Kit (AMBION INC, Austin, TX) 
and then reverse transcribed into cDNA using the Transcriptor First Strand cDNA Synthesis kit 
(Roche, Mannheim, Germany) with the oligo-dT primer following the manufacturer‟s 
instructions. The qPCR was performed with LightCycler 480 SYBR Green Master reagents 
(Roche) using the Roche Light Cycler® 480 System (Roche, Indianapolis, IN). The relative 
abundance of the mRNA levels for the target genes was normalized to the asparagine-linked 
glycosylation 9 gene (alg9) expression to determine expression levels. 
 
3.5.10 GFP Fusion  
The β-glucosidase and the cellodextrin transporter genes were C-terminally tagged with GFP via 
the (Gly-Gly-Gly-Gly-Ser)2 linker using primers described in Table 3.4 and DNA Assembler. 
Strains harboring the GFP-tagged proteins were grown in the same conditions as the protein 
activity assays: inoculated to an initial OD of 0.2 and grown at 30°C at 100 rpm orbital shaking 
until the cells reached OD 15-20. The cells were then diluted in PBS to an OD of about 0.1-0.2 
and were analyzed on a flow cytometer (Biosciences LSR II Flow Cytometry Analyzer, BD 
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Biosciences, San Jose, CA) to quantify GFP fluorescence of each mutant protein in the strain, 
with excitation wavelengths at 488 nm and emission band pass 550/30.  
 
3.5.11 Western Blot Analysis 
The β-glucosidase and the cellodextrin transporter genes were C-terminally tagged with a 3x-flag 
tag and a c-myc antibody tags respectively, using the primers described in Table 3.4 and DNA 
Assembler. Strains harboring the tagged proteins were grown in the same conditions as the 
protein activity assays: inoculated to an initial OD of 0.2 and grown at 30 °C at 100 rpm orbital 
shaking until the cells reached OD 15-20. Cells were lysed following standard manufacturer‟s 
protocol of the YPER Extraction Reagent (Thermo Scientific, Rockford, IL). The protein 
concentration was determined via the BCA protein assay kit (Pierce, Rockford IL), following the 
standard manufacturer protocol. Each sample was normalized by total protein concentration and 
applied to a 12% agarose- SDS-page gel (Bio-Rad, Hercules, CA) at 100 V for 60 minutes. The 
gel was then transferred to a PVDF membrane for 60 minutes at 100 V at 4°C. The membrane 
was washed three times with PBS before being treated with the respective 3x Flag tag or c-myc 
antibodies from mouse (Thermo Fischer Scientific, Rockford, IL) for two hours are room 
temperature. The membrane was then washed and treated with goat anti-mouse antibody for two 
hours at room temperature. Finally, the membrane was washed and stained with Western Blue 
stabilized substrate (Promega, Madison Wisconsin) until bands were visualized. 
 
3.5.12 Homology Modeling 
A homology model of the β-glucosidase enzyme was constructed to identify the structure-
function relationships of the mutations discovered. The gene encoding the β-glucosidase from 
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Trichoderma reesei (6) (PDB accession code 3AHY) afforded the highest homology to the gh1-1 
gene from N. crassa with 73% sequence identity and was used as a template for homology 
modeling. The structure model of the β-glucosidase from N. crassa was constructed using the 
modeling program Molecular Operating Environment (Chemical Computing Group, Montreal, 
Canada). After constructing the homology model, the substrate in the co-crystal structure of 
Neotermes koshunensis β-glucosidase (PDB accession code 3VIK) was docked into the model 
(5). The model was energy minimized before ligand interactions were investigated. To identify 
the effects of the mutations, the mutations were introduced to the model and energy minimized 
again before investigating the ligand interactions.  
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3.7 Tables 
 
Table 3.1: Parameters for the improved pathways identified through directed evolution. Key 
parameters for an improved pathway include specific growth rate, cellobiose consumption, and 
ethanol productivity. Errors are derived from biological duplicates. Fermentations conditions in 
8% cellobiose rich media and oxygen limited conditions. 
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Table 3.2: Specific activity measured from the crude lysate of the engineered β-glucosidase. One 
unit is defined as one µmol/min and the control is the lysate from a strain with no heterologously 
expressed β-glucosidase. Each mutant was quantified with p-NPG and cellobiose as a substrate 
to demonstrate the increased substrate specificity towards cellobiose. Errors are derived from the 
standard deviation of biological triplicates. 
 
 
 
 
 
 
 
 
 
 
Table 3.3:  Specific activity measurements from the cellodextrin transporter as determined 
through radioactive-labeled cellobiose uptake rate assay. One unit is defined as one µmol/min. 
The control is the lysate from a strain with no heterologously expressed cellodextrin transporter. 
Errors represent the standard deviation of biological triplicates. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
p-NGP  
(U/mg protein) 
Cellobiose 
 (U/mg protein) 
Control 0.00729 ± 0.0001 0.0021 ± 0.002 
Wild-type 0.193  ± 0.01 0.0668 ± 0.001 
L173H 0.130  ± 0.01 0.124 ± 0.004 
H23L 0.219 ± 0.004 0.0738 ± 0.006 
L173H + H23L  0.156 ± 0.007 0.170 ± 0.01 
 
 
 
Cellobiose Uptake Rate  
(U/gCDW) 
Control               0.006 ± 0.001 
Wild-type               1.77 ± 0.07 
D433G               2.09 ± 0.05 
C82S               2.63 ± 0.2 
D433G + C82S               2.82 ± 0.2 
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Table 3.4: Primers used in this study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PGKt-kanMX-R 5‟-CCTCACTAAAGGGAACAAAAGCTGGAGCTCCACCGCGGTGGCAGGAAGAATACACTATAC-3‟ 
BGL EP-F 5‟-CTCTCTTGTTTCTATTTACAAGACACCAATCAAAACAAATAAAACATCATCACAATG-3‟ 
BGL EP-R 5‟-GCCGACAACCTTGATTGGAGACTTGACCAAACCTCTGGCGAAGAAGTCCAAAGCTTTA-3‟ 
CDT EP- F 5‟-CTTCTTGCTCATTAGAAAGAAAGCATAGCAATCTAATCTAAGTTTTAATTACAAAATG-3‟ 
CDT EP-R 5‟-GGATGGGGAAAGAGAAAAGAAAAAAATTGATCTATCGATTTCAATTCAATTCAATCTA-3‟ 
internal-BGL-
ADHt-F 
5‟-GAAGCCGCTCTTTGACTCTTTGATCAAGAAGGACTAAAGCTTTGGACTTCTTCGCCAGAG-3‟ 
internal-TEFp-
CDT-R 
5‟-CGGTGCTGGCCCCGTCATGGGAGCCGTGAGACGACATTTTGTAATTAAAACTTAGATTAG-3‟ 
B2-H23L-F 5‟-GGGTGCTATCCTCGCCGACGGCCGTGGC-3‟ 
B2-H23L-R 5‟-GCCACGGCCGTCGGCGAGGATAGCACCC-3‟ 
C2-C82S-F 5‟-CGCCTTTTGTAGTGCATGCGCCAACGG-3‟ 
C2-C82S-F 5‟-CCGTTGGCGCATGCACTACAAAAGGCG-3‟ 
qPCR-BGL-F 5‟-AACCAGAAGGGCATCGACCACTAT-3‟ 
qPCR-BGL-R 5‟-GCACTTGGGAATGGCCTTGAACAT-3‟ 
qPCR-CDT-F 5‟-AATCCCCTCGCTTCCTATTTG-3‟ 
qPCR-CDT-R 5‟-TCCTGATACCGTCCCTCATC-3‟ 
CDT 
sequencing-
TEPp-F 
5‟-CTTTCGATGACCTCCCATTGATATTTAAG-3‟ 
CDT 
sequencing- 
PGKt-R 
5‟-CGAATGGGAAAAAAAAACTGCATAAAGGC-3‟ 
BGL 
sequencing-F 
5‟-CCTTTGGTTTTTTATTCTTAACTTG-3‟ 
BGL 
sequencing- R 
5‟-GAAGTGTCAACAACGTATCTACCAACG-3‟ 
Prs Kanmx-
PYK-BGL-F 
5‟-CGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGAATGCTACTATTTTGGAG-3‟ 
BGL-
Linker+GFP-R 
5‟-CTCATAGAACCTCCACCTCCAGAACCTCCACCTCCGTCCTTCTTGATCAAAGAGTC-3‟ 
BGL-
Linker+GFP-F 
5‟GAGCTTGAAGCCGCTCTTTGACTCTTTGATCAAGAAGGACGGAGGTGGAGGTTCTGGAGGTGGAGGTTCTATGAGTAAAGGAG
AAGAACTTTTCACTGG-3‟ 
Linker+GFP-
AHDt-R 
5‟-GGAGACTTGACCAAACCTCTGGCGAAGAAGTCCAAAGCTCTATTTGTATAGTTCATCC-3‟ 
 Linker+GFP-
ADHt-F 
5‟-GCTGGGATTACACATGGCATGGATGAACTATACAAATAGAGCTTTGGACTTCTTCGCCAG-3‟ 
 ADHt-CDT 
Cas-KanMX-R 
5‟-CCTCACTAAAGGGAACAAAAGCTGGAGCTCCACCGCGGTGGCAGGAAGAATACACTATAC-3‟ 
BGL CDT 
Cassette-Linker 
GFP-R 
5‟-CTTTACTCATAGAACCTCCACCTCCAGAACCTCCACCTCCAGCAACGATAGCTTCGGAC-3‟ 
BGL CDT- 
Linker GFP-F 
5‟CGTCCAGGCCGACGGCCATGTGTCCGAAGCTATCGTTGCTGGAGGTGGAGGTTCTGGAGGTGGAGGTTCTATGAGTAAAGGAG
AAGAACTTTTCACTGG-3‟ 
Linker GFP- 
PGKt-R 
5‟-GAAAAAAATTGATCTATCGATTTCAATTCAATTCAATCTATTTGTATAGTTCATCC-3‟ 
Linker GFP-
PGKt-f 
5‟-GCTGGGATTACACATGGCATGGATGAACTATACAAATAGATTGAATTGAATTGAAATCG-3‟ 
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3.8 Figures 
 
 
 
 
Figure 3.1: Fermentation profiles of the directed evolution  rounds for the pathway libraries 
from Yuan et al. (3). (a,b) Cellobiose consumption and ethanol production of the cellobiose 
utilization pathway from the promoter-based directed evolution. The square represents the parent 
pathway with no mutations in the PDC1 and ENO2 promoter. The circles are the first round of 
error-prone PCR of both promoters. The triangles represent the second round of directed 
evolution, and the grey triangle represents the final round of mutagenesis.  
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Figure 3.2: A general scheme for the directed evolution of multiple proteins within a metabolic 
pathway. Diversity is introduced to the genes through error-prone PCR, DNA shuffling, or other 
mutagenesis techniques. The genes are then recombined through homologous recombination into 
the pathway. A non-mutagenized fragment for the interior - promoter and terminator is also 
amplified and assembled. Screening is accomplished via colony size on cellobiose agarose 
plates. Large colonies are associated with faster growth and selected for further analysis. To 
confirm phenotype is a result of the improved pathway and not from adaption, the pathways are 
restransformed. Improved mutants are selected for a second round of diversification and 
screening. 
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             (a)      (b) 
 
Figure 3.3: Selection plates of the error-prone library on cellobiose plates, depicting the large 
colonies. (a) wild-type pathway with all uniform colonies (b) error-prone PCR library. 
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Figure 3.4: (a) Specific growth rates of mutants in the top 10% fastest growers in the initial tube 
screening of the library created by the first round of error-prone PCR. (♦) is the wild-type 
pathway (♦) depicts the selected clones, numbered on the x-axis. (b) Cellobiose utilization from 
confirmation of clones with high specific growth rate fermentation carried out in oxygen limited 
conditions in un-baffled flasks. (■) (♦) denote the wild-type pathway cellobiose consumption, (■) 
(x) represent two of the faster cellobiose utilizing pathways. 
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(a)  
 
(b)  
(c)  
 
Figure 3.5: Fermentation profile of the improved cellobiose utilization pathways under oxygen 
limited conditions: (■) wild-type pathway, (●) R1 pathway, (▲) R2 pathway (a) Growth curve, 
(b) Cellobiose utilization, (c) Ethanol production. Error bars derived from biological triplicates. 
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Figure 3.6: Glucose accumulation in oxygen limited fermentation (■) wild-type pathway, (●) R1 
pathway, (▲) R2 pathway. 
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Figure 3.7: Consistent protein expression levels between mutants. Quantitative PCR analysis of 
relative mRNA levels of the mutations (a) of the gh1-1  and (b) the cdt-1. Relative expression is 
normalized to the average value of the housekeeping gene. GFP-fusion to the wild-type and 
mutant proteins was also performed to compare specific protein concentration of the strains (c) 
β-glucosidase and (d) cellodextrin transporter. Arbitrary fluorescence units (AFU) are 
normalized to the wild-type average value. Error bars represent the standard deviation of at least 
three biological triplicates. A two-tailed student t-test confirmed that there were no significant 
differences in mRNA levels or protein concentration levels when tagged with GFP (p-values all 
greater than 0.05). 
(a) 
(b) (a) 
(c) (d) 
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(a)    (b)  
 
Figure 3.8: Consistent protein expression levels between mutants shown through Western blot 
analysis. Cell lysates have been normalized by total protein concentration. (a) Samples read from 
left to right, β-glucosidase wild-type, R1, and R2 and (d) Samples read from left to right, 
cellodextrin transporter wild-type, R1, and R2. No significant difference in protein expression 
can be discerned through Western Blot analysis. 
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(a)     
(b)  
 
Figure 3.9:  (a) Growth rate and (b) ethanol productivity of the single and double mutants on 
cellobiose as a sole carbon source. Error bars are derived from biological triplicates. Each bar 
represents the mutation in the β-glucosidase coupled with that of the cellodextrin transporter. The 
black bar is the wild-type, the red bar is the L173H, the blue bar represents the double mutant 
L173H and H23L, and the final grey bar is the single H23L. The dotted line denotes statistically 
significant values over the wild-type (p < 0.05). 
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Figure 3.10:  Homology model of the N. crassa β-glucosidase with the cellobiose substrate 
docked into the active site. The L23 mutation is notably far from the active site and the 
cellobiose substrate down in the center. 
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(a)  
(b)  
 
Figure 3.11:  Homology model of the N. crassa β-glucosidase with the cellobiose substrate 
docked into the active site. (a) The critical residue in the wild-type enzyme L173 has no 
predicted interaction with the cellobiose molecule. (b) The mutated residue H173 is predicted to 
have direct hydrogen bonding with the hydroxyl group on the C1 atom of the cellobiose 
molecule.  
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Figure 3.12: Sequence-structure based mapping of the cellodextrin mutations. The HMMTOP 
software predicted sequence-structure of the transmembrane helix, inner, and outer loops of the 
cellodextrin transporter in the cell membrane. The top of the graphic depicts outside of the cell, 
while the bottom. The mutations were overlaid onto the structure prediction. 
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Chapter 4: Engineering a Novel Pathway for Advanced Biofuel Production 
4.1 Background 
To compete in a market dominated by fossil fuels, biofuels must be economically competitive 
and also offer the variety of molecules and compounds which are currently derived from fossil 
fuels. In the evolution of microbial-based biofuels, bioethanol has been the first major player, 
with a large market share coming from Brazil and the USA (1). However, as a fuel alternative 
ethanol is not ideal when compared to petrol, due to its low energy density, high recovery costs, 
corrosiveness, and high hygroscopy (2-4). Additionally, though bioethanol could be used in car 
engines, it is likely not to be successful in higher powered vehicles such as planes, buses, and 
trains (1). The molecule is also curbed in potential market share, due to the limited commodity 
and special chemicals which can be derived from it. The fossil fuels that biofuels are 
endeavoring to replace more closely resemble fatty acids.  
 
Fatty acids are only one catalytic step away from petroleum-derived diesel molecules and have 
become a focus in advanced biofuel production. Derived from fatty acids, fatty acid ethyl esters 
(FAEEs), a type of biodiesel, are a non-toxic, biodegradable, drop-in fuel. Compared to fossil 
fuel derived diesel, the use of biodiesel in current engines can reduce emissions due to less 
carbon monoxide, sulfur, aromatic hydrocarbons, and soot particles produced from the 
combustion process (4,5). Considering market prospects, FAEEs and longer chain hydrocarbons 
are already one of the largest renewable fuels in Europe (6) and have the potential to meet 
commodity/specialty chemical demands (7). 
 
115 
 
4.1.1 Fatty Acid Synthesis and FAEE Production 
Fatty acid biosynthesis is a complicated, iterative process which requires the coordination of 
many different reactions to elongate the carbon chain. There are various platforms and systems 
to produce fatty acids in different organisms; however the overall catalytic mechanisms are the 
same. The first committed step in fatty acid biosynthesis is the carboxylation of acetyl-CoA by 
acetyl-CoA carboxylase (ACC). This forms malonyl-CoA, which is subsequently converted by a 
malonyl CoA:ACP transacylase to malonyl-ACP. A series of iterative chain elongation steps that 
occur in a cyclical fashion then occurs. The growing acyl chain is covalently attached to the acyl-
carrier protein (ACP) through a thioester linkage on the terminal sulfhydryl of the 
phosphopantetheine prosthetic group. The first elongation step is initiated by the Claisen 
condensation of malonyl-ACP with an acyl-CoA, catalyzed by the first condensing enzyme 
β-ketoacyl-ACP synthase III. This forms 3-ketoacyl-ACP. The β-ketoacyl-ACP synthases 
condense malonyl-ACP with acyl-ACP to extend the acyl chain by two carbons. The NADPH-
dependent β-ketoacyl-ACP reductase reduces the 3-keto group to a 3-hydroxy intermediate. This 
intermediate is then dehydrated by the 3-hydroxyacyl-ACP dehydratase to a trans-2-enoyl-ACP. 
The final step reduces the enoyl chain by a NAD(P)H dependent enoyl-ACP reductase. After 
each complete cycle of condensation and chain reduction, the growing acyl chain is transferred 
back to the ketosynthase to initiate the next cycle (8). 
 
Two classes of enzymes catalyze these reactions: Type-I and Type-II, which are categorized 
based on the enzyme architecture. Type-II fatty acid synthases are comprised of distinct 
individualized enzymes, completing each condensation and reduction separately. All of these 
enzymes require independent expression mechanisms or operon structures. Type-I fatty acid 
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synthase (FAS) is a large multifunctional enzyme, wherein nearly all of the enzymes involved in 
the fatty acid synthesis are combined into a single protein.  
 
Fatty acids can be converted to FAEEs through an esterification reaction with ethanol, performed 
by a bacterial wax ester synthase (WS) (5). The initial microdiesel studies were done in E. coli 
(5). However, S. cerevisiae is more intuitive chassis for the biodiesel production due to its 
endogenous ethanol supply. Some of the original work on FAEE production in S. cervisiae 
investigated five different wax ester synthases in S. cerevisiae and identified the most active 
enzyme as WS2 from Marinobacter hydrocarbonoclasticus (9). This enzyme was subjected to 
further enzymatic studies and the residues critical for selectivity to reduce the promiscuity were 
discovered (10,11).  
 
Host engineering strategies have been successful in increasing FAEE production in S. cerevisiae 
(9,12-14). However, in these studies, the endogenously produced fatty acids which are used to 
generate the FAEEs are diverted from growth and cellular metabolism. Synthetic biology offers 
an orthologous approach to the fatty acid production, by heterologously overexpressing a parallel 
fatty acid synthesis pathway. This would provide additional fatty acids to supplement growth and 
to provide fatty acids needed for FAEE synthesis. By supplying a heterologous fatty acid pool, 
the flux redirected from endogenous cellular metabolism to FAEE production would be reduced. 
More importantly, it was hypothesized the endogenous fatty acid system could be limiting the 
flux towards fatty acids due to strong regulation. Therefore, it was expected that the endogenous 
regulation for fatty acid biosynthesis could be overcome by the heterologous expression of the 
fatty acid synthesis genes (15-17). In this study, we endeavored to overexpress the bacterial FAS 
117 
 
Brevibacterium ammoniagenes FAS-B (bafas) gene (18). This baFAS enzyme has previously 
exhibited a high activity in S. cerevisiae (19). The ppt1 gene from Brevibacterium 
ammoniagenes was co-expressed with the bafas gene, encoding for the phosphopantetheine 
transferase (PPT1), which activates the FAS. Co-expression of the bafas  and ppt1  genes in 
E. coli produced palmitic acid (18). Fatty acids produced by the baFAS would then be converted 
to the activated acyl-CoA form by an acyl-CoA ligase (FAA1). In the final step on the pathway, 
the fatty acid acyl-CoA molecules would be converted to FAEEs by a wax ester 
synthatase/acyl-coenzyme A:diacylgylcerol acyltransferase (WSDGAT), which has been 
extensively studied for FAEE production (5,9,12,13,20) (Figure 4.1). 
 
4.2 Results  
4.2.1 WS Functionality 
Initial experiments investigated the activity of two WS/DGAT genes. One WS originated from 
Marino hydrocarbonoclasticus (ws2) and the other from Acinetobacter baylyi (ab). The ws2 
gene was codon optimized for expression in S. cerevisiae by DNA 2.0 (Menlo Park, CA), 
whereas the ab gene was cloned directly from the native organism using the primers described in 
Table 4.1. Both genes were cloned under the PGK promoter and PGK terminator into a pRS426 
plasmid. Using culture conditions which were shown to produce FAEEs (9), it was discovered 
the AB enzyme did not produce any significant FAEEs. Considering that this gene was not 
codon optimized for expression in S. cerevisiae, this result is not surprising. However, the strain 
harboring the codon optimized gene encoding for the WS2 enzyme did produce FAEEs (Figure 
4.2a). The WS2 enzyme was further characterized: the activity towards its native substrate 
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hexadecanol and ethanol were analyzed (Figure 4.2b). This WS2 has been previously utilized in 
FAEE studies in yeast (9,12), therefore our continued work focused on this WS2 enzyme. 
 
4.2.2 FAS Functionality 
The bafas and ppt1 genes were cloned from plasmid PGM44 (18,21) using the primers from 
Table 4.1. The bafas gene was cloned under control of the TPI promoter, which was expected to 
be a strong promoter (22). The ppt1 gene was cloned under control of the TEF1 promoter, also 
expected to be strong (22). The corresponding bafas and ppt1 expression cassettes were cloned 
into two different plasmids for use in different strains with varying selection markers: pRS424 
and pRS426. The pRS424-FAS&PPT1 plasmid was co-expressed with the PRS426-WS2 
plasmid (strain DE17) and improved FAEE production through the baFAS enzyme was not 
observed (Figure 4.3). 
 
To investigate if the heterologous genes bafas and ppt1 could function similarly to the 
endogenous fatty acid synthase in S. cerevisiae, the genes were expressed in a BY4741 strain 
deficient in endogenous fatty acid production, which was previously constructed by graduate 
student Jiazhang Lian in our laboratory (Table 4.2). The ∆fas strain harboring the 
pRS426-FAS&PPT1 plasmid generated strain DE09. Strain DE09 was able to grow without 
exogenous fatty acid supplementation, therefore it was concluded that the bafas and ppt1 genes 
complemented fatty acid synthesis (Figure 4.4). The titer of the heterologous free fatty acids of 
strain DE09 was then compared to the endogenous free fatty acid pool titer of strain DE13, 
which is parental BY4741 (Figure 4.5). Strain DE09 yielded a 2.75-fold increase in free palmitic 
acid (p-value <0.05) compared to strain DE13.  
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4.2.3 Confirmation of a Heterologous FAEE Pathway 
The endogenous fas knockout strain was also used to confirm if a strain harboring the full 
biodiesel pathway (FAS-PPT1-FAA1-WS2) could successfully produce FAEEs without 
endogenous fatty acids. The heterologous pathway enzymes would need to provide fatty acids 
for both cell growth and also for FAEE synthesis. The plasmid pRS426-FBDP (Table 4.2) was 
transformed into the knockout strain, generating strain DE10. After a very long recovery phase, 
the strain did grow and produced detectable FAEEs.  
 
The FAEE production of strain DE10 was compared to the FAEE production of the BY4741 
strain, which over-expressed only the ws2 gene (DE01). Strain DE10 yielded a 7-fold increase in 
total FAEE production (Figure 4.6) over strain DE01. It is important to note that this increase in 
FAEE titer could be due to an increase in copy number of the plasmid, based on an increased 
selection pressure, which would increase ws2 gene expression. This work demonstrates that the 
heterologous fatty acid synthase genes bafas and ppt1 can restore fatty acid synthesis for cell 
growth while simultaneously providing sufficient fatty acids for FAEE production in yeast 
 
4.2.4 Media Testing 
Fatty acid production is a very energy intensive process and it was hypothesized that the system 
could be nutrient limited. The pRS426-WS2 plasmid was reconstructed with antibiotic based 
markers (G418) for fermentation in rich medium rather than drop-out synthetic media and tested 
for FAEE production (strain DE06). However, no FAEEs were detected in the rich media 
fermentations. It was possible that the selection pressure using the antibiotic marker was not high 
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enough for adequate expression of the ws2 gene. The experiment was repeated using strain 
DE10, which had previously demonstrated high expression of the pathway genes when cultured 
in synthetic media. However, fermentation in rich (YPD) media produced very small amounts of 
FAEEs while the same clone cultured in synthetic media (SCD-URA) produced significant 
FAEEs (Figure 4.7). Strain DE10 was able to grow in YPD media, therefore the plasmid was 
present and the baFAS enzyme was producing enough fatty acids. The WS2 enzyme must have 
become inactivated, either through loss of expression or inhibition. The PGK1 promoter 
controlling the ws2 gene has shown to be active in YPD media (23). Therefore, the absence of 
FAEE production in YPD media has remained unsolved, though future industrial systems will 
apply a synthetic complex media, more similar to the SCD media. Thus, the SCD media 
fermentations are recommended for all further analysis. 
 
4.2.5 HXT5 Promoter 
Expressing the pRS426-FBDP yielded heterologously produced FAEEs in the ∆fas strain 
(DE10). However, transformation of the pRS426-FBDP plasmid into BY4741 (DE03) did not 
yield significantly improved FAEE titers. Subsequent qPCR analysis revealed very low 
expression of the bafas gene (Figure 4.8). The bafas gene mRNA levels showed a 10-fold 
decrease in the levels of the bafas gene in DE03 compared to DE10. It was determined that the 
selection pressure was higher in DE10, which improved the expression of the bafas gene. A 
stronger promoter was needed to express the bafas gene in the wild-type BY4741 strain. A 
systematic look at promoters through microarray studies conducted by graduate student Jonathan 
Ning suggested that the promoter HXT5 had significantly strong activity, especially in SC media 
(Figure 4.9). 
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The bafas gene was cloned under control of the strong HXT5 promoter, generating plasmid 
pRS426-HFBDP. This plasmid was transformed into BY474, generating strain DE04, and the 
FAEE production from the strain was compared to the titer of the BY4741 strain harboring only 
the pRS426-WS2 plasmid (DE01). Strain DE04 resulted in an improved FAEE production 
compared to FAEEs produced from strain DE01. Palmitic acid ethyl ester production in DE04 
was increased by 4.6-fold with a p-value of 0.003 using a standard one-tailed, two sample 
unequal variances t-test. Palmitoleic acid ethyl ester production increased 6.6-fold over DE01 
with a p-value of 0.047. Stearic acid ethyl ester was also increased by 7.3-fold with a p-value 
of 0.017. Oleic acid ethyl ester production increased by 12-fold compared to DE01 with a 
p-value of 0.009. Total FAEE production was improved 6.3-fold in DE04 compared to DE01 
with a p-value of 0.007 (Figure 4.10). Strain DE01 produced 1670 µg FAEE/ g CDW compared 
to the 10,498 µg FAEE/ g CDW, produced by strain DE04. Sample size for the strain DE01 was 
9 and sample size of the DE04 was 11. Margin of error was high, a common problem found in 
the fatty acid ethyl ester quantification (12).   
 
4.2.6 Integrated ws2 Gene 
In efforts to reduce the variability in the data and to simplify the system, the ws2 expression 
cassette was integrated into multiple δ-sites of the S. cerevisiae chromosome. The integrated ws2 
expression system produced only slightly more FAEEs than the plasmid system, but still with 
large margins of error (Figure 4.11). The clone named Int7 (DE14) conferred the lowest margin 
of error and was chosen for further analysis.  Interestingly, mRNA levels of the ws2 gene were 
extremely high in the integrated version. The integrated clones of DE14 had a 65-fold 
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improvement in ws2 gene mRNA levels as compared to the mRNA levels of strains harboring 
the plasmid version of the ws2 gene (DE01). The discrepancy in high mRNA level and moderate 
FAEE production has not been investigated (Figure 4.12) 
 
4.2.7 Integrated Coexpression 
Super-copy plasmids with truncated promoters for the uracil selection gene were constructed by 
graduate student Jiazhang Lian and undergraduate Run Jin. These plasmids have been shown to 
have extremely high expression abilities due to increased selectivity (24). The bafas gene under 
the TPI promoter and also the HXT5 promoter was cloned with the ppt1 expression cassette into 
the supercopy plasmid. These fatty acid synthase plasmids were expressed in the ws2 integrated 
strain, named DE11 and DE12 for the TPI and HXT5 promoter respectively (Table 4.2). 
However, no increase in FAEE production compared to FAEEs produced from DE14 was 
observed (Figure 4.13).  
 
4.2.8 Cellobiose Utilization for FAEE production 
Ultimately, any advanced biofuel production will come from biomass, of which cellobiose is a 
major constituent, therefore proof-of-concept studies to be able to produce FAEEs from 
cellobiose are significant. The cellobiose utilization pathway which had been engineered in 
Chapter 3 was transformed into the DE14 strain. After 200 hours in SC media supplemented with 
8% cellobiose as the sole carbon, nearly 2/3 of the cellobiose had been consumed. Extraction and 
quantification of the FAEEs in the culture yielded FAEE production from cellobiose as the sole 
carbon source (Figure 4.14). 
 
123 
 
4.3 Discussion 
Fatty acids are energy-dense long chain carboxylic acids used in energy storage for many 
different organisms. These molecules are the precursors to fatty acid ethyl esters (FAEEs), which 
are a more effective biofuel than bioethanol and significant efforts have investigated biodiesel 
production in microbes (4,5,9,12-14,25). Host engineering strategies have been successful in 
increasing FAEE production in S. cerevisiae. Shi et al. overexpressed the endogenous ACCp1 
gene to overproduce acetyl-CoA, a major precursor of fatty acids (9) and more recent work 
looked into multiple integrations of the ws2 gene into the chromosome (26). Rungphan et al. 
considered endogenous regulation, by replacing the endogenous promoter of the FAS1 and FAS2 
with the TEF1 constitutive promoter (13). In another host engineering strategy, de Jong et al. 
overexpressed genes in the ethanol degradation system to improve availability of NADPH, a 
major component in fatty acid synthesis. A second strategy de Jong used was to over-express a 
phosphoketolase pathway to re-channel the carbon flux through the oxidative section of the 
pentose phosphate pathway, pushing the production of precursors to fatty acids (12). These 
strategies have all focused on using the endogenous fatty acid biosynthetic pathway of 
S. cerevisiae. Fatty acid synthesis genes were over-expressed to produce a larger flux of fatty 
acids to be shared between basic cell metabolism and growth with the FAEE production.  
 
A complementary strategy to these host engineering methods is the use of a heterologous fatty 
acid synthetic pathway.  This strategy can offer a completely parallel and orthologous system to 
produce sufficient fatty acids to minimize the flux being redirected from cellular metabolism. 
Additionally, this strategy can overcome the endogenous regulation mechanisms which have 
evolved to control the energy-intensive fatty acid biosynthesis. The endogenous FAS system has 
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evolved to have tight regulation and control, which could be difficult to overcome with only host 
engineering strategies. 
 
4.3.1 Fatty Acid Synthesis Systems 
Here we describe a heterologous FAS production system, through the use of a Type-I FAS from 
actinobacteria. Type-I FAS systems offer a simplified approach for overproduction of fatty acids, 
as compared to the Type-II FAS systems, which have been investigated for over production of 
fatty acids in E. coli (25). Type-II FAS systems consist of independently expressed genes which 
could require some significant engineering and balancing to optimize the pathway in a 
heterologous host. The Type-I system relies on a single multi-functional enzyme under a single 
expression system and the iterative chain elongation mechanism involves enzyme-bound 
intermediates being cycled through the catalytic domains. A single enzyme system is beneficial 
because gene expression of the individual domains do not need to be balanced and mass transfer 
between the enzymes is not a concern as the enzymes are linked together in their own natural 
protein scaffold. Balancing protein expression and mass transfer are two problems which could 
occur in heterologous expression of Type-II systems and have been shown to be significant in 
optimizing biosynthetic pathways (27-29). Each specific Type-I FAS will produce different 
chain length fatty acids, an inherent characteristic of the enzyme (30). Bacterial Type-I fatty acid 
synthases have shown to be different from other FASs by being primarily bimodal in the chain 
length products, generally producing a chain length of 16 to 18 and also 24 to 30 carbons.  
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4.3.2 Heterologous Fatty Acid Ethyl Ester Synthesis 
The heterologous pathway in this work involved the Type-I fatty acid synthase (FAS) from 
B. ammoniagenes coupled with independent expression of its respective phosphopantetheine 
transferase (PPT1). The PPT1 is responsible for activating the acyl carrier protein of the baFAS. 
Additionally, the free thiol moiety of the PPT1 covalently binds to the elongating fatty acid 
chain, transferring the chain through the distinct reaction domains of the FAS (31). The 
heterologously produced fatty acids are processed by an over-expressed fatty acid acyl-CoA 
ligase from S. cerevisiae. The activated fatty acids are then used as a co-substrate with ethanol by 
the wax synthase to produce FAEEs. Through this strategy, total FAEE production was increased 
6.3-fold compared to a strain expressing only the ws gene, with a p-value of 0.0078 using a 
standard one-tailed, two sample unequal variances t-test (Figure 4.10). The p-value statistical 
analysis is important to consider based on the variation from biological clones. It is expected that 
the variation is due to the 2-micron plasmids variations, introducing different copy numbers of 
plasmids to each clone. 
 
4.3.3 HXT5 Promoter and FAS Expression 
Addition of the HXT5 promoter was also important in this study as the bafas gene would not 
express unless it was under the control of the very strong promoter HXT5. Graduate student 
Jonathan Ning investigated a microarray study to determine strong promoters. Of the eight 
promoters investigated in his study, the HXT5 promoter was the strongest in synthetic (SC) 
drop-out media. Often the TEF1 is considered a strong promoter, but the HXT5 exhibited a 
3-fold increase in GFP-expression in control studies compared to the TEF1. The HXT5 
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transporter protein is known to have a low affinity for glucose and is expressed in nutrient 
limiting conditions, therefore a strong expression is required for growth in minimal media (32). 
 
It is important to note that there was significant variation in this system. With each biological 
replicate there was a large error for the FAEE quantification, which is attributed to the variation 
in the copy number of the plasmid and also in the extensive extraction protocol. One strain 
(DE04) exhibited the 6.3-fold improvement in the total FAEE production. Initial work with this 
clone resulted in a total FAEE titer of 10, 498 µg/ gCDW, averaged from 11 independent clones. 
However, after retrieving this clone from the frozen stock, the titer decreased to 2,780 µg/ 
gCDW, though the overall titer from DE01 also decreased. The fold improvement was still 6-
fold over the DE01 strain. To confirm this improvement was coming from the plasmid, the DNA 
was transformed into fresh BY4741 cells, clones from these new transformants also exhibited 
increased FAEE production, however none has significantly improved as strain DE04. These 
fresh transformants, compared to DE01, exhibited a 2- and 5- fold improvement instead. 
Additionally, some clones exhibited a decrease in FAEE production compared to DE01. Causes 
of these major variations are currently unknown, but assumed to be due to copy number 
variations in the plasmid. However, DE04 has been tested many times and has continuously 
exhibited the significant improvement in the FAEE production, with a final titer of 2,780 µg/ 
gCDW . 
 
4.3.4 Cellobiose Consumption for FAEE Production 
Coming full-circle in this thesis, the cellobiose utilization pathway which was optimized in 
Chapter 4 was used to produce FAEEs from cellobiose as a sole carbon source. The media and 
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host conditions were not the same as which were used to optimize the cellobiose utilization 
pathway, therefore this pathway is not extremely efficient. However, we wanted to simply 
demonstrate that cellobiose can be consumed as the sole carbon source to produce FAEEs. It is 
hypothesized that use of cellobiose or xylose as a substrate could improve the availability of 
NADPH, by shuttling through the pentose phosphate pathway, instead of glycolysis, however no 
significant controlled experiments were conducted for this analysis in this study. 
 
This work represents the first time a heterologous FAS pathway has been constructed to 
over-produce fatty acids for the production of biofuels in S. cerevisiae. This strategy yielded a 
6.3-fold improvement in total FAEEs produced. This improvement is based on increased 
availability of heterologously produced fatty acids providing an orthologous route for FAEE 
production, which essentially decoupled the FAEE production from endogenous metabolism. 
However, it should be noted that even though the fatty acid synthesis is heterologous and 
orthologous, the fact that the precursor of fatty acid synthesis, acetyl-CoA, is not heterologously 
produced should not be ignored. Using host engineering strategies to improve production of the 
acetyl-CoA could increase the productivity of the pathway even more. Additionally, combining 
this synthetic biology approach with the host engineering strategies previously mentioned could 
synergistically increase the FAEE titer (9,12,13).  
 
4.3.5 Future work 
Figure 4.15 is a thin layer chromatography plate visualizing the lipids extracted from strains 
DE01 and DE04. Unidentified lipid spots in strain DE04, harboring the full biodiesel pathway, 
have a higher concentration than compared to spots on DE01, the strain harboring only the ws2 
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gene. It is suggested for future work in this pathway to consider these unidentified lipids and 
knockout these competing routes to redirect the flux towards FAEEs. 
 
4.4 Conclusion 
Strategies and solutions to identify future renewable energy sources will be complex and diverse. 
In order to construct a broad arsenal of possible routes for success, different strategies must be 
explored and combined for synergistic improvements. We offer here, a new pathway for FAEE 
production in S. cerevisiae. By an orthogonal fatty acid synthesis, the supply of fatty acids for 
both growth and for FAEE production is increased, therefore not diverting the flux of fatty acids 
away from cellular metabolism. 
 
4.5 Materials and Methods 
4.5.1 Strains and plasmids 
S. cerevisiae strains used in this work are provided in Table 4.2. All plasmid constructions were 
accomplished through DNA assembler (33) unless otherwise noted. The ws2 gene was codon 
optimized and synthesized by DNA 2.0 (Menlo Park, CA) and assembled under control of the 
PGK1 promoter/terminator in a pRS426 plasmid (pRS426-WS2). The bafas and ppt1 genes from 
Brevibacterium ammoniagenes were cloned from pGM44 (18) under control of the TPI1/TPI1 
promoter/terminator and TEF1/TEF1 promoter/terminator respectively (pRS426-FAS). The faa1 
gene from S. cerevisiae was expressed under control of the PYK1/ADHt promoter and terminator 
(pRS425-scFAA1). Due to the size and GC composition of the bafas gene, we endeavored to 
avoid excessive PCR amplification of the gene. For ease of plasmid construction, a helper 
plasmid was assembled first which included the expression cassettes for the ppt1, ws2, and faa1. 
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The pRS426-FAS plasmid was linearized and used as backbone to insert the helper plasmid 
expression cassettes in 5 kilobase (kb) fragments with 2 kb homologous region overlap. Further 
work required replacing the TPI1 promoter of the bafas gene with the HXT5 promoter, which 
was completed by using restriction digests PacI and RsrII to separate the TPIp and part of the 
bafas gene. The plasmid was reassembled with the HXT5 promoter and the bafas gene fragment. 
Construction of all plasmids was confirmed via restriction digest maps and partial sequencing. 
 
The SuperCopy plasmid was constructed by graduate student Jiazhang Lian and undergraduate 
student Run Jin. Truncation of the promoter of the selection marker weakened the cell‟s ability to 
synthesize uracil. This weakened expression forced a high copy number of the plasmid to 
accommodate for the loss of activity. This plasmid was used to force a high selection pressure 
and therefore high expression of the bafas and ppt1 gene.  
 
The BY4741 ∆fas was constructed by graduate student Jiazhang Lian. The full fas1 gene was 
replaced with a KanMX expression cassette, completely disrupting the endogenous fatty acid 
synthesis. 
 
All transformations followed standard Lithium Acetate transformation protocol for S. cerevisiae 
as described previously (33). However, transformation of DNA into the ∆fas strain required a 12 
hour incubation period after inoculation, supplemented with exogenous 2% palmitic acid and 
G418 for selection of the knockout. The transformants were recovered in YPD media with 0.01% 
palmitic acid for five hours. The cells were then transferred to agar plates or liquid media with 
and without palmitic acid supplementation. 
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4.5.2 Media, and Culture Conditions  
Seed cultures of strains for FAEE detection were grown in 2% glucose CSM-URA or CSM-LEU 
(MP Biomedical, Santa Ana California) to stationary phase at 30°C with orbital shaking at 
250 rpm and then transferred to 125-mL baffled flasks with 25 mL SC-URA at an initial OD of 
0.05 at 30°C with orbital shaking at 100 rpm. As needed, 200 µg/mL G418 (KSE Scientific, 
Durham, NC) supplemented media for selection. Escherichia coli 10-β (New England Biolabs, 
Ipswich, MA) was used for recombinant DNA manipulations. E. coli strains were cultured in 
Luria broth (LB) (Fischer Scientific, Pittsburgh, PA) at 37 °C and 250 rpm, supplemented with 
50 µg/mL ampicillin. Yeast and bacterial strains were flask frozen and stored in 15% glycerol 
at -80 °C. All chemicals were purchased from Sigma Aldrich or Fisher Scientific. 
 
4.5.3 Lipid Extraction and Thin Layer Chromatography 
FAEE detection was conducted as previously reported (5,9,34). Cells were harvested and washed 
with sterile water before being applied to a freeze-dryer overnight. Dried cell weight was 
normalized and then rehydrated with digestion buffer (1.2 M glycerol, 100 mM sodium 
thioglycolate, 50 mM Tris-SO4, pH 7.5) and 15 Units of zymolase (Zymo Research, Irvine CA). 
After incubation at 37°C and 250 rpm, cells were extracted twice with 2:1 chloroform methanol 
mixture at 4°C with continuous vortexing. 25 µg of lauric acid ethyl ester was used as an internal 
standard. The lipid mixture was applied to a TLC silica gel 60 F254 plate (EMB Millipore, 
Darmstadt, Germany) with a mobile phase of heptane, 2-proanpol, and acetic acid (95:5:1 v/v/v). 
Lipids were visualized through a 0.05% 2,7-dichlorofluesceine mixture in ethanol. The FAEEs 
were isolated by scraping the FAEEs off the TLC plates using a scalpel and then extracted from 
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the TLC power with a mixture of hexane, methanol, and water (3:2:2). The upper phase was 
separated and transferred to glass GC-vial inserts for analysis. 
 
4.5.4 Free Fatty Acid Extraction 
Quenching was conducted on the cells to quantify the free fatty acid pool. Cells were flash 
frozen by a methanol-dry ice bath. The mixture was centrifuged at 4000 rpm for 5 minutes and 
then the cell pellet was separated from the media. Cells pellets were then lysed by boiling at 
100°C in ethanol for 10 minutes. Cell membrane was separated by centrifugation and the 
supernatant was applied to a freeze-dryer overnight or until dry. The lipids were then extracted 
twice with 2:1 chloroform/methanol using 50 µM myristic acid as an internal standard. After 
extraction, the fatty acids were allowed to derivatize for 2 hours at room temperature with 
200 µL of 2N TMS-diazomethane, 10 µL methanol and 10 µL HCL. The sample was then 
transferred to a glass GC vial for analysis. 
 
4.5.5 GC-MS Analysis  
The fatty acids were separated and quantified through a GC-MS-QP 2010 Plus (Shimadzu, 
Kyoto Japan). The separation was performed by a DB-WAX GC column with the following 
dimensions: 30 mm x 0.25 mm internal diameter, 0.25 µm film thickness, from Agilent 
Technologies (Santa Clara, CA). A 1 µL portion was injected via split-less injection at 250 °C at 
an initial pressure of 98 kPA and a total flow of 14.1 mL/min helium carrier gas. The 
chromatograph separation initially occurred at a temperature of 40 °C for 1.2 minutes and then 
increased at a rate of 30 °C per minute to 220°C and then held for fifteen minutes. The mass 
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transfer line and ion source were at 250 and 200 °C respectively. The fatty acids were detected 
with an electron ionization method in scan mode from 50 to 650 m/z.  
 
FAEEs were quantified through the same GC, column, and injection procedure. The 
chromatograph separation initially occurred at a temperature of 50°C for 1.5 minutes and then 
increased at a rate of 25°C per minute to 180°C, finally increasing the temperature at 10°C per 
minute to 250°C which was held for 3 minutes. The mass transfer line and ion source were at 
250 and 200 °C respectively. The FAEEs were detected with an electron ionization method in 
scan mode from 50 to 650 m/z. The identification of both the fatty acids and the FAEEs were 
achieved by comparison of retentions times and mass spectrum. 
 
4.5.6 qPCR Analysis 
The total RNA was isolated from fresh or frozen samples stored at -80°C using the MP 
Biomedical Fast RNA Prep for Yeast kit (Santa Ana, California) following manufacturer‟s 
instructions. Samples were reverse transcribed into cDNA using the Transcriptor First Strand 
cDNA Synthesis kit (Roche, Mannheim, Germany) with the oligo-dT primer following the 
manufacturer‟s instructions. The qPCR was performed with LightCycler 480 SYBR Green 
Master reagents (Roche) using the Roche Light Cycler
®
 480 System (Roche, Indianapolis, IN) 
using gene specific primers (Table 4.1). The relative abundance of the mRNA levels for the 
target genes was normalized to the asparagine-linked glycosylation 9 gene (alg9) expression to 
determine expression levels. 
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4.5.7 Radioactive WS Enzyme Activity Assay 
Cells harboring the pRS426-WS2 plasmids were harvested at mid to late exponential phase and 
washed twice with potassium phosphate containing 2 mM magnesium chloride at pH 7.5, then 
resuspended with 1 mM DTT in the potassium phosphate buffer. Cells were lysed using MP 
Biomedical FastPrep 24 with Lysing Matrix B. The total protein concentration was determined 
via the BCA protein assay kit (Pierce, Rockford, IL) and the standard manufacturer protocol was 
followed. 3.75 mM of the substrate of interest (ethanol or hexadecanol) were combined with 
5 mg/mL BSA in potassium phosphate buffer with 2 mM MgCl2. 1.17 ng of C-14 labeled 
palmitoyl-CoA labeled was added. The reaction was started with the addition of 100 µg of crude 
cell lysate and allowed to react for 30 minutes. The reaction was halted by addition of 500 µL of 
chloroform:methanol. 25 µg of lauric acid ethyl ester was used as an internal standard. The 
reaction mixture was applied to a TLC silica gel 60 F254 plate (EMB Millipore, Darmstadt, 
Germany) with a mobile phase of heptane, 2-proanpol, and acetic acid (95:5:1 v/v/v). Lipids 
were visualized through a 0.05% 2,7-dichlorofluesceine mixture in ethanol. The FAEEs were 
isolated by scraping the FAEEs off the TLC plates using a scalpel. The FAEEs were extracted 
from the powder by vortexing in hexane, methanol, and water. Finally, the hexane layer was 
added to 3 mL scintillation fluid and analyzed for radioactivity, quantified by a Beckman Coulter 
LS 6500 liquid scintillation counter (Brea, CA). 
 
4.5.8 Integration of WS2 
Integration of the ws2 gene into S. cerevisiae chromosome was achieved through recombination 
at the δ sites. The plasmid pITy2 (35) was linearized by digestion with KpnI and SacI to insert 
the WS2 expression cassette under control of the PGK promoter using Gibson Assembly (New 
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England Biolabs, Ipswich, MA). For integration, the plasmid harboring the ws2 expression 
cassette was linearized with XhoI and 5 µg of linearized DNA was transformed into CEN.PK 
S. cerevisiae strain using the Lithium Acetate method. The transformed cells were plated on 3.5 
g/L G418 for selection of the integrated expression cassette. Integration into the chromosome 
was confirmed by whole-cell PCR amplification of the ws2 cassette.  
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4.7 Tables 
Table 4.1: Selected primers used in this study. 
Table 4.1: Select primers used in this study 
  
FAS Primers       
TPI F 5'- 
GACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGATATATCTAGGAACCCATCA 
-3' 
TPI R 5'- 
AAACACATACATAAACTAAAAATGACTATTGGCATCTCTAACCACCGCCTGGTGAACCG 
-3' 
FAS  F 5'- 
TAAATCTATAACTACAAAAAACACATACATAAACTAAAAATGACTATTGGCATCTCTAAC 
-3' 
FAS R 5'- 
CTACGGCAAGCCACCAGTGAGATTAATATAATTATATAAAAATATTATCTTCTTTTCTT 
-3' 
TPIt F 5'- 
CAAGGCGTGGTCGCAAGCGATCTACGGCAAGCCACCAGTGAGATTAATATAATTATATAA 
-3' 
TPIt R 5'- 
AAATTTCAACTGTTATATAATAGCTTCAAAATGTTTCTACTCCTTTTTTACTCTTCCAG 
-3' 
TEFP 5'- 
GTTGAGAAGATGTTCTTATCCAAATTTCAACTGTTATATAATAGCTTCAAAATGTTTC 
-3' 
TEF t 5'- 
CTAAGTTTTAATTACAAAATGCTCGACAACCGTGAAGCGATGACCGTGGGTGTGGACTTG 
-3' 
PPT1 5'- 
GAAAGAAAGCATAGCAATCTAATCTAAGTTTTAATTACAAAATGCTCGACAACCGTGAAG 
-3' 
PPT1 R 5'- 
CTGCGGTACCAGCGGTAAGGAGATTGATAAGACTTTTCTAGTTGCATATCTTTTATAT 
-3' 
TEF t 5'- 
CGCCACCGCGCAGTGCCTGCTGCGGTACCAGCGGTAAGGAGATTGATAAGACTTTTC 
-3' 
TEF t R 5'- 
CTTTGATCGGCGCTATACGCGTCCACCGCGGTGGAGCTCCAGCTTTTGTTCCCTTTAG 
-3' 
WSDGAT Primers       
PGKp F 5'- 
CAAATACTTTGATCGGCGCTATACGCACAGATATTATAACATCTGCACAATAGGCATTTG 
-3' 
PGKp R - to ab 5'- 
CAAGGAAGTAATTATCTACTTTTTACAACAAATATAAAACAATGCGCCCATTACATCCG 
-3' 
ab F 5'- 
CAAGGAAGTAATTATCTACTTTTTACAACAAATATAAAACAATGCATCATCATCATCATC 
-3' 
ab r 5'- 
GTAATTGCAAAGCAGGAAGATATTAAAACAGCCAATTAAATTGAATTGAATTGAAATCG 
-3' 
PGKp  Rto WS2 5'- 
TACAACAAATATAAAACA ATGAAGAGATTAGGTACTCTAGACGCTAGTTGGCTTGCAG 
-3' 
WS2 F 5'- 
GGAAGTAATTATCTACTTTTTACAACAAATATAAAACAATGAAGAGATTAGGTACTCTAG 
-3' 
WS2 R 5'- 
GCGTGCCCGTACTAGAAAGTAAATTGAATTGAATTGAAATCGATAGATCAATTTTTTTC 
-3' 
PGKt F to ab 5'- 
GTAATTGCAAAGCAGGAAGATATTAAAACAGCCAATTAAATTGAATTGAATTGAAATC 
-3' 
PGKt F to WS2 5'- 
CTAATTCTGCCACCAAAGAAGCGTGCCCGTACTAGAAAGTAAATTGAATTGAATTGAAATC 
-3' 
PGKt R 5'- 
GTATAGTGTATTCTTCCTGCCATGGCCAGCTTTTGTTCCCTTTAGTGAGGGTTAATTGCGCG 
-3' 
 
139 
 
Table 4.2: Strains and plasmids used in this study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Plasmids         
Name Genes Promoters/Terminator Marker Source 
pRS426- abWS A. baylyi WS PGK1/PGKt URA This study 
pRS426- WS2 M. hydrocarbonoclasticus WS2 PGK1/PGKt URA This study 
pRS424-FAS B. ammoniagenes FAS and PPT1 TPI/TPI , TEF1/TEF TRP This study 
pRS426-FAS B. ammoniagenes FAS and PPT1 TPI/TPI , TEF1/TEF URA This study 
pRS425-scFAA1 S. cerevisiae FAA1 PYK1/ADH1 LEU This study 
pRS416-Helper PPT1, FAA1, WS2 TEF1/TEF, PYK1/ADH1, PGK1/PGK1 URA This study 
pRS426-FBDP baFAS, PPT1, FAA1, WS2 TPI/TPI ,TEF1/TEF, PYK1/ADH1, PGK1/PGK1 URA This study 
pRS426-HFBDP baFAS, PPT1, FAA1, WS2 HXT5/TPI ,TEF1/TEF, PYK1/ADH1, PGK1/PGK1 URA This study 
pRS426-K1 FBDP KanMX, baFAS, PPT1, FAA1, WS2 TPI/TPI ,TEF1/TEF, PYK1/ADH1, PGK1/PGK1 G418 This study 
pRS426- K1 WS2 KanMX,  WS2 PGK1/PGKt G418 This study 
SuperCopy (SC)     URA This study 
SC-TFAS baFAS TPI/TPI URA This study 
SC-HFAS baFAS HXT5/TPI URA This study 
pITy       (31) 
pITy+WS2 WS2 PGK1/PGKt G418 This study 
 
Strains     
Genetic Background Plasmid   
BY4741 pRS426- WS2 DE01 
BY4741 pRS426-FAS DE02 
BY4741 pRS426-FBDP DE03 
BY4741 pRS426-HFBDP DE04 
BY4741 pRS426-K1 FBDP DE05 
BY4741 pRS426- K1 WS2 DE06 
BY4741 SC-TFAS DE07 
BY4741 SC-HFAS DE08 
BY4741 ∆fas1 pRS426-FAS DE09 
BY4741 ∆fas1 pRS426-FBDP DE10 
CEN.PK ::WS2 SC-TFAS DE11 
CEN.PK ::WS2 SC-HFAS DE12 
BY4741   DE13 
CEN.PK ::WS2   DE14 
CEN.PK pRS426- WS2 DE15 
CEN.PK pRS426- WS2 + pRS424 DE16 
CEN.PK pRS426- WS2 + pRS424-FAS DE17 
CEN.PK   DE18 
CEN.PK ::WS2 R2 Cellobiose utilization pathway DE19 
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4.8 Figures 
 
Figure 4.1: Description of microbial production of FAEEs. Heterologous pathway used in this 
study is depicted by red arrows (9). In this study, the heterologous expression of the Type-I FAS 
is a key component. This heterologous expression provides an orthogonal route for fatty acid 
synthesis to reduce the flux diverted from cellular metabolism. The WS/DGAT enzyme uses the 
activated form of fatty acids and ethanol as a co-substrate to form fatty acid ethyl esters. 
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Figure 4.2: Initial characterization of the WS/DGAT genes cloned. (a) FAEE production from 
heterologous expression of the wax synthase genes. The gene ab is cloned from the bacteria 
Acinetobacter baylyi and the ws2 gene has been codon optimized for S. cerevisiae from 
Marino hydrocarbonoclasticus. (b) Radio-labeled activity assay of the WS2 enzyme testing for 
preferred substrate. 
(a)   
(b)                               
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Figure 4.3: Dual plasmid expression of the bafas and ws2 genes in a single strain (DE17) in two 
different plasmids. No increase in FAEE production was observed with the addition of the FAS 
enzyme. C16 represents the palmitic acid ethyl ester, C16:1 is palmitoleic acid ethyl ester. 
Values are averages of two biological replicates. 
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Figure 4.4: Strain DE09, which expressed the bafas gene in the ∆fas BY4741 strain under the 
TPI promoter, was able to grow without exogenously supplied fatty acids (FA). This illustrated 
that the bafas gene was able to complement the ∆fas strain. Therefore, the FAS is functional in 
yeast and can produce palmitic acid, which can be used for cell growth. 
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Figure 4.5: Free fatty acid pools of the wild-type BY4741 strain (DE13) compared to the free 
fatty acid pools of the BY4741 ∆fas1 + pRS426-baFAS (DE09). Strain DE09, heterologously 
expressing the bafas gene, was able to produce up to 2-fold increase in free fatty acids compared 
to strain DE13. Values are averages of biological triplicates with one standard deviation. The 
asterix symbolizes samples with a p-value of less than 0.05. C16 is palmitic acid, C16:1 is 
palmitoleic acid. C18 is stearic acid, and C18:1 is oleic acid. Values are relative to the internal 
standard. 
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Figure 4.6: Comparing the FAEE production of the BY4741 strain expressing only the ws2 gene 
(DE01) to the ∆fas knockout strain complemented with the heterologous FAS and WS2 pathway 
(DE10). There is a 7-fold increase in total FAEE production in DE10 compared to FAEE 
production in strain DE01. Each sample was repeated in triplicate and one standard deviation is 
represented. The asterix symbolizes a p-value of less than 0.05 compared to the parental BY4741 
strain expressing the ws2 gene. C14 is myristic acid ethyl ester. C16 is palmitic acid ethyl ester 
and C16:1 is palmitoleic acid ethyl ester. C18 is stearic acid ethyl ester and C16:1 is oleic acid 
ethyl ester.  
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Figure 4.7: The BY4741 ∆fas1 complemented with the pRS426-FBDP (DE10) in different 
media selections. A clone which had previously exhibited significant FAEE production in SCD 
media was separated into YPD and SCD media, using three different biological replicates. Even 
considering a strong selection pressure to complement the ∆fas1 for growth, no significant 
FAEEs were produced in YPD media. C14 is myristic acid ethyl ester. C16 is palmitic acid ethyl 
ester and C16:1 is palmitoleic acid ethyl ester. YPD media is not suggested for any future work 
with the WS2 enzyme. 
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Figure 4.8: mRNA levels of the bafas and ws2 genes in different strains. The strain DE09 
(∆fas+pRS426-FAS) exhibited a 10-fold increase in bafas mRNA levels compared to the strain 
DE03 (BY4741+pRS426-FBDP) and DE02 (BY4741+ pRS426-FAS). This experiment 
demonstrates that the FAS can be expressed in S. cerevisiae. The relative abundance of the 
mRNA levels for the target genes was normalized to the asparagine-linked glycosylation 9 gene 
(alg9) expression to determine expression levels. 
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Figure 4.9: Fluorescence levels of green fluorescence protein (GFP) under control of eight 
different promoters in synthetic drop-out media. Data collected by graduation student Jonathan 
Ning. HXT5 was shown to express extremely well in SC media. 
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Figure 4.10: Comparison of FAEE production strain harboring the heterologous pathways in 
wild type BY4741 strain. The FAEE production is increased in strain DE04, when the HXT5-
FBDP (FAS+PPT1+FAA1+WS) is heterologously expressed. This strain exhibited a 6.3-fold 
increase in total production of FAEEs compared to strain DE01. The asterix symbols represent 
chain lengths of fatty acids which are statistically greater than the pRS426-WS control (p<0.05), 
the double asterix symbol represents chain lengths of fatty acids which are significantly 
statistically greater than the pRS425-WS control (p<0.01). Sample sizes ranged from n= 9 for 
DE01 and n= 11 for DE 04. C14 is myristic acid ethyl ester. C16 is palmitic acid ethyl ester and 
C16:1 is palmitoleic acid ethyl ester. C18 is stearic acid ethyl ester and C16:1 is oleic acid ethyl 
ester. 
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Figure 4.11: FAEE production of the WS integrated version compared to the WS plasmid 
version (DE01). There was no major increase in FAEE production or significant reduction in 
error in the integrated version as compared to the plasmid-based system. Continued work with 
the integrated strain used clone Int7 (DE14) due to the lower error margin. C14 is myristic acid 
ethyl ester. C16 is palmitic acid ethyl ester and C16:1 is palmitoleic acid ethyl ester. C18 is 
stearic acid ethyl ester and C16:1 is oleic acid ethyl ester. 
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Figure 4.12: Expression levels of the ws integrated version (DE14) compared to the plasmid 
strain (DE01). Though the increase in FAEE production of the integrated strain was marginal, 
the relative expression level of the ws2 gene in the DE14 strain was nearly 60-fold greater than 
that of the mRNA levels of the ws2 gene in the plasmid version (DE01). The relative abundance 
of the mRNA levels for the target genes was normalized to the asparagine-linked glycosylation 9 
gene (alg9) expression to determine expression levels. 
 
  
pRS426-WS Int WS
0.0
0.5
1.0
1.5
2.0
2.5
60
80
100
DE14
R
e
la
ti
v
e
 E
x
p
re
s
s
io
n
 L
e
v
e
l
DE01
152 
 
 
 
 
Figure 4.13: FAEE production in co-expression of integrated WS strain (DE14) and supercopy 
FAS. Both promoters TPI (DE11) and HXT5 (DE12) were investigated to determine if the bafas 
gene would express under these highly-selective conditions. After 48 hours, no significant 
increase in FAEE production was detected though expression of the FAS under the super-copy 
plasmid. C14 is myristic acid ethyl ester. C16 is palmitic acid ethyl ester and C16:1 is 
palmitoleic acid ethyl ester. C18 is stearic acid ethyl ester and C16:1 is oleic acid ethyl ester. 
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Figure 4.14: FAEE production from cellobiose as a sole-carbon source. Ultimately, any 
advanced biofuels will be produced from biomass, of which cellobiose is a major constituent of. 
Therefore a proof-of-concept study was examined here to identify if FAEEs could be produced 
from cellobiose as a sole carbon source, using the pathways optimized in Chapter 3 for 
cellobiose utilization. This pathway was transformed into DE14, a strain with the ws gene 
integrated into the chromosome and grown on SC-8% cellobiose. Samples taken after 200 hour 
fermentation when nearly all of the cellobiose had been utilized. C14 is myristic acid ethyl ester. 
C16 is palmitic acid ethyl ester and C16:1 is palmitoleic acid ethyl ester. C18 is stearic acid ethyl 
ester and C16:1 is oleic acid ethyl ester. 
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Figure 4.15: Thin layer chromatography visualization of the lipids extracted from the cells. The 
first three lanes are biological replicates of strain DE01, BY4741harboring the WS2 enzyme. 
The last three samples are biological replicates of strain DE04, harboring the full biodiesel 
pathway. The black arrows indicate unidentified lipids which are produced in higher quantities in 
DE04 than DE01. Future work is suggested to identify these lipids and consider knocking out the 
key enzymes in their synthesis to redirect flux towards the FAEEs. 
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Chapter 5: Developing a High-throughput Screen for FAEE production in S. cerevisiae 
5.1 Background 
Recent advances in DNA assembly methods have provided scientists and engineers 
extraordinary freedom in constructing large DNA pathways (1). This has given synthetic 
biologists an unprecedented ability to make vast quantities of biosynthetic systems for nearly any 
desired purpose, with applications in genetic circuitry, microbial chemical production, or 
biomedical devices and treatments. Furthermore, high efficiency and modularity of these 
advanced DNA assembly methods makes in silico design (2) and automated assembly (3) of 
these constructs possible. Large combinations of DNA parts and libraries can be individually 
constructed by robotic platforms, further increasing the potential for immense libraries of 
pathways and biosynthetic systems.   
 
Despite the rapid progress of DNA assembly technologies, widespread application of large-scale 
DNA assembly and pathway libraries is currently limited by the ability to effectively and 
efficiently interrogate the resulting pathways and libraries. Without the ability to easily and 
economically quantify for the phenotype of interest, these large-scale methods will not be able to 
fulfill their maximum potential.  
 
Chapters 2 and 3 of this thesis focused on developing pathway library optimization strategies. It 
is desired to apply these optimization methods to the fatty acid ethyl ester (FAEE) pathway 
constructed in Chapter 4. However, there is a major hurdle which must first be overcome before 
applying these methods to the FAEE pathway. Optimization of the cellobiose utilization pathway 
from Chapter 2 and 3 was readily performed through visual check of large colonies (4). Strains 
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harboring an improved cellobiose utilization pathway would grow the quickest on media with 
cellobiose as the sole carbon source.  However, such a simple screen is not available for FAEE 
synthesis in S. cerevisiae. This final chapter of the thesis will consider three different strategies 
to develop a high throughput screen and ultimately apply pathway optimization strategies to 
FAEE synthesis developed in Chapter 4.  
 
5.1.1 Transcription Factor based Biosensors 
Biosensors have significant potential in high-throughput screening methods. This has been 
demonstrated by the large number of transcription factor based biosensors engineered to detect 
small molecules (5-8). These biosensors can link the small molecule concentration to an easily 
measurable signal such as fluorescence and cell growth via gene circuits.  
 
Promoters have evolved over millions of years to function in response to certain stimuli, 
therefore utilizing transcription factors and their cognate promoters seems only sensible for a 
high-throughput screen. Developing screens based on the response of transcription factors for a 
detectable, phenotypic response has been well documented (5,8). Biosensors can be used to 
detect environmental factors such as pH, temperature, light, and nutrient limiting conditions. 
Though these sensors are significant, the most important type of biosensors for metabolic 
engineering is sensors which can detect intracellular chemicals and metabolites. Regulatory RNA 
molecules have been evolved by nature to act as biosensors for intercellular metabolites. For 
example, B. subtilis has evolved a riboflavin or a thiamin-responsive mRNA riboswitch: once the 
ligand (riboflavin) binds to the RNA, a conformational change is induced in the mRNA, which 
leads to premature transcription termination (9). It is possible to mine other organism genomes to 
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identify other regulatory elements which respond to a metabolite of interest. Once a transcription 
factor and its respective promoter which are sensitive to that metabolite are identified, the DNA 
parts can be cloned in a system that will trigger a phenotype in the presence of the metabolite.  
 
5.1.2 Growth Based Screen  
Perhaps one of the most basic forms of a high–throughput screen is the growth-based screen. In 
this strategy the metabolite or component being interrogated is fundamental to cell growth. The 
presence or absence of this compound will affect cell growth, either positively or negatively. 
This strategy was used by Du et al. and Kim et al. to screen for improved pentose sugar 
utilization (4,10). The libraries were grown on the pentose sugar as a sole carbon source, strains 
which harbored an improved sugar utilization pathway would grow faster. Therefore, these 
improved strains would have a larger colony size on the agar plate.  A similar strategy was used 
by Kambam et al. (11). In this work to engineer the substrate specificity of the RhlI, a 
component in a complex genetic circuit, the RhlI specificity was linked to ampicillin resistance. 
Therefore, a mutated RhlI protein with improved substrate specificity towards acyl-ACPs would 
yield a higher ampicillin resistance. Thus, colonies which appeared first on high concentrations 
of ampicillin agar plates were associated with the improved protein mutants. Another example is 
screening in toxicity studies. Genetic diversity can be introduced to the cell through a variety of 
methods, either through pathway engineering (4,10,12), RAGE (13), MAGE (14), mutator 
strains (15), and then the strains are applied to a toxic chemical with increasing concentrations 
(16). The strains which grow the fastest and the best in these toxic situations have improved 
tolerance. 
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5.1.3 Dyes and stains 
Dyes and stains have also often been used for screening strategies. These strategies were 
originally developed as visualization methods of structures within the cell. Of particular interest 
in this project are lipohillic fluorescent dyes, including Sudan black (17), Nile Red (18), Nile 
blue (19) and BODIPY (20). The Nile Red (9-diethyl amino-5H-benzo[a]phenoxazine-5-one) 
stain has been used most commonly (21). When this fluorogenic dye interacts with cellular lipids 
in solution, it emits a fluorescence signal which is significantly higher than background. 
Additionally, the emission wavelengths change with the hydrophobicity. Polar lipids interacting 
with the Nile Red will lead to an emission longer than 590 nm, while neutral lipid interaction 
will emit at 520 and 290 nm (21). 
 
High-throughput applications of Nile Red have also been studied (22,23). Of particular interest, 
Sitepu et al. investigated the high-throughput use of Nile red in yeast species (23). In this study, 
the addition of dimethyl sulfoxide (DMSO) was used to improve the diffusion of the Nile red 
across the cell membrane. Additionally, kinetic studies were implemented, monitoring the 
change in fluorescent emission over a 20 min period. This allowed for the optimal fluorescence 
reading to be discovered. 
 
5.1.4 Project Overview 
This project was intended to identify a high–throughput screening method which would allow for 
optimization of the FAEE pathway constructed in Chapter 4. Unfortunately, direct product 
detection will be extremely difficult as a complicated extraction and separation method is used 
which depends on a GC-MS analysis. However, during construction of the pathway, expression 
159 
 
of the fatty acid synthase (FAS) gene was very difficult. Therefore, it was expected that if a 
screen could be based on the product of the FAS gene, it would improve overall activity of the 
pathway. Therefore, the following assays are based on fatty acid detection. 
 
5.2 Results 
5.2.1 POX1- GFP Expression Dynamic Range 
For fatty acid detection, a green fluorescence protein (GFP) was put under control of the fatty 
acid sensitive POX1 promoter. In this system, with the presence of fatty acids, the POX1 would 
initiate expression of the GFP. This expression cassette was successfully cloned into a p403 
integration plasmid. Integration plasmid p403 was required due to the auxotrophic markers of 
strain BY4741, which was used in this study. The linear plasmid was transformed into BY4741 
and plated into SC-Leu. Any resulting colonies were confirmed for integration (Figure 1). 
 
POX1 is inhibited by glucose, therefore the strain was grown in raffinose and glycerol and 
supplemented with exogenous fatty acids. After six hours, the fluorescence was quantified. 
Though in this study, no fluorescence was observed, graduate student Tong Si has shown the 
range to be 0.5-2 g/L oleic acid (Figure 2), with the linear range being between 0 and 1 g/L of 
exogenously added oleic acid. 
 
5.2.2 Growth Based Assay 
Fatty acids are essential for growth. Therefore, a ∆fas strain cannot grow without fatty acids and 
the more fatty acids present in vivo, the faster the strain will be able to grow. Initial 
high-throughput tests were conducted on the Bioscreen C and exogenously supplied fatty acid 
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(data not shown). It was shown that increased concentration of exogenous fatty acids did 
improve cell growth of the ∆fas strain. Further testing considered in vivo fatty acid concentration. 
Graduate student Sam Hamedi Rad cloned a series of homologous FAS genes from several 
organisms in the actinobacteria family and also eukaryotic origins: Brevibacterium 
ammoniagenes, Gordonia terrae, Mycobacterium smegmatis, Saccharomyces cerevisiae, and 
Yarrowia lipolytica. When these genes were expressed in S. cerevisiae, the resulting proteins 
produced varied free fatty acid pool concentrations (Figure 3). These FAS genes were then 
expressed in the ∆fas strain and each strain harboring the different FAS genes were shown to 
have unique growth patterns in YP and SC Media (Figure 4). The difference in growth rate 
amongst the strains is attributed to the different free fatty acid pool concentration. Further testing 
on the system incorporated a high-throughput analysis on the Bioscreen C to test for error ranges 
(Figure 5). 
 
5.2.3 Nile Red Fluorescence Assay  
Parental strain BY4741 was grown overnight to saturation and then inoculated to an OD of 0.2 
and grown in the presence of 1% and 2% palmitic acid for six hours in YP media at 250 rpm and 
30°C. The cells were then stained with Nile red using the Nile Red Lipid Staining kit from 
Cayman Chemical (Ann Arbor, Michigan), according to the manufacturer‟s protocol. The 
samples were then read on a Tecan plate reader. However, there was no discernable difference in 
fluorescence between the controls with no exogenous fatty acid addition and the samples with 
exogenous fatty acids added (Figure 6). 
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5.3 Discussion  
High-throughput screens are very important for interrogating genetically diverse pathways and 
strains for the phenotype of interest. Researchers are increasingly realizing that high-throughput 
screen and selection methods are needed to reach a new phase of synthetic biology and metabolic 
engineering: large-scale combinatorial library engineering. The ability to construct these large 
libraries are now well established (1,12), but without a high-throughput screen, these methods 
will not be very effective. 
 
Here we investigated three different strategies to use as a high-throughput screen for the 
optimization of a heterologous fatty acid ethyl ester synthesis pathway. This pathway was 
successfully developed in Chapter 4, however pathway optimization is needed. Therefore, it is 
desired to apply pathway optimization strategies, the same techniques developed in Chapter 2 
and 3. However, there is no high-throughput screen for FAEEs. Detection of these molecules 
requires an arduous 12-hour multi-step extraction and isolation, which is then applied to a 
GC-MS (24,25). A high-throughput screen to detect FAEEs directly is not likely, therefore the 
screens studied in this chapter investigated a precursor of FAEEs and a major component of the 
pathway established in Chapter 4: fatty acids. 
 
5.3.1 Transcriptional Biosensor 
 In this study the POX1 promoter is sensitive to acyl-CoA motives, therefore any increase in 
acyl-CoA molecules could trigger the POX1 expression (26). A disadvantage of this is that the 
POX1 expression has no specificity in distinguishing between acyl-CoA molecules. However, as 
this strategy would be used for the optimization of the FAS enzyme, the only variation and 
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diversity introduced to the system would be based on the FAS activity. Therefore, any increase 
compared to the wild type enzyme would be directly related to the fatty acids produced by the 
FAS. Work completed by graduate student Tong Si showed that the POX1 promoter had a linear 
dynamic range from 0 g/L to 1 g/L of exogenous fatty acids (Figure 2). However, as POX1 is the 
transcriptional control for β-oxidation, the process in which fatty acids are broken down for 
energy consumption, the promoter is inhibited by glucose (26). Therefore, for the use of POX1 
as a biosensor, the strain must use non-fermentable sugars as a carbon source, such as glycerol. 
Unfortunately, the ws2 gene and activity of the WS2 enzyme has been shown to be greatly 
affected by culture conditions (see Chapter 4) and also, it has been proven that different 
substrates can greatly affect the optimization of the pathway (4). Therefore, if pathway 
optimization strategies will be applied, future work with this biosensor is not suggested.  
However, overall host engineering strategies to improve fatty acids could potentially find this 
screening strategy very helpful. 
 
5.3.2 Growth Based Complementation 
By knocking-out the cell‟s ability to synthesize its own fatty acids, the cells cannot grow without 
either exogenous supplementation of fatty acids or through complementation of a heterologous 
gene. In this study, the efficiency of the heterologously expressed FAS could be assessed based 
on the growth rate of the strain harboring the heterologously expressed FAS. The free fatty acid 
pool had been quantified to show each enzyme studied produced a different concentration of 
fatty acids (Figure 3). This difference in fatty acid concentration was exemplified by different 
growth rates of strains harboring these different fatty acids (Figure 4). A more high-throughput 
version of this screen was performed through the use of the BioscreenC (Oy Growth Curves Ab 
163 
 
Ltd, Finland) (Figure 5). In this study, the differences in growth were significant for small 
changes in fatty acid concentration in YP media. However, the BioscreenC readings using SC 
media were subject to large margins of error. A moving average was used for analysis. If the 
screen were conducted in YP, there would be enough sensitivity and dynamic range for a 
controlled screen. However, if the screen were conducted in SC media, the error in the readings 
would limit the sensitivity of the assay. Further analysis could be conducted by changing settings 
on the machine to improve readings. Chapter 4 reported that the biodiesel pathway was not 
functional in YP media and it has been established that promoter engineering is sensitive to the 
media screened in (10). Though this strategy is promising, further tests in SC media are 
suggested. Additional experiments could focus on colony-size on agar plates screening, which 
could be sensitive enough to identify improved fas gene expression. 
 
5.3.3 Nile Red Staining 
Using the lipophilic stain was actually more difficult than anticipated. After six hour incubation 
with palmitic acid, the BY4741 strain did not react to the Nile Red stain (Figure 6). It is assumed 
in this study that the difficulty lies in the transient nature of exogenous fatty acids. Though the 
time-frame was suggested by the manufacturer‟s protocol, it was still difficult to discern if the 
exogenously fatty acids were still present the in the cell. Continued work with this screen is 
suggested, especially using intra-cellular fatty acid concentrations, which could be compared 
using plasmids and strains with known differences in fatty acid contents. 
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5.4 Future Work  
Final product detection will be difficult to develop a high-throughput screen in this FAEE project 
because FAEEs require GC-MS analysis for quantification. Though, if the above-mentioned 
strategies are not stringent enough for further optimization and engineering, another strategy is 
suggested here. One of the major challenges of Chapter 4 and the development of the biodiesel 
pathway was expression of the fas gene. The qPCR analysis illustrated that in samples with high 
selection of the fas gene, there was significantly higher mRNA levels for the fas gene than for 
samples without the high selection (Figure 7). Therefore, another high-throughput strategy is 
suggested: to increase mRNA levels and consistency of the fas gene expression. It has been 
shown that mRNA stability and relative levels can affect protein expression and overall titer of 
proteins expressed by the engineered mRNA (27). Reasons for differential mRNA levels can be 
complicated. However, promoter strength has shown to be a major factor in mRNA levels 
(28,29). Promoter engineering, either combinatorial or through directed evolution (10,30), could 
be monitored through mRNA levels. Increased mRNA levels would be indicative of improved 
expression. The mRNA could be quantified and monitored through a high-throughput Taq-man 
RT-PCR (31,32). This method has been shown to be reliable and accurate at low mRNA levels. 
In 384-well plates, a diverse library of either combinatorial promoters or mutated promoters 
could be screened to identify a pathway with improved expression of the fas gene. It is suggested 
that this be considered as a future potential screen to improve the fas gene expression. 
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5.5 Materials and Methods 
5.5.1 Plasmid Construction and Strains  
All plasmid construction was accomplished through DNA assembler (33) unless otherwise noted. 
The fas and ppt1 genes from Brevibacterium ammoniagenes were cloned from pGM44 (34) 
under control of the TPI1/TPI1 promoter/terminator and TEF1/TEF1 promoter/terminator 
respectively (pRS426-FAS). Due to the size and GC composition of the fas gene, we endeavored 
to reduce PCR amplification of the gene. The GT, MS, SC, YL fas genes were cloned from 
Gordonia terrae, Mycobacterium smegmatis, Saccharomyces cerevisiae, and Yarrowia lipolytica 
respectively, by graduate student Sam Hamedi Rad. Each gene was cloned with a TPI1 
promoter/terminator and the PPT1 gene from Brevibacterium ammoniagenes, also under the 
TEf1/TEF1 promoter/terminator in the pRS 426 plasmid. 
 
 The BY4741 ∆fas was constructed by graduate student Jiazhang Lian. The full fas1 gene was 
replaced with a KanMX expression cassette, completely disrupting the endogenous fatty acid 
synthesis. All transformations followed standard Lithium Acetate transformation protocol for 
S. cerevisiae as described previously (33). However, transformation in the ∆fas strain required a 
12 hour incubation period after inoculation, supplemented with exogenous 2% palmitic acid and 
G418 for selection of the knockout. The transformants were recovered in YPD media with 0.01% 
palmitic acid for five hours. The cells were then transferred to agar plates or liquid media with 
and without palmitic acid supplementation. Parental BY4741 was used for Nile Red staining and 
also the POX1 biosensor. 
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5.5.2 Culture Conditions 
Seed cultures of strains for free fatty acid detection and growth curves were grown in 2% glucose 
CSM-Ura (MP Biomedical, Santa Ana California) or yeast (1%), peptone (2%), dextrose (2%) 
(YPD) supplemented with 200 µg/mL G418 (KSE Scientific, Durham, NC) to stationary phase at 
30°C with orbital shaking at 250 rpm. Seed cultures were then transferred to 125-mL baffled 
flasks with 25 mL CSM-URA or YPD supplemented with 200 µg/mL G418 (KSE Scientific, 
Durham, NC) at an initial OD of 0.05 at 30°C with orbital shaking at 100rpm.  
 
For Nile Red staining, seed cultures of BY4741 were grown overnight in YPD. The cultures 
were inoculated to an OD(600nm) of 0.2 in fresh YPD media and varied concentrations of 
palmitic acid for six hours at 250 rpm and 30°C. Culturing to test for the activity of the POX1 
promoters involved growing seed cultures of the POX1 biosensor strain in 2% glucose CSM-His 
(MP Biomedical, Santa Ana California).The cultures were inoculated to an OD (600 nm) of 0.2 
in CSM-His with 2% galactose or 2% glycerol and various concentrations of palmitic acid. 
Escherichia coli 10-β (New England Biolabs, Ipswich, MA) was used for recombinant DNA 
manipulations. E. coli strains were cultured in Luria broth (LB) (Fischer Scientific, Pittsburgh, 
PA) at 37°C and 250 rpm, supplemented with 50 µg/mL ampicillin. Yeast and bacterial strains 
were flash frozen and stored in 15% glycerol at -80 °C. All chemicals were purchased from 
Sigma Aldrich or Fisher Scientific. 
 
5.5.3 Integration of POX-GFP 
Integration of the POX-GFP expression cassette into S. cerevisiae chromosome was achieved 
through recombination into the his selection marker of BY4741 strain. The p403 plasmid was 
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linearized by BamHI and ClaI at the multiple cloning site and the POX-GFP cassette was 
inserted into the plasmid through Gibson Assembly (New England Biolabs, Ipswich, MA). For 
integration, this plasmid was linearized in the his3 selection marker through digest with HindIII. 
5 µg of linearized plasmid was transformed into the BY4741 strain using the Lithium Acetate 
method. The transformed cells were plated on SC-his plates and colonies which grew were tested 
by colony PCR to confirm the integration.  
 
5.5.4 Free Fatty Acid Extraction 
Quenching was conducted on the cells to quantify the free fatty acid pool (35). Cells were flash 
frozen by a methanol-dry ice bath. The mixture was centrifuged at 4000 rpm for 5 minutes and 
then the cell pellet was separated from the media. Cells pellets were then lysed by boiling at 
100°C in ethanol for 10 minutes. Cell membrane was separated by centrifugation and the 
supernatant was applied to a freeze-dryer overnight or until dry. The lipids were then extracted 
twice with 2:1 chloroform/methanol using 50 µM myristic acid as an internal standard. After 
extraction, the fatty acids were allowed to derivatize for 2 hours at room temperature with 
200 µL of 2N TMS-diazomethane, 10 µL methanol and 10 µL HCL. The sample was then 
transferred to a glass GC vial for analysis. 
 
5.5.5 Free fatty acid detection 
The fatty acids were separated and quantified through a GC-MS-QP 2010 Plus (Shimadzu, 
Kyoto Japan) (36). The separation was performed by a DB-WAX GC column with the following 
dimensions: 30mm x 0.25 mm internal diameter, 0.25 µm film thickness, from Agilent 
Technologies (Santa Clara, CA). A 1 µL portion was injected via splitless injection at 250 °C at 
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an initial pressure of 98 kPA and a total flow of 14.1 mL/min helium carrier gas. The 
chromatography separation initially occurred at a temperature of 40°C for 1.2 minutes and then 
increased at a rate of 30 °C per minute to 220 °C and then held for fifteen minutes. The mass 
transfer line and ion source were at 250 and 200°C respectively. The fatty acids were detected 
with an electron ionization method in scan mode from 50 to 650 m/z.  
 
5.5.6 Nile Red Staining 
Strains to be tested through Nile red staining were inoculated to an initial OD of 0.2 and grown 
at 30 °C at 250 rpm orbital shaking until the desired time-points. At inoculation, 1% and 2% 
exogenous palmitic acid was added as needed. Cells were normalized to an OD of 20 and were 
aliquoted into black 96-well UV-plates flat bottom plates (Corning, Corning, NY). Cells were 
washed twice with Potassium Phosphate Buffer 100mM, as supplied by the Caymen Chemical 
(Ann Arbor, Michigan) Nile Red Staining Kit. Then a fixative agent was also used to wash the 
cells per the protocol. Finally, the cells were stained with Nile Red staining solution, per 
manufacturer‟s instructions for 5 minutes. After washing with Potassium Phosphate Buffer, the 
cells were then visualized on a 96-well plate reader from Tecan (Mannedorf, Germanyh) at an 
excitement of 485 and emission of 535 nm. 
 
5.5.7 FACS 
Integrated strains of the POX1 promoter were inoculated to an initial OD of 0.2 and grown at 
30°C at 100 rpm orbital shaking until the cells reached OD 15-20. The cells were then diluted in 
PBS to an OD of about 0.1-0.2 and were analyzed on a flow cytometer (Biosciences LSR II Flow 
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Cytometry Analyzer, BD Biosciences, San Jose, CA) to quantify GFP fluorescence, with 
excitation wavelengths at 488 nm and emission band pass 550/30. 
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5.7 Figures 
 
Figure 5.1: Confirmation of correct integration of the POX1-GFP expression cassette into 
chromosome of BY4741 using gel electrophoresis. Expression cassette is 1.8 kilobase (kb) and 
the PCR amplification yielded a band at 1.8 kb according to the 1kb Plus TrackIt ladder 
(Invitrogen). The first three samples are the BY4741 integration with the POX1-GFP, PCR 
conducted from whole-cells. The final sample is a control, which used the integration plasmid as 
a template for PCR. This strain was used as a biosensor for increased fatty acid production, as 
the POX1 promoter is sensitive to acyl-CoA molecules such as fatty acids. 
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Figure 5.2: Dynamic range of the POX1-GFP fluorescence with respect to exogenous fatty 
acids. Data collected by graduate student Tong Si. POX1 is a promoter sensitive to fatty acids 
and was shown to activate expression of a GFP gene in the presence of exogenously added fatty 
acids. Though this strategy is promising, the POX1 promoter is inhibited by glucose and is only 
effective in non-fermentable sugar substrates. Ultimately, the FAEE pathway will be produced 
with glucose as the substrate and optimizing the pathway in another sugar substrate will not 
transfer to the glucose system (4).  
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Figure 5.3: Free fatty acid concentration in the ∆fas BY4741 strain complemented with 
heterologous FAS genes as measured by GC-MS analysis at 100 hours in YPD media. Sample 
BA is the fatty acid synthase cloned from Brevibacterium ammoniagenes. Sample GT is the fatty 
acid synthase cloned from Gordonia terrae. Sample YL is the fatty acid synthase cloned from 
Yarrowia lipolytica. Data is the result of one biological replicate. 
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(a)  
(b)  
Figure 5.4:  Growth curve of strains deficient in endogenous fatty acid synthesis complemented 
with heterologous FAS expression in (a) YPD media and (b) SC media. The BA, GT, MS, SC, 
YL FAS genes were cloned from Brevibacterium ammoniagenes, Gordonia terrae, 
Mycobacterium smegmatis, Saccharomyces cerevisiae and Yarrowia lipolytica respectively. The 
growth profile is indicative of fatty acid availability within the cell. Strains harboring more 
efficient FAS enzymes, which produce increased fatty acids (Figure 3), will grow faster than 
strains with inefficient FAS enzymes. A growth curve based assay is beneficial to consider for 
optimization of the fas gene either through protein engineering or promoter engineering. 
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(a)                                                                (b) 
Figure 5.5: Growth curve profiles of strains deficient in endogenous fatty acid synthesis 
complemented with heterologous FAS expression completed in a high throughput manner on the 
BioscreenC. Data is the average of twenty samples from one biological replicate for each fas 
gene. The wt is parental strain BY4741 with no knockout of the fatty acid synthesis. The BA, 
SC, YL FAS genes were cloned from Brevibacterium ammoniagenes, Saccharomyces cerevisiae, 
and Yarrowia lipolytica respectively. The margin of error was very low if screening in YP, 
however use of SC media increased error significantly. Data for the SC media screen is based on 
a moving average analysis for the profile. Sensitivity becomes a problem if screening in SC 
media, as promoter engineering could introduce small changes in expression which would not be 
distinguished by this screen. 
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Figure 5.6: Nile Red staining with exogenously supplied fatty acids with BY4741 strain. Cells 
were incubated with the fatty acid for six hours, per manufacturer‟s protocol and then were 
stained with Nile Red for five minutes. Samples were run on a plate reader with at excitation at 
485 nm and emission at 535 nm. No significant differences in fluorescence reading were found 
in comparison to the negative. Continued work with this strain is suggested with strain 
containing in vivo differences in fatty acid concentrations. 
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Figure 5.7: Relative expression or mRNA levels of the bafas gene under different selection 
pressures. mRNA levels of the bafas gene in a highly selective system were extremely high, 
while the bafas gene expression using the HXT5 promoter in the wild-type system had very low 
mRNA levels. It has been shown that mRNA stability and relative levels can affect protein 
expression and overall abundance of proteins expressed by the engineered mRNA (27). 
Increasing the mRNA levels could improve the bafas gene expression and overall improve the 
FAEE production. It is suggested to use mRNA levels as a high-throughput screen to improve 
the bafas gene expression. 
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